Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.


Funktionen

  • Direktor, Klinik für Nuklearmedizin

Aktuelle Veranstaltungen

Vergangene Veranstaltungen (max. 10)

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Unsortiert

  • Lanzafame, Helena; Mavroeidi, Ilektra A.; Pabst, Kim M.; Desaulniers, Mélanie; Ingenwerth, Marc; Hirmas, Nader; Kessler, Lukas; Nader, Michael; Bartel, Timo; Leyser, Stephan; Barbato, Francesco; Schuler, Martin; Bauer, Sebastian; Siveke, Jens; Herrmann, Ken; Hamacher, Rainer; Fendler, Wolfgang
    68Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy
    In: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 6, S. 880 - 887
  • Krafft, Ulrich; Hadaschik, Boris; Lückerath, Katharina; Herrmann, Ken
    A New Chapter in Neoadjuvant Therapy for High-risk Prostate Cancer?
    In: European Urology Jg. 85 (2024) Nr. 3, S. 227 - 228
  • Moraitis, Alexandros; Jentzen, Walter; Reiter, Gloria; Schmitz, Jochen; Pöppel, Thorsten Dirk; Weber, Manuel; Herrmann, Ken; Fendler, Wolfgang Peter; Fragoso Costa, Pedro; Bockisch, Andreas; Kersting, David
    Biodistribution and radiation dosimetry of ¹²⁴I-mIBG in adult patients with neural crest tumours and extrapolation to paediatric models
    In: EJNMMI Physics Jg. 11 (2024) Nr. 1, 3
  • Weber, Manuel; Pettersson, Olof; Seifert, Robert; Schaarschmidt, Benedikt; Fendler, Wolfgang; Rischpler, Christoph; Lahner, Harald; Herrmann, Ken; Sundin, Anders
    Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 51 (2024) Nr. 3, S. 841 - 851
  • Kupusovic, Jana; Kessler, Lukas; Kazek, Sandra; Chodyla, Michal Kamil; Umutlu, Lale; Zarrad, Fadi; Nader, Michael; Fendler, Wolfgang; Varasteh, Zohreh; Herrmann, Ken; Dobrev, Dobromir; Wakili, Reza; Rassaf, Tienush; Siebermair, Johannes; Rischpler, Christoph
    Delayed ⁶⁸Ga-FAPI-46 PET/MR imaging confirms ongoing fibroblast activation in patients after acute myocardial infarction
    In: International Journal of Cardiology (IJC) Heart & Vasculature Jg. 50 (2024) 101340
  • Sartor, Oliver; Fizazi, Karim; Herrmann, Ken; Morris, Michael J.
    Design Considerations in the PSMAfore Trial
    In: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 2, S. 226 - 227
  • Hirmas, Nader; Hamacher, Rainer; Sraieb, Miriam; Kessler, Lukas; Pabst, Kim M.; Barbato, Francesco; Lanzafame, Helena; Kasper, Stefan; Nader, Michael; Kesch, Claudia; von Tresckow, Bastian; Hautzel, Hubertus; Aigner, Clemens; Glas, Martin; Stuschke, Martin; Kümmel, Sherko; Harter, Philipp; Lugnier, Celine; Uhl, Waldemar; Hadaschik, Boris; Grünwald, Viktor; Siveke, Jens; Herrmann, Ken; Fendler, Wolfgang
    Diagnostic Accuracy of ⁶⁸Ga-FAPI Versus ¹⁸F-FDG PET in Patients with Various Malignancies
    In: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 3, S. 372 - 378
  • Stokke, Caroline; Gnesin, Silvano; Tran-Gia, Johannes; Cicone, Francesco; Holm, Søren; Cremonesi, Marta; Blakkisrud, Johan; Wendler, Thomas; Gillings, Nic; Herrmann, Ken; Mottaghy, Felix M.; Gear, Jonathan
    EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials
    In: European Journal of Nuclear Medicine and Molecular Imaging (2024) in press
  • Schuler, Martin; Hense, Jörg; Darwiche, Kaid; Michels, Sebastian; Hautzel, Hubertus; Kobe, Carsten; Lueong, Smiths; Metzenmacher, Martin; Herold, Thomas; Zaun, Gregor; Laue, Katharina; Drzezga, Alexander; Theegarten, Dirk; Nensa, Felix; Wolf, Jürgen; Herrmann, Ken; Wiesweg, Marcel
    Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in EGFR-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance
    In: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 6, S. 851 - 855
  • Oprea-Lager, Daniela-Elena; MacLennan, Steven; Bjartell, Anders; Briganti, Alberto; Burger, Irene A.; de Jong, Igle; De Santis, Maria; Eberlein, Uta; Emmett, Louise; Fizazi, Karim; Gillessen, Silke; Herrmann, Ken; Heskamp, Sandra; Iagaru, Andrei; Jereczek-Fossa, Barbara Alicja; Kunikowska, Jolanta; Lam, Marnix; Nanni, Cristina; O'Sullivan, Joe M.; Panebianco, Valeria; Sala, Evis; Sathekge, Mike; Sosnowski, Roman; Tilki, Derya; Tombal, Bertrand; Treglia, Giorgio; Tunariu, Nina; Walz, Jochen; Yakar, Derya; Dierckx, Rudi; Sartor, Oliver; Fanti, Stefano
    European Association of Nuclear Medicine Focus 5 : Consensus on Molecular Imaging and Theranostics in Prostate Cancer
    In: European Urology Jg. 85 (2024) Nr. 1, S. 49 - 60
  • Hamacher, Rainer; Pabst, Kim M.; Cheung, Phyllis F.; Heilig, Christoph E.; Hüllein, Jennifer; Liffers, Sven-Thorsten; Borchert, Sabrina; Costa, Pedro Fragoso; Schaarschmidt, Benedikt; Kessler, Lukas; Miera, Monika A.; Droste, Margret; Akbulut, Merve; Falkenhorst, Johanna; Zarrad, Fadi; Kostbade, Karina; Mavroeidi, Ilektra A.; Glimm, Hanno; Umutlu, Lale; Schuler, Martin; Hübschmann, Daniel; Bauer, Sebastian; Fröhling, Stefan; Herrmann, Ken; Siveke, Jens; Schildhaus, Hans-Ulrich; Fendler, Wolfgang
    Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous Tumor
    In: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 2, S. 252 - 257
  • Webendoerfer, Maximilian; Konik, Margarethe; Zettler, Markus; Wienker, Johannes; Rawitzer, Josefine; Esser, Stefan; Kehrmann, Jan; Herrmann, Ken; Reinhardt, Hans Christian; Witzke, Oliver; Dolff, Sebastian
    Hypercalcemia as a rare manifestation of immune reconstitution inflammatory syndrome (IRIS) in a person living with Human Immunodeficiency Virus (HIV) with disseminated nontuberculous mycobacteriosis
    In: Infection - A Journal of Infectious Disease (2024) in press
  • Telli, Tugce; Hosseini, Atefeh; Settelmeier, Stephan; Kersting, David; Kessler, Lukas; Weber, Wolfgang A.; Rassaf, Tienush; Herrmann, Ken; Varasteh, Zohreh
    Imaging of Cardiac Fibrosis : How Far Have We Moved From Extracellular to Cellular?
    In: Seminars in Nuclear Medicine (2024) in press
  • Grünwald, Viktor; Hadaschik, Boris; Klümper, Niklas; Herrmann, Ken
    Kick-Starting Molecular Theranostics in Renal Cell Carcinoma
    In: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 5, S. 744 - 745
  • Guberina, Maja; Pöttgen, Christoph; Guberina, Nika; Hoffmann, Christian; Wiesweg, Marcel; Richlitzki, Cedric; Metzenmacher, Martin; Aigner, Clemens; Bölükbas, Servet; Gauler, Thomas; Eberhardt, Wilfried; Forsting, Michael; Herrmann, Ken; Theegarten, Dirk; Darwiche, Kaid; Jendrossek, Verena; Stuschke, Martin; Schuler, Martin
    Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment : Comparison with Stage III Disease
    In: Cancers Jg. 16 (2024) Nr. 6, 1174
  • Voltin, Conrad-Amadeus; Paccagnella, Andrea; Winkelmann, Michael; Heger, Jan-Michel; Casadei, Beatrice; Beckmann, Laura; Herrmann, Ken; Dekorsy, Franziska J.; Kutsch, Nadine; Borchmann, Peter; Fanti, Stefano; Kunz, Wolfgang G.; Subklewe, Marion; Kobe, Carsten; Zinzani, Pier Luigi; Stelljes, Matthias; Roth, Katrin S.; Drzezga, Alexander; Noppeney, Richard; Rahbar, Kambiz; Reinhardt, H. Christian; von Tresckow, Bastian; Seifert, Robert; Albring, Jörn C.; Blumenberg, Viktoria; Farolfi, Andrea; Flossdorf, Sarah; Gödel, Philipp; Hanoun, Christine
    Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 51 (2024) Nr. 5, S. 1361 - 1370
  • Püllen, Lukas; Costa, Pedro F.; Darr, Christopher; Heß, Jochen A.; Kesch, Claudia; Rehme, Christian R.; Wahl, Milan; Yirga, Leubet; Reis, Henning; Szarvas, Tibor; van Leeuwen, Fijs W. B.; Herrmann, Ken; Hadaschik, Boris; Tschirdewahn, Stephan; Krafft, Ulrich
    Near-infrared fluorescence lymph node template region dissection plus backup lymphadenectomy in open radical cystectomy for bladder cancer using an innovative handheld device : A single center experience
    In: Journal of Surgical Oncology (2024) in press
  • Jannusch, Kai; Dietzel, Frederic; Bruckmann, Nils Martin; Morawitz, Janna; Boschheidgen, Matthias; Minko, Peter; Bittner, Ann-Kathrin; Mohrmann, Svjetlana; Quick, Harald H.; Herrmann, Ken; Umutlu, Lale; Antoch, Gerald; Rubbert, Christian; Kirchner, Julian; Caspers, Julian
    Prediction of therapy response of breast cancer patients with machine learning based on clinical data and imaging data derived from breast [¹⁸F]FDG-PET/MRI
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 51 (2024) Nr. 5, S. 1451 - 1461
  • Weber, Manuel; Fendler, Wolfgang P.; Ravi Kumar, Aravind S.; Calais, Jeremie; Czernin, Johannes; Ilhan, Harun; Saad, Fred; Kretschmer, Alexander; Hekimsoy, Turkay; Brookman-May, Sabine D.; Mundle, Suneel D.; Small, Eric J.; Smith, Matthew R.; Perez, Paola M.; Hope, Thomas A.; Herrmann, Ken; Hofman, Michael S.; Eiber, Matthias; Hadaschik, Boris A.
    Prostate-specific Membrane Antigen Positron Emission Tomography–detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer : An International Multicenter Retrospective Study
    In: European Urology (2024) in press
  • Gafita, Andrei; Djaileb, Loic; Rauscher, Isabel; Fendler, Wolfgang; Hadaschik, Boris; Rowe, Steven P.; Herrmann, Ken; Solnes, Lilja B.; Calais, Jeremie; Rettig, Matthew B.; Weber, Manuel; Farolfi, Andrea; Benz, Matthias R.; Eiber, Matthias
    RECIP 1.0 Predicts Progression-Free Survival After [¹⁷⁷Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer
    In: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 6, S. 917 - 922
  • Al-Ibraheem, Akram; Zimmermann, Richard; Abdlkadir, Ahmed S.; Herrmann, Ken
    Radiotheranostics Global Market and Future Developments
    In: Seminars in Nuclear Medicine (2024) in press
  • Herrmann, Ken; Rahbar, Kambiz; Eiber, Matthias; Sparks, Richard; Baca, Nicholas; Krause, Bernd J.; Lassmann, Michael; Jentzen, Walter; Tang, Jun; Chicco, Daniela; Klein, Patrick; Blumenstein, Lars; Basque, Jean-René; Kurth, Jens
    Renal and Multiorgan Safety of ¹⁷⁷Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
    In: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 1, S. 71 - 78
  • Vardarli, Irfan; Tan, Susanne; Brandenburg, Tim; Weidemann, Frank; Görges, Rainer; Herrmann, Ken; Führer, Dagmar
    Risk and Incidence of Endocrine Immune-Related Adverse Effects under Checkpoint Inhibitor Mono- or Combination Therapy in Solid Tumors : A Meta-Analysis of Randomized Controlled Trials
    In: The Journal of Clinical Endocrinology & Metabolism (JCEM) Jg. 109 (2024) Nr. 4, S. 1132 - 1144
  • Chi, Kim N.; Armstrong, Andrew J.; Krause, Bernd J.; Herrmann, Ken; Rahbar, Kambiz; de Bono, Johann S.; Adra, Nabil; Garje, Rohan; Michalski, Jeff M.; Kempel, Mette M.; Fizazi, Karim; Morris, Michael J.; Sartor, Oliver; Brackman, Marcia; DeSilvio, Michelle; Wilke, Celine; Holder, Geoffrey; Tagawa, Scott T.
    Safety Analyses of the Phase 3 VISION Trial of [¹⁷⁷Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer
    In: European Urology (2024) in press
  • Seifert, Robert; Telli, Tugce; Lapa, Constantin; Desaulniers, Mélanie; Hekimsoy, Turkay; Weber, Wolfgang A.; Pfob, Christian; Hadaschik, Boris; Bögemann, Martin; Schäfers, Michael; Herrmann, Ken; Rahbar, Kambiz; Eiber, Matthias; Fendler, Wolfgang
    Safety and Efficacy of Extended Therapy with [¹⁷⁷Lu]Lu-PSMA: A German Multicenter Study
    In: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 6, S. 909 - 916
  • Moraitis, Alexandros; Jentzen, Walter; Fragoso Costa, Pedro; Kersting, David; Himmen, Stephan; Coelho, Marta; Meckel, Marian; van Echteld, Cees J A; Fendler, Wolfgang; Herrmann, Ken; Sraieb, Miriam
    Safety and Efficacy of Para-Aminohippurate Coinfusion for Renal Protection During Peptide Receptor Radiotherapy in Patients with Neuroendocrine Tumors
    In: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 6, S. 931 - 937
  • Jakstaite, Aiste Monika; Vogel, Julia Kirsten; Lüdike, Peter; Janosi, Rolf Alexander; Carpinteiro, Alexander; Rischpler, Christoph; Herrmann, Ken; Rassaf, Tienush; Papathanasiou, Maria
    Screening for Occult Transthyretin Amyloidosis in Patients with Severe Aortic Stenosis and Amyloid Red Flags
    In: Journal of Clinical Medicine (JCM) Jg. 13 (2024) Nr. 3, 671
  • Hyseni, Arberit; Viehof, Jan; Hockmann, Jan; Metzenmacher, Martin; Eberhardt, Wilfried; Herrmann, Ken; Hautzel, Hubertus; Aigner, Clemens; Plönes, Till
    The Incidence of Distant Metastases in Patients with Pleural Mesothelioma Screened for a Multimodal Approach : How Much Staging Do We Really Need?
    In: Cancers Jg. 16 (2024) Nr. 10, 1917
  • Seifert, Robert; Eiber, Matthias; Herrmann, Ken; Hadaschik, Boris; Fendler, Wolfgang
    The novel PROMISE framework for PSMA-PET reporting : Ready for the clinical routine?
    In: Clinical and Translational Imaging Jg. 12 (2024) Nr. 1, S. 1 - 3
  • Tolboom, Nelleke; Verger, Antoine; Albert, Nathalie L.; Fraioli, Francesco; Guedj, Eric; Traub-Weidinger, Tatjana; Morbelli, Silvia; Herrmann, Ken; Zucchetta, Pietro; Plasschaert, Sabine L A; Yakushev, Igor; Weller, Michael; Glas, Martin; Preusser, Matthias; Cecchin, Diego; Barthel, Henryk; Van Weehaeghe, Donatienne
    Theranostics in Neurooncology : Heading Toward New Horizons
    In: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 2, S. 167 - 173
  • Costa, Pedro Fragoso; Püllen, Lukas; Kesch, Claudia; Krafft, Ulrich; Tschirdewahn, Stephan; Moraitis, Alexandros; Radtke, Jan Philipp; Ting, Saskia; Nader, Michael; Wosniack, Jasmin; Kersting, David; Lückerath, Katharina; Herrmann, Ken; Fendler, Wolfgang; Hadaschik, Boris; Darr, Christopher
    18F-PSMA Cerenkov Luminescence and Flexible Autoradiography Imaging in a Prostate Cancer Mouse Model and First Results of a Radical Prostatectomy Feasibility Study in Men
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 4, S. 598 - 604
  • Mei, Riccardo; Kessler, Lukas; Pabst, Kim M.; Weber, Manuel; Schmidkonz, Christian; Rischpler, Christoph; Zacho, Helle Damgaard; Hope, Thomas; Schwarzenböck, Sarah M.; Allen-Auerbach, Martin; Emmett, Louise; Ferdinandus, Justin; Unterrainer, Marcus; Schaarschmidt, Benedikt M.; Umutlu, Lale; Farolfi, Andrea; Castellucci, Paolo; Nanni, Cristina; Telo, Silvi; Fanti, Stefano; Herrmann, Ken; Fendler, Wolfgang
    68Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment : An International Multicenter Prospective Study
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 7, S. 1043 - 1048
  • Lanzafame, Helena; Hamacher, Rainer; Mavroeidi, Ilektra-Antonia; Pabst, Kim; Hirmas, Nader; Kessler, Lukas; Bartel, Timo; Leyser, Stephan; Barbato, Francesco; Schuler, Martin; Bauer, Sebastian; Siveke, Jens; Herrmann, Ken; Fendler, Wolfgang;
    68Ga-FAPI PET/CT novel diagnostic tool in sarcoma
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S415
  • Bartel, Timo; Fendler, Wolfgang; Pabst, Kim; Hirmas, Nader; Umutlu, Lale; Grafe, Hong; Praus, Christine; Nader, Michael; Podleska, Lars; Barbato, Francesco; Siveke, Jens; Herrmann, Ken; Grünwald, Viktor; Hamacher, Rainer
    68Ga-FAPI-46 PET for imaging of FAP expressing cancer - interim findings from a single-center prospective interventional single-arm clinical trial
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P706
  • Kessler, Lukas; Hirmas, Nader; Pabst, Kim M.; Hamacher, Rainer; Ferdinandus, Justin; Schaarschmidt, Benedikt M.; Milosevic, Aleksandar; Nader, Michael; Umutlu, Lale; Uhl, Waldemar; Reinacher-Schick, Anke; Lugnier, Celine; Witte, David; Niedergethmann, Marco; Herrmann, Ken; Fendler, Wolfgang P.; Siveke, Jens T.
    68Ga-Labeled Fibroblast Activation Protein Inhibitor (⁶⁸Ga-FAPI) PET for Pancreatic Adenocarcinoma : Data from the ⁶⁸Ga-FAPI PET Observational Trial
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 12, S. 1910 - 1917
  • Kersting, David; Lazaridis, Lazaros; Barbato, Francesco; Kebir, Sied; Kümmel, Sherko; Welt, Anja; Umutlu, Lale; Milosevic, Aleksandar; Nader, Michael; Costa, Pedro Fragoso; Schmidt, T.; Oster, Christoph; Deuschl, Cornelius; Sure, Ulrich; Stuschke, Martin; Kleinschnitz, Christoph; Scheffler, Björn; Hautzel, Hubertus; Schuler, Martin; Glas, Martin; Fendler, Wolfgang; Herrmann, Ken;
    68Ga-NeoB PET for Glioma and Breast Cancer : First Results from a Prospective Observational Trial
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S265
  • Kersting, David; Sandach, Patrick; Sraieb, Miriam; Wiesweg, Marcel; Metzenmacher, Martin; Darwiche, Kaid; Oezkan, Filiz; Bölükbas, Servet; Stuschke, Martin; Umutlu, Lale; Nader, Michael; Hamacher, Rainer; Fendler, Wolfgang; Wienker, Johannes; Eberhardt, Wilfried; Schuler, Martin; Herrmann, Ken; Hautzel, Hubertus
    68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients : A Single-Center Retrospective Study
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 10, S. 1540 - 1549
  • Kersting, David; Sandach, Patrick; Sraieb, Miriam; Wiesweg, Marcel; Metzenmacher, Martin; Darwiche, Kaid; Özkan, Filiz; Bölükbas, Servet; Stuschke, Martin; Umutlu, Lale; Nader, Michael; Hamacher, Rainer; Fendler, Wolfgang; Wienker, Johannes; Eberhardt, Wilfried; Schuler, Martin; Herrmann, Ken; Hautzel, H.
    68Ga-SSO-120 versus 18F-FDG PET in the Initial Staging of Small-Cell Lung Cancer Patients
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. Suppl. 1, Annual Congress of the European Association of Nuclear Medicine September 9–13, 2023 Vienna, Austria, S. 488 - S489
  • Kersting, David; Sandach, Patrick; Sraieb, Miriam; Wiesweg, Marcel; Metzenmacher, Martin; Darwiche, Kaid; Oezkan, Filiz; Bolukbas, Servet; Stuschke, Martin; Umutlu, Lale; Nader, Michael; Fendler, Wolfgang; Wienker, Johannes; Eberhardt, Wilfried; Schuler, Martin; Herrmann, Ken; Hautzel, Hubertus
    68Ga-Satoreotide PET for Staging of Small-Cell Lung Cancer Patients
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P165
  • Serani, Francesca; Fendler, Wolfgang; Castellucci, Paolo; Berliner, Christoph; Barbato, Francesco; Herrmann, Ken; Farolfi, Andrea; Fanti, Stefano
    A Retrospective Multicenter Analysis of the Incidence of Bone-Only Disease at PSMA PET/CT in Castration Resistant Prostate Cancer Patients
    In: Cancers Jg. 15 (2023) Nr. 8, 2208
  • Serani, Francesca; Castellucci, Paolo; Fendler, Wolfgang; Barbato, Francesco; Herrmann, Ken; Farolfi, Andrea;
    A retrospective multicenter analysis of the incidence of bone only disease at PSMA PET/CT in Castration Resistant Prostate Cancer (CRPC) patients
    55th Annual Conference of the Society-of-Nuclear-Medicine (SNMICON); NOV 16-19, 2023; Jodhpur, India,
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P299
  • Hockmann, Jan; Hautzel, Hubertus; Darwiche, Kaid; Eberhardt, Wilfried; Stuschke, Martin; Aigner, Clemens; Herrmann, Ken; Plönes, Till
    Accuracy of nodal staging by 18F-FDG-PET/CT in limited disease small-cell lung cancer
    In: Asian Cardiovascular and Thoracic Annals Jg. 31 (2023) Nr. 6, S. 506 - 511
  • Hautzel, Hubertus; Özkan, Filiz; Laschinsky, Christina; Kersting, David; Opitz, Marcel; Theegarten, Dirk; Darwiche, Kaid; Herrmann, Ken;
    Added diagnostic sensitivity of MTV and TLG in the assessment of left adrenal gland metastasis in lung cancer with [18F]FDG PET/CT
    Annual Congress of the European Association of Nuclear Medicine, 19-13 September 2023, Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S485
  • Simeone, Diane M.; Herrmann, Ken; Czernin, Johannes
    Advancing Clinical Trial Innovation in Pancreatic Cancer : A Conversation Between Diane Simeone, Ken Herrmann, and Johannes Czernin
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 2, S. 185 - 187
  • Pouget, Jean-Pierre; Konijnenberg, Mark; Eberlein, Uta; Glatting, Gerhard; Gabina, Pablo Minguez; Herrmann, Ken; Holm, Søren; Strigari, Lidia; van Leeuwen, Fijs W B; Lassmann, Michael
    An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 2, S. 242 - 246
  • Handke, A.; Kesch, Claudia; Fendler, Wolfgang; Telli, Tugce; Liu, Y.; Hakansson, A.; Davicioni, E.; Hughes, J.; Song, H.; Lückerath, Katharina; Herrmann, Ken; Hadaschik, Boris; Seifert, Robert;
    Analysing the Tumour Transcriptome of Prostate Cancer to Predict Efficacy of Lu-PSMA Therapy
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S180
  • Handke, Analena; Kesch, Claudia; Fendler, Wolfgang; Telli, Tugce; Liu, Yang; Hakansson, Alexander; Davicioni, Elai; Hughes, Jason; Song, Hong; Lückerath, Katharina; Herrmann, Ken; Hadaschik, Boris; Seifert, Robert
    Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy
    In: Journal for ImmunoTherapy of Cancer Jg. 11 (2023) Nr. 10, e007354
  • Delgado Bolton, Roberto C.; Calapaquí Terán, Adriana K.; Herrmann, Ken; Fanti, Stefano; Giammarile, Francesco
    Are We Approaching a Change in Paradigm in PET/CT Imaging of Solid Gastrointestinal (or Digestive) Tract Tumors with the Clinical Application of FAPI Imaging?
    In: Clinical Nuclear Medicine Jg. 48 (2023) Nr. 4, S. 318 - 319
  • Gafita, A.; Djaileb, L.; Rauscher, I.; Hadaschik, Boris; Herrmann, Ken; Weber, Manuel;
    Assessment of Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-Resistant Prostate Cancer
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S544 - S545
  • Kuo, P.H.; Morris, M.; Kendi, A.T.; Herrmann, Ken;
    Association of baseline quantitative [68Ga]Ga-PSMA-11 PET imaging parameters with clinical outcomes in patients with mCRPC receiving [177Lu]Lu-PSMA-617 : a VISION sub-study
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S155
  • Morris, M.J.; Armstrong, A.J.; Chi, K.N.N.; de Bono, J.S.; Herrmann, Ken; Krause, B.; Rahbar, K.; Sartor, O.; Tagawa, S.T.; Nagarajah, J.; Wei, X.X.; Nordquist, L.T.; Koshkin, V.S.; Saad, F.; Vickers, A.; Ghouse, R.; Wu, J.; Mirante, O.; Fizazi, K.;
    Association of health-related quality of life with efficacy outcomes in the VISION study of patients with metastatic castration-resistant prostate cancer
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology Jg. 34 (2023) Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S979 - S980
  • Jeschke, Matthias; Ludwig, Johannes M.; Leyh, Catherine; Pabst, Kim M.; Weber, Manuel; Theysohn, Jens; Lange, Christian; Herrmann, Ken; Schmidt, Hartmut; Jochheim, Leonie S.
    Bilobar Radioembolization Carries the Risk of Radioembolization-Induced Liver Disease in the Treatment of Advanced Hepatocellular Carcinoma : Safety and Efficacy Comparison to Systemic Therapy with Atezolizumab/Bevacizumab
    In: Cancers Jg. 15 (2023) Nr. 17, 4274
  • Mathew, Annie; Fendler, Wolfgang; Theysohn, Jens; Herrmann, Ken; Führer, Dagmar; Lahner, Harald
    Bone Metastases in Patients with Pancreatic NETs : Prevalence and Prognosis
    In: Hormone and Metabolic Research Jg. 28 (2023) Nr. 4,
  • Morawitz, Janna; Sigl, Benjamin; Rubbert, Christian; Bruckmann, Nils-Martin; Dietzel, Frederic; Häberle, Lena J.; Ting, Saskia; Mohrmann, Svjetlana; Ruckhäberle, Eugen; Bittner, Ann-Kathrin; Hoffmann, Oliver; Baltzer, Pascal; Kapetas, Panagiotis; Helbich, Thomas; Clauser, Paola; Fendler, Wolfgang; Rischpler, Christoph; Herrmann, Ken; Schaarschmidt, Benedikt M.; Stang, Andreas; Umutlu, Lale; Antoch, Gerald; Caspers, Julian; Kirchner, Julian
    Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on ¹⁸F-FDG PET/MRI and Machine Learning
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 2, S. 304 - 311
  • Feuerecker, Benedikt; Kratochwil, Clemens; Ahmadzadehfar, Hojjat; Morgenstern, Alfred; Eiber, Matthias; Herrmann, Ken; Pomykala, Kelsey L.
    Clinical Translation of Targeted α-Therapy: An Evolution or a Revolution?
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 5, S. 685 - 692
  • Morawitz, Janna; Bruckmann, Nils-Martin; Jannusch, Kai; Dietzel, Frederic; Milosevic, Aleksandar; Bittner, Ann-Kathrin; Hoffmann, Oliver; Mohrmann, Svjetlana; Ruckhäberle, Eugen; Häberle, Lena; Fendler, Wolfgang; Herrmann, Ken; Giesel, Frederik Lars; Antoch, Gerald; Umutlu, Lale; Kowall, Bernd; Stang, Andreas; Kirchner, Julian
    Conventional Imaging, MRI and ¹⁸F-FDG PET/MRI for N and M Staging in Patients with Newly Diagnosed Breast Cancer
    In: Cancers Jg. 15 (2023) Nr. 14, 3646
  • Thimm, Andreas; Carpinteiro, Alexander; Oubari, Sara; Papathanasiou, Maria; Kessler, Lukas; Rischpler, Christoph; Malik, Rayaz Ahmed; Herrmann, Ken; Reinhardt, Hans Christian; Rassaf, Tienush; Kleinschnitz, Christoph; Hagenacker, Tim; Stettner, Mark
    Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosis
    In: Journal of Neurology Jg. 270 (2023) Nr. 7, S. 3483 - 3491
  • Gear, Jonathan; Stokke, Caroline; Terwinghe, Christelle; Gnesin, Silvano; Sandström, Mattias; Tran‑Gia, Johannes; Cremonesi, Marta; Cicone, Francesco; Verburg, Fredrik; Hustinx, Roland; Giovanella, Luca; Herrmann, Ken; Gabiña, Pablo Minguez
    Correction to: EANM enabling guide: how to improve the accessibility of clinical dosimetry
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 10, S. 3157 - 3158
  • Dierckx, Rudi; Herrmann, Ken; Hustinx, Roland; Lassmann, Michael; Wadsak, Wolfgang; Kunikowska, Jolanta
    Correction to: European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 2, S. 630 - 630
  • Totzeck, Matthias; Aide, Nicolas; Bauersachs, Johann; Bucerius, Jan; Georgoulias, Panagiotis; Herrmann, Ken; Hyafil, Fabien; Kunikowska, Jolanta; Lubberink, Mark; Nappi, Carmela; Rassaf, Tienush; Saraste, Antti; Sciagra, Roberto; Slart, Riemer H.J.A.; Verberne, Hein; Rischpler, Christoph
    Correction to: Nuclear medicine in the assessment and prevention of cancer therapy‑related cardiotoxicity : prospects and proposal of use by the European Association of Nuclear Medicine (EANM) (European Journal of Nuclear Medicine and Molecular Imaging, (2023), 50, 3, (792-812), 10.1007/s00259-022-05991-7)
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 3, S. 970
  • Pacelli, Anna; Zarrad, Fadi; Warnier, Corentin; Gendron, Thibault; Otabashi, Muhammad; Vriamont, Charles; Jackson, Alex; Fendler, Wolfgang; Herrmann, Ken; Nader, Michael
    Correction: Fully Automated, High-Dose Radiosynthesis of [18F]PARPi
    In: Pharmaceuticals Jg. 16 (2023) Nr. 7, 1024
  • Jannusch, Kai; Bittner, Ann-Kathrin; Bruckmann, Nils Martin; Morawitz, Janna; Stieglitz, Cleo; Dietzel, Frederic; Quick, Harald H.; Baba, Hideo Andreas; Herrmann, Ken; Umutlu, Lale; Antoch, Gerald; Kirchner, Julian; Kasimir-Bauer, Sabine; Hoffmann, Oliver
    Correlation between Imaging Markers Derived from PET/MRI and Invasive Acquired Biomarkers in Newly Diagnosed Breast Cancer
    In: Cancers Jg. 15 (2023) Nr. 6, 1651
  • Afshar-Oromieh, Ali; Eiber, Matthias; Fendler, Wolfgang; Schmidt, Matthias; Rahbar, Kambiz; Ahmadzadehfar, Hojjat; Umutlu, Lale; Hadaschik, Boris; Hakenberg, Oliver W.; Fornara, Paolo; Kurth, Jens; Neels, O.; Wester, Hans-Jürgen; Schwaiger, Markus; Kopka, Klaus; Haberkorn, Uwe; Herrmann, Ken; Krause, Bernd J.
    DGN-Handlungsempfehlung (S1-Leitlinie) : PSMA-Liganden-PET/CT in der Diagnostik des Prostatakarzinoms - Stand: 01/2022 - AWMF-Registernummer: 031-055
    In: Nuklearmedizin = Nuclear Medicine Jg. 62 (2023) Nr. 1, S. 5 - 19
  • Slama, Alexis; Schaarschmidt, Benedikt M.; Okumus, Özlem; Herrmann, Ken; Aigner, Clemens; Collaud, Stephane; Hautzel, Hubertus
    DOTATOC PET/CT imaging of a typical carcinoid tumor in a human ex-vivo perfused lung lobe
    In: Quantitative Imaging in Medicine and Surgery Jg. 13 (2023) Nr. 7, S. 4716 - 4722
  • Nanni, Cristina; Kobe, Carsten; Herrmann, Ken; Kunikowska, Jolanta
    Defining the role of nuclear medicine in haematological tumours—EANM Focus 4 : consensus on molecular imaging and therapy in haematological tumours
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 10, S. 2925 - 2926
  • Berrens, Anne-Claire; Scheltema, Matthijs; Maurer, Tobias; Herrmann, Ken; Hamdy, Freddie C.; Knipper, Sophie; Dell’Oglio, Paolo; Mazzone, Elio; de Barros, Hilda A.; Sorger, Jonathan M.; van Oosterom, Matthias N.; Stricker, Philip D.; van Leeuwen, Pim J.; Rietbergen, Daphne D. D.; Valdes Olmos, Renato A.; Vidal-Sicart, Sergi; Carroll, Peter R.; Buckle, Tessa; van der Poel, Henk G.; van Leeuwen, Fijs W. B.
    Delphi consensus project on prostate-specific membrane antigen (PSMA)-targeted surgery : Outcomes from an international multidisciplinary panel
    In: European Journal of Nuclear Medicine and Molecular Imaging (2023) in press
  • Settelmeier, Stephan; Varasteh, Zohreh; Staniszewska, Magdalena; Beerlage, Anna-Lena; Zarrad, Fadi; Fendler, Wolfgang; Rischpler, Christoph; Notni, Johannes; Totzeck, Matthias; Herrmann, Ken; Rassaf, Tienush; Hendgen-Cotta, Ulrike B.
    Demonstration of the Early Cardiac Bioavailability of a Non-Specific Cell-Targeted Peptide Using Radionuclide-Based Imaging In Vivo
    In: Pharmaceuticals Jg. 16 (2023) Nr. 6, 824
  • Pasquier, David; Bidaut, Luc; Oprea-Lager, Daniela Elena; deSouza, Nandita M; Krug, David; Collette, Laurence; Kunz, Wolfgang; Belkacemi, Yazid; Bau, Maria Grazia; Caramella, Caroline; De Geus-Oei, Lioe-Fee; De Caluwé, Alex; Deroose, Christophe; Gheysens, Olivier; Herrmann, Ken; Kindts, Isabelle; Kontos, Michalis; Kümmel, Sherko; Linderholm, Barbro; Lopci, Egesta; Meattini, Icro; Smeets, Ann; Kaidar-Person, Orit; Poortmans, Philip; Tsoutsou, Pelagia; Hajjaji, Nawale; Russell, Nicola; Senkus, Elżbieta; Talbot, Jean-Noël; Umutlu, Lale; Vandecaveye, Vincent; Verhoeff, Joost J C; van Oordt, Willemien Menke-van der Houven; Zacho, Helle D; Cardoso, Fatima; Fournier, Laure; Van Duijnhoven, Frederieke; Lecouvet, Frédéric E
    Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer : a consensus recommendation from the EORTC Imaging and Breast Cancer Groups
    In: The Lancet Oncology Jg. 24 (2023) Nr. 8, S. e331 - e343
  • Gudenkauf, Lisa M.; Chavez, Melody N.; Maconi, Melinda Leigh; Geiss, Carley; Seyedroudbari, Ameen; Thin, Pan; Hoogland, Aasha I.; Nguyen, Kathleen; Murthy, Vishnu; Armstrong, Wesley R.; Komrokji, Khaled; Oswald, Laura B.; Jim, Heather S.L.; El-Haddad, Ghassan; Fendler, Wolfgang P.; Herrmann, Ken; Cella, David; Czernin, Johannes; Hofman, Michael S.; Dicker, Adam P.; Calais, Jeremie; Tagawa, Scott T.; Gonzalez, Brian D.
    Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 6, S. 869 - 872
  • Lam, Marnix; Garin, Etienne; Palard-Novello, Xavier; Mahvash, Armeen; Kappadath, Cheenu; Haste, Paul; Tann, Mark; Herrmann, Ken; Barbato, Francesco; Geller, Brian; Schaefer, Niklaus; Denys, Alban; Dreher, Matthew; Fowers, Kirk D.; Gates, Vanessa; Salem, Riad
    Direct comparison and reproducibility of two segmentation methods for multicompartment dosimetry : Round robin study on radioembolization treatment planning in hepatocellular carcinoma
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 51 (2023) Nr. 1, S. 245 - 257
  • Gear, Jonathan; Stokke, Caroline; Terwinghe, Christelle; Gnesin, Silvano; Sandström, Mattias; Tran-Gia, Johannes; Cremonesi, Marta; Cicone, Francesco; Verburg, Fredrik; Hustinx, Roland; Giovanella, Luca; Herrmann, Ken; Gabiña, Pablo Minguez
    EANM enabling guide : How to improve the accessibility of clinical dosimetry
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 7, S. 1861 - 1868
  • Tolboom, Nelleke; Verger, Antoine; Albert, Nathalie L.; Brendel, Matthias; Cecchin, Diego; Fernandez, Pablo Aguiar; Fraioli, Francesco; Guedj, Eric; Herrmann, Ken; Traub-Weidinger, Tatjana; Morbelli, Silvia; Yakushev, Igor; Zucchetta, Pietro; Barthel, Henryk; Van Weehaeghe, Donatienne
    EANM position paper: theranostics in brain tumours : The present and the future
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 51 (2023) Nr. 1, S. 202 - 205
  • Dickson, John C.; Armstrong, Ian S.; Gabiña, Pablo Minguez; Denis-Bacelar, Ana M.; Krizsan, Aron K.; Gear, Jonathan M.; Van den Wyngaert, Tim; de Geus-Oei, Lioe-Fee; Herrmann, Ken
    EANM practice guideline for quantitative SPECT-CT
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 4, S. 980 - 995
  • Maric, Ines; Weber, Manuel; Prochnow, Andre; Schmitz, Jochen; Unger, Nicole; Schaarschmidt, Benedikt M.; Poeppel, Thorsten D.; Rischpler, Christoph; Bockisch, Andreas; Herrmann, Ken; Jentzen, Walter; Fendler, Wolfgang
    Efficacy and Safety of¹²⁴I-MIBG Dosimetry-Guided High-Activity¹³¹I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 6, S. 885 - 891
  • Nanni, Cristina; Kobe, Carsten; Baeßler, Bettina; Baues, Christian; Boellaard, Ronald; Borchmann, Peter; Buck, Andreas; Buvat, Irène; Chapuy, Björn; Cheson, Bruce D; Chrzan, Robert; Cottereau, Ann-Segolene; Dührsen, Ulrich; Eikenes, Live; Hutchings, Martin; Jurczak, Wojciech; Kraeber-Bodéré, Françoise; Lopci, Egesta; Luminari, Stefano; MacLennan, Steven; Mikhaeel, N George; Nijland, Marcel; Rodríguez-Otero, Paula; Treglia, Giorgio; Withofs, Nadia; Zamagni, Elena; Zinzani, Pier Luigi; Zijlstra, Josée M; Herrmann, Ken; Kunikowska, Jolanta
    European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations : molecular imaging and therapy in haematological tumours
    In: The Lancet Haematology Jg. 10 (2023) Nr. 5, S. e367 - e381
  • Milosevic, Aleksandar; Styczen, Hanna; Grueneisen, Johannes; Li, Yan; Weber, Manuel; Fendler, Wolfgang; Kirchner, Julian; Damman, Philipp; Wrede, Karsten; Lazaridis, Lazaros; Glas, Martin; Guberina, Maja; Eckstein, Anja; Blau, Tobias; Herrmann, Ken; Umutlu, Lale; Forsting, Michael; Deuschl, Cornelius; Schaarschmidt, Benedikt
    Evaluation of [⁶⁸Ga]-DOTATOC PET/MRI in Patients with Meningioma of the Subcranial and Intraorbital Space
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 8, S. 1185 - 1190
  • Kim, Moon; Seifert, Robert; Fragemann, Jana; Kersting, David; Murray, Jacob; Jonske, Frederic; Pomykala, Kelsey L.; Egger, Jan; Fendler, Wolfgang; Herrmann, Ken; Kleesiek, Jens
    Evaluation of thresholding methods for the quantification of [⁶⁸Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 7, S. 2196 - 2209
  • Schmidt, Teresa; Agkatsev, Sarina; Feldheim, Jonas; Oster, Christoph; Blau, Tobias; Sure, Ulrich; Keyvani, Kathy; Kleinschnitz, Christoph; Stuschke, Martin; Herrmann, Ken; Deuschl, Cornelius; Scheffler, Björn; Kebir, Sied; Glas, Martin; Lazaridis, Lazaros
    Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma
    In: Neuro-Oncology Advances Jg. 5 (2023) Nr. 1, vdad090
  • Oster, Christoph; Blau, Tobias; Keyvani, Kathy; Schmidt, Teresa; Lazaridis, Lazaros; Agkatsev, Sarina; Sure, Ulrich; Kleinschnitz, Christoph; Scheffler, Björn; Barbato, Francesco; Herrmann, Ken; Kebir, Sied; Glas, Martin
    Fet pet sensitivity in primary brain tumors according to cns who 2021 : value and pitfalls in presurgical implementation
    In: Neuro-Oncology Jg. 25 (2023) Nr. Suppl. 5, S. v204 - v205
  • Hamacher, Rainer; Lanzafame, Helena; Mavroeidi, Ilektra A.; Pabst, Kim M.; Kessler, Lukas; Cheung, Phyllis F.; Bauer, Sebastian; Herrmann, Ken; Schildhaus, Hans-Ulrich; Siveke, Jens; Fendler, Wolfgang
    Fibroblast Activation Protein Inhibitor Theranostics : The Case for Use in Sarcoma
    In: PET Clinics Jg. 18 (2023) Nr. 3, S. 361 - 367
  • Hicks, Rodney J.; Giesel, Frederik; Herrmann, Ken
    Fibroblast Activation Protein as a Diagnostic and Therapeutic Target : Where Do We Go from Here?
    In: PET Clinics Jg. 18 (2023) Nr. 3, S. xv - xx
  • Pabst, Kim; Hamacher, Rainer; Schaarschmidt, Benedikt; Kessler, Lukas; Cheung, Phyllis; Liffers, Sven-Thorsten; Miera, Monika; Kostbade, Karina; Lanzafame, Helena; Mavroeidi, Ilektra; Hirmas, Nader; Costa, Pedro Fragoso; Nader, Michael; Bartel, Timo; Schuler, Martin; Bauer, Sebastian; Herrmann, Ken; Siveke, Jens; Schildhaus, Hans-Ulrich; Fendler, Wolfgang
    Fibroblast activation protein alpha (FAPα) directed imaging and radioligand therapy in patients with solitary fibrous tumor (SFT)
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P714
  • Hirmas, Nader; Hamacher, Rainer; Sraieb, Miriam; Ingenwerth, Marc; Kessler, Lukas; Pabst, Kim M.; Barbato, Francesco; Lückerath, Katharina; Kasper, Stefan; Nader, Michael; Schildhaus, Hans-Ulrich; Kesch, Claudia; von Tresckow, Bastian; Hanoun, Christine; Hautzel, Hubertus; Aigner, Clemens; Glas, Martin; Stuschke, Martin; Kümmel, Sherko; Harter, Philipp; Lugnier, Celine; Uhl, Waldemar; Niedergethmann, Marco; Hadaschik, Boris; Grünwald, Viktor; Siveke, Jens; Herrmann, Ken; Fendler, Wolfgang
    Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 5, S. 711 - 716
  • Unterrainer, L.; Hope, T. A.; Ndlovu, H.; Barbato, Francesco; Fendler, Wolfgang; Herrmann, Ken; Sathekge, M.; Czernin, J.; Calais, J.;
    From CHAARTED low- and high-volume disease to PSMA PET imaging volume in mHSPC patients : an international multicenter retrospective study
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S230 - S231
  • Karbhari, Aashna; Mosessian, Sherly; Trivedi, Kamaxi H.; Valla, Frank; Jacobson, Mark; Truty, Mark J.; Patnam, Nandakumar G.; Simeone, Diane M.; Zan, Elcin; Brennan, Tracy; Chen, Hongli; Kuo, Phillip H.; Herrmann, Ken; Goenka, Ajit H.
    Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma : A phase 2, multicenter, single arm, open label non-randomized study protocol
    In: PLoS ONE Jg. 18 (2023) Nr. 11, e0294564
  • Watanabe, Masao; Grafe, Hong; Hirmas, N.; Hamacher, Rainer; Lanzafame, Helena; Pabst, Kim; Nader, Michael; Siveke, Jens; Fendler, Wolfgang; Herrmann, Ken; Weber, Manuel;
    Head-to-head comparison of68Ga-FAPI46 PET/CT,18F-FDG PET/CT, and contrast- enhanced CT in patient with various solid tumors
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. 166 - S167
  • Fizazi, Karim; Herrmann, Ken; Krause, Bernd J; Rahbar, Kambiz; Chi, Kim N; Morris, Michael J; Sartor, Oliver; Tagawa, Scott T; Kendi, Ayse T; Vogelzang, Nicholas; Calais, Jeremie; Nagarajah, James; Wei, Xiao X; Koshkin, Vadim S; Beauregard, Jean-Mathieu; Chang, Brian; Ghouse, Ray; DeSilvio, Michelle; Messmann, Richard A; de Bono, Johann
    Health-related quality of life and pain outcomes with [¹⁷⁷Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION) : a multicentre, open-label, randomised, phase 3 trial
    In: The Lancet Oncology Jg. 24 (2023) Nr. 6, S. 597 - 610
  • Ambrosini, Valentina; Carrilho Vaz, Sofia; Ahmadi Bidakhvidi, Niloefar; Chanchou, Marion; Cysouw, Matthijs C. F.; Serani, Francesca; Voltin, Conrad-Amadeus; Kraeber-Bodere, Francoise; Deroose, Christophe M.; De Geus-Oei, Lioe-Fee; Eiber, Matthias; Gnanasegaran, Gopinath; Gotthardt, Martin; Kobe, Carsten; Konijnenberg, Mark W.; Nanni, Cristina; Oprea Lager, Daniela E.; Rahbar, Kambiz; Taieb, David; Mottaghy, Felix M.; Goffin, Karolien; Herrmann, Ken
    How to attract young talent to nuclear medicine step 1 : a survey conducted by the EANM Oncology and Theranostics Committee to understand the expectations of the next generation
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 51 (2023) Nr. 1, S. 3 - 11
  • Pedro, Costa Fragoso; Darr, Christopher; Moraitis, Alexandros; Kahl, T.; Engel, J.; Al-Nader, Mulham; Henning, Monika; Köllermann, J.; Kesch, Claudia; Krafft, Ulrich; Maurer, T.; Köhler, D.; Klutmann, S.; Falkenbach, F.; Kleesiek, Jens; Fendler, Wolfgang; Herrmann, Ken; Hadaschik, Boris;
    Improving radical prostatectomy with intraoperative ex-vivo PSMA-PET/CT imaging
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S586
  • Domouchtsidou, Aglaia; Beckmann, Ferdinand; Marenbach, Beate; Mueller, Stefan P.; Best, Jan; Herrmann, Ken; Horn, Peter; Barsegian, Vahé; Lindemann, Monika
    In Patients Treated by Selective Internal Radiotherapy, Cellular In Vitro Immune Function Is Predictive of Survival
    In: Cancers Jg. 15 (2023) Nr. 16, 4055
  • Sellmann, Timur; Staak, Felicitas; Maurer, Clemens; Rott, Gernot; Witzke, Oliver; Fendler, Wolfgang; Schildhaus, Hans-Ulrich; Podleska, Lars; Herrmann, Ken; Rischpler, Christoph
    Incidental Detection of a Tenosynovial Giant Cell Tumor of the Thigh on [⁶⁸Ga]Ga-FAPI PET/CT : Presentation of an Unusual Case
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 7, S. 1162 - 1163
  • Farolfi, A.; Armstrong, W.; Djaileb, L.; Fendler, Wolfgang; Hadaschik, Boris; Herrmann, Ken
    Inter-institutional differences and common ground in 177Lu-PSMA radionuclide therapy : International survey in 95 theranostic centers
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. Suppl. 1, S. S92
  • Farolfi, Andrea; Armstrong, Wesley; Djaileb, Loic; Gafita, Andrei; Hotta, Masatoshi; Auerbach, Martin; Fendler, Wolfgang; Rettig, Matthew; Eiber, Matthias; Hofman, Michael; Hadaschik, Boris; Herrmann, Ken; Czernin, Johannes; Calais, Jeremie; Benz, Matthias;
    Inter-institutional differences and common ground in 177Lu-PSMA radionuclide therapy : International survey in 95 theranostic centers
    55th Annual Conference of the Society-of-Nuclear-Medicine (SNMICON); NOV 16-19, 2023; Jodhpur, India,
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P843
  • Veit-Haibach, Patrick; Ahlström, Håkan; Boellaard, Ronald; Delgado Bolton, Roberto C.; Hesse, Swen; Hope, Thomas; Huellner, Martin W.; Iagaru, Andrei; Johnson, Geoffrey B.; Kjaer, Andreas; Law, Ian; Metser, Ur; Quick, Harald H.; Sattler, Bernhard; Umutlu, Lale; Zaharchuk, Greg; Herrmann, Ken
    International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 12, S. 3513 - 3537
  • Darr, Christopher; Costa, Pedro Fragoso; Kahl, Theresa; Moraitis, Alexandros; Engel, Jenna; Al-Nader, Mulham; Reis, Henning; Köllermann, Jens; Kesch, Claudia; Krafft, Ulrich; Maurer, Tobias; Köhler, Daniel; Klutmann, Susanne; Falkenbach, Fabian; Kleesiek, Jens; Fendler, Wolfgang P.; Hadaschik, Boris; Herrmann, Ken
    Intraoperative Molecular Positron Emission Tomography Imaging for Intraoperative Assessment of Radical Prostatectomy Specimens
    In: European Urology Open Science Jg. 54 (2023) S. 28 - 32
  • Darr, C.; Fragoso Costa, P.; Kahl, T.; Alexandros, M.; Fendler, Wolfgang P.; Barbato, F.; Bartel, T.; Reis, H.; Köllermann, J.; Pullen, L.; Kesch, C.; Krafft, Ulrich; Kleesiek, Jens; Herrmann, Ken; Hadaschik, Boris A.;
    Intraoperative microPET/CT imaging for PSMA-positive cancer foci in radical prostatectomy – feasibility study
    38th Annual EAU (European Association of Urology) Congress ; EAU23 ; 10 - 13 March 2023, Milan, Italy,
    In: European Urology Jg. 83 (2023) Nr. Supplement 1, S. S687
  • Seifert, Robert; Telli, Tugce; Hadaschik, Boris; Fendler, Wolfgang; Kuo, Phillip H.; Herrmann, Ken
    Is ¹⁸F-FDG PET Needed to Assess ¹⁷⁷Lu-PSMA Therapy Eligibility? : A VISION-like, Single-Center Analysis
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 5, S. 731 - 737
  • Kratochwil, Clemens; Fendler, Wolfgang P.; Eiber, Matthias; Hofman, Michael S.; Emmett, Louise; Calais, Jeremie; Osborne, Joseph R.; Iravani, Amir; Koo, Phillip; Lindenberg, Liza; Baum, Richard P.; Bozkurt, Murat Fani; Delgado Bolton, Roberto C.; Ezziddin, Samer; Forrer, Flavio; Hicks, Rodney J.; Hope, Thomas A.; Kabasakal, Levent; Konijnenberg, Mark; Kopka, Klaus; Lassmann, Michael; Mottaghy, Felix M.; Oyen, Wim J. G.; Rahbar, Kambiz; Schoder, Heiko; Virgolini, Irene; Bodei, Lisa; Fanti, Stefano; Haberkorn, Uwe; Herrmann, Ken
    Joint EANM/SNMMI procedure guideline for the use of ¹⁷⁷Lu-labeled PSMA-targeted radioligand-therapy (¹⁷⁷Lu-PSMA-RLT)
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 9, S. 2830 - 2845
  • Kersting, David; Jentzen, Walter; Jeromin, Daniel; Mavroeidi, Ilektra-Antonia; Conti, Maurizio; Büther, Florian; Herrmann, Ken; Rischpler, Christoph; Hamacher, Rainer; Fendler, Wolfgang Peter; Seifert, Robert; Fragoso Costa, Pedro
    Lesion Quantification Accuracy of Digital 90Y PET Imaging in the Context of Dosimetry in Systemic FAPI Radionuclide Therapy
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 2, S. 329 - 336
  • Guberina, Nika; Padeberg, Florian; Pöttgen, Christoph; Guberina, Maja; Lazaridis, Lazaros; Jabbarli, Ramazan; Deuschl, Cornelius; Herrmann, Ken; Blau, Tobias; Wrede, Karsten; Keyvani, Kathy; Scheffler, Björn; Hense, Jörg; Layer, Julian P.; Glas, Martin; Sure, Ulrich; Stuschke, Martin
    Location of Recurrences after Trimodality Treatment for Glioblastoma with Respect to the Delivered Radiation Dose Distribution and Its Influence on Prognosis
    In: Cancers Jg. 15 (2023) Nr. 11, 2982
  • Guberina, Maja; Pöttgen, Christoph; Wiesweg, Marcel; Metzenmacher, Martin; Richlitzki, Cedric; Plönes, Till; Guberina, Nika; Forsting, Michael; Herrmann, Ken; Gauler, Thomas; Hoffmann, Christian; Theegarten, Dirk; Darwiche, Kaid; Garcia, Alina Santiago; Stuschke, Martin; Schuler, Martin
    Long-term Survival in Patients with oligometastatic Lung Cancer (cT4 or cN2-3, cM1a-c) after thoracic Chemoradiation, Metastasis-directed and Systemic Therapy compared with the Outcome in locally advanced Lung Cancer (cT4 or cN2-3, cM0)
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 199 (2023) Nr. Suppl. 1, S. S101 - S102
  • Unterrainer, L.M.; Hope, T.; Fendler, Wolfgang; Ndlovu, H.; Barbato, F.; Sathekge, M.; Herrmann, Ken; Czernin, J.; Calais, J.;
    Low- and high-volume disease in mHSPC : From CHAARTED to PSMA PET
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology Jg. 34 (2023) Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S967
  • Gillessen, Silke; Bossi, Alberto; Davis, Ian D.; de Bono, Johann; Fizazi, Karim; James, Nicholas D.; Mottet, Nicolas; Shore, Neal; Small, Eric; Smith, Mathew; Sweeney, Christopher; Tombal, Bertrand; Antonarakis, Emmanuel S.; Aparicio, Ana M.; Armstrong, Andrew J.; Attard, Gerhardt; Beer, Tomasz M.; Beltran, Himisha; Bjartell, Anders; Blanchard, Pierre; Briganti, Alberto; Bristow, Rob G.; Bulbul, Muhammad; Caffo, Orazio; Castellano, Daniel; Castro, Elena; Cheng, Heather H.; Chi, Kim N.; Chowdhury, Simon; Clarke, Caroline S.; Clarke, Noel; Daugaard, Gedske; De Santis, Maria; Duran, Ignacio; Eeles, Ros; Efstathiou, Eleni; Efstathiou, Jason; Ngozi Ekeke, Onyeanunam; Evans, Christopher P.; Fanti, Stefano; Feng, Felix Y.; Fonteyne, Valerie; Fossati, Nicola; Frydenberg, Mark; George, Daniel; Gleave, Martin; Gravis, Gwenaelle; Halabi, Susan; Heinrich, Daniel; Herrmann, Ken; Higano, Celestia; Hofman, Michael S.; Horvath, Lisa G.; Hussain, Maha; Jereczek-Fossa, Barbara Alicja; Jones, Robert; Kanesvaran, Ravindran; Kellokumpu-Lehtinen, Pirkko-Liisa; Khauli, Raja B.; Klotz, Laurence; Kramer, Gero; Leibowitz, Raya; Logothetis, Christopher J.; Mahal, Brandon A.; Maluf, Fernando; Mateo, Joaquin; Matheson, David; Mehra, Niven; Merseburger, Axel; Morgans, Alicia K.; Morris, Michael J.; Mrabti, Hind; Mukherji, Deborah; Murphy, Declan G.; Murthy, Vedang; Nguyen, Paul L.; Oh, William K.; Ost, Piet; O'Sullivan, Joe M.; Padhani, Anwar R.; Pezaro, Carmel; Poon, Darren M.C.; Pritchard, Colin C.; Rabah, Danny M.; Rathkopf, Dana; Reiter, Robert E.; Rubin, Mark. A.; Ryan, Charles J.; Saad, Fred; Pablo Sade, Juan; Sartor, Oliver A.; Scher, Howard I.; Sharifi, Nima; Skoneczna, Iwona; Soule, Howard; Spratt, Daniel E.; Srinivas, Sandy; Sternberg, Cora N.; Steuber, Thomas; Suzuki, Hiroyoshi; Sydes, Matthew R.; Taplin, Mary-Ellen; Tilki, Derya; Türkeri, Levent; Turco, Fabio; Uemura, Hiroji; Uemura, Hirotsugu; Ürün, Yüksel; Vale, Claire L.; van Oort, Inge; Vapiwala, Neha; Walz, Jochen; Yamoah, Kosj; Ye, Dingwei; Yu, Evan Y.; Zapatero, Almudena; Zilli, Thomas; Omlin, Aurelius
    Management of Patients with Advanced Prostate Cancer : Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
    In: European Urology Jg. 83 (2023) Nr. 3, S. 267 - 293
  • Gillessen, Silke; Bossi, Alberto; Davis, Ian D.; de Bono, Johann; Fizazi, Karim; James, Nicholas D.; Mottet, Nicolas; Shore, Neal; Small, Eric; Smith, Matthew; Sweeney, Christopher J.; Tombal, Bertrand; Antonarakis, Emmanuel S.; Aparicio, Ana M.; Armstrong, Andrew J.; Attard, Gerhardt; Beer, Tomasz M.; Beltran, Himisha; Bjartell, Anders; Blanchard, Pierre; Briganti, Alberto; Bristow, Rob G.; Bulbul, Muhammad; Caffo, Orazio; Castellano, Daniel; Castro, Elena; Cheng, Heather H.; Chi, Kim N.; Chowdhury, Simon; Clarke, Caroline S.; Clarke, Noel; Daugaard, Gedske; De Santis, Maria; Duran, Ignacio; Eeles, Ross; Efstathiou, Eleni; Efstathiou, Jason; Ekeke, Onyeanunam Ngozi; Evans, Christopher P.; Fanti, Stefano; Feng, Felix Y.; Fonteyne, Valerie; Fossati, Nicola; Frydenberg, Mark; George, Dan; Gleave, Martin; Gravis, Gwenaelle; Halabi, Susan; Heinrich, Daniel; Herrmann, Ken; Higano, Celestia; Hofman, Michael S.; Horvath, Lisa G.; Hussain, Maha; Jereczek-Fossa, Barbara A.; Jones, Rob; Kanesvaran, Ravindran; Kellokumpu-Lehtinen, Pirkko-Liisa; Khauli, Raja B.; Klotz, Laurence; Kramer, Gero; Leibowitz, Raja; Logothetis, Christopher; Mahal, Brandon; Maluf, Fernando; Mateo, Joaquin; Matheson, David; Mehra, Niven; Merseburger, Axel; Morgans, Alicia K.; Morris, Michael J.; Mrabti, Hind; Mukherji, Deborah; Murphy, Declan G.; Murthy, Vedang; Nguyen, Paul L.; Oh, William K.; Ost, Piet; O'Sullivan, Joe M.; Padhani, Anwar R.; Pezaro, Carmel J.; Poon, Darren M.C.; Pritchard, Colin C.; Rabah, Danny M.; Rathkopf, Dana; Reiter, Robert E.; Rubin, Mark A.; Ryan, Charles J.; Saad, Fred; Sade, Juan Pablo; Sartor, Oliver; Scher, Howard I.; Sharifi, Nima; Skoneczna, Iwona; Soule, Howard; Spratt, Daniel E.; Srinivas, Sandy; Sternberg, Cora N.; Steuber, Thomas; Suzuki, Hiroyoshi; Sydes, Matthew R.; Taplin, Mary-Ellen; Tilki, Derya; Türkeri, Levent; Turco, Fabio; Uemura, Hiroji; Uemura, Hirotsugu; Ürün, Yüksel; Vale, Claire L.; van Oort, Inge; Vapiwala, Neha; Walz, Jochen; Yamoah, Kosj; Ye, Dingwei; Yu, Evan Y.; Zapatero, Almudena; Zilli, Thomas; Omlin, Aurelius; O’Sullivan, Joe M.
    Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer : report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
    In: European Journal of Cancer (EJC) Jg. 185 (2023) S. 178 - 215
  • Posdzich, Philip; Darr, Christopher; Hilser, Thomas; Wahl, Milan; Herrmann, Ken; Hadaschik, Boris; Grünwald, Viktor
    Metastatic Prostate Cancer : A Review of Current Treatment Options and Promising New Approaches
    In: Cancers Jg. 15 (2023) Nr. 2, 461
  • Kersting, David; Mavroeidi, Ilektra-Antonia; Settelmeier, Stephan; Seifert, Robert; Schuler, Martin; Herrmann, Ken; Rassaf, Tienush; Rischpler, Christoph
    Molecular Imaging Biomarkers in Cardiooncology : A View on Established Technologies and Future Perspectives
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 2, S. 29S - 38S
  • Pomykala, Kelsey L.; Fendler, Wolfgang P.; Vermesh, Ophir; Umutlu, Lale; Herrmann, Ken; Seifert, Robert
    Molecular Imaging of Lymphoma : Future Directions and Perspectives
    In: Seminars in Nuclear Medicine Jg. 53 (2023) Nr. 3, S. 449 - 456
  • Laschinsky, Christina; Theurer, Sarah; Herold, Thomas; Rawitzer, Josefine; Weber, Frank; Herrmann, Ken; Brandenburg, Tim; Führer-Sakel, Dagmar; Fendler, Wolfgang P.; Weber, Manuel
    Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid Carcinoma
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 12, S. 1865 - 1868
  • Ayati, Narjess; Herrmann, Ken; Fanti, Stefano; Murphy, Declan G.; Hofman, Michael S.
    More Accurate Imaging Is Not Stage Migration : Time To Move from “Hubble” to “Webb” in Hormone-sensitive Prostate Cancer
    In: European Urology Jg. 83 (2023) Nr. 1, S. 6 - 9
  • Pomykala, K.L.; Hadaschik, Boris; Sartor, O.; Gillessen, S.; Sweeney, C.J.; Maughan, T.; Hofman, M.S.; Herrmann, Ken
    Next generation radiotheranostics promoting precision medicine
    In: Annals of Oncology Jg. 34 (2023) Nr. 6, S. 507 - 519
  • Demmert, Tristan T.; Maric, Ines; Pomykala, Kelsey L.; Lueckerath, Katharina; Siveke, Jens; Schaarschmidt, Benedikt M.; Hamacher, Rainer; Herrmann, Ken; Fendler, Wolfgang P.
    Novel ⁶⁸Ga-FAPI PET/CT Offers Oncologic Staging Without COVID-19 Vaccine-Related Pitfalls
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 3, S. 368 - 371
  • Totzeck, Matthias; Aide, Nicolas; Bauersachs, Johann; Bucerius, Jan; Georgoulias, Panagiotis; Herrmann, Ken; Hyafil, Fabien; Kunikowska, Jolanta; Lubberink, Mark; Nappi, Carmela; Rassaf, Tienush; Saraste, Antti; Sciagra, Roberto; Slart, Riemer; Verberne, Hein; Rischpler, Christoph
    Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity : Prospects and proposal of use by the European Association of Nuclear Medicine (EANM)
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 3, S. 792 - 812
  • Siyanbola, R.; Coelho, Marta; Costa, Pedro Fragoso; Moraitis, Alexandros; Herrmann, Ken; Hautzel, Hubertus;
    Occupational Radiation exposure from PET/CT during patient positioning
    Annual Congress of the European Association of Nuclear Medicine, 19-13 September 2023, Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S150 - S150
  • Pabst, Kim; Hamacher, Rainer; Lanzafame, Helena; Mavroeidi, Ilektra-Antonia; Bartel, Timo; Nader, Michael; Bauer, Sebastian; Siveke, Jens; Weber, Manuel; Kersting, David; Jentzen, Walter; Ahrens, M.; Herrmann, Ken; Fragoso Costa, Pedro;
    Occurence of hematotoxic side effects during 90Y-FAPI-46 radioligand therapy (RLT) in patients with advanced metastatic tumor diseases
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S671
  • Demmert, Tristan T.; Pomykala, Kelsey L.; Lanzafame, Helena; Pabst, Kim M.; Lueckerath, Katharina; Siveke, Jens; Umutlu, Lale; Hautzel, Hubertus; Hamacher, Rainer; Herrmann, Ken; Fendler, Wolfgang P.
    Oncologic Staging with ⁶⁸Ga-FAPI PET/CT Demonstrates a Lower Rate of Nonspecific Lymph Node Findings Than ¹⁸F-FDG PET/CT
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 12, S. 1906 - 1909
  • Hager, Thomas; Borchert, Sabrina; Wessolly, Michael; Mathilakathu, Alexander; Mairinger, Elena; Kollmeier, Jens; Mairinger, Thomas; Hegedus, Balazs; Greimelmaier, Kristina; Wohlschläger, Jeremias; Herrmann, Ken; Mairinger, Fabian Dominik
    One Third of Malignant Pleural Mesothelioma Shows High Immunohistochemical Expression of MSLN or CXCR4 Which Indicates Potent Candidates for Endo-Radiotherapy
    In: International Journal of Molecular Sciences (IJMS) Jg. 24 (2023) Nr. 7, S. 6356
  • Voltin, Conrad-Amadeus; Gödel, Philipp; Beckmann, Laura; Heger, Jan-Michel; Kobe, Carsten; Kutsch, Nadine; Borchmann, Peter; Dietlein, Markus; Herrmann, Ken; Stelljes, Matthias; Rahbar, Kambiz; Lenz, Georg; Reinhardt, Christian; Teichert, Marcel; Noppeney, Richard; Albring, Jörn C.; Seifert, Robert; von Tresckow, Bastian; Flossdorf, Sarah; Hanoun, Christine
    Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell Therapy
    In: HemaSphere: Open Access Journal of the European Hematology Association Jg. 7 (2023) Nr. 1, S. E817
  • Hammersen, N.; Jentzen, Walter; Stawitzki, F.; Herrmann, Ken; Kersting, David; Costa, P. Fragoso; Moraitis, Alexandros;
    PET Quantification Performance of the Oversize-Volume-of-Interest Approach in the Context of Tumour Dosimetry in Radionuclide Therapy Planning
    Annual Congress of the European Association of Nuclear Medicine, 19-13 September 2023, Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S363
  • Fendler, Wolfgang; Eiber, Matthias; Beheshti, Mohsen; Bomanji, Jamshed; Calais, Jeremie; Ceci, Francesco; Cho, Steve Y.; Fanti, Stefano; Giesel, Frederik L.; Goffin, Karolien; Haberkorn, Uwe; Jacene, Heather; Koo, Phillip J.; Kopka, Klaus; Krause, Bernd J.; Lindenberg, Liza; Marcus, Charles; Mottaghy, Felix M.; Oprea-Lager, Daniela E.; Osborne, Joseph R.; Piert, Morand; Rowe, Steven P.; Schöder, Heiko; Wan, Simon; Wester, Hans-Jürgen; Hope, Thomas A.; Herrmann, Ken
    PSMA PET/CT : Joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 5, S. 1466 - 1486
  • Civan, Caner; Kasper, Stefan; Berliner, Christoph; Fragoso-Costa, Pedro; Grünwald, Viktor; Pogorzelski, Michael; Schaarschmidt, Benedikt Michael; Lang, Stephan; Kersting, David; Nader, Michael; Lückerath, Katharina; Herrmann, Ken; Fendler, Wolfgang P.; Weber, Manuel
    PSMA-Directed Imaging and Therapy of Salivary Gland Tumors : A Single-Center Retrospective Study
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 3, S. 372 - 378
  • Palmedo, Holger; Ahmadzadehfar, Hojjat; Eschmann, Susanne; Niesen, Andreas; Schönberger, Johann; Barsegian, Vahé; Liepe, Knut; Mottaghy, Felix M.; Guan, Rongjin; Pinkert, Joerg; Sandström, Per; Herrmann, Ken
    Pain Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with ²²³Ra : PARABO, a Prospective, Noninterventional Study
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 9, S. 1392 - 1398
  • Moraitis, Alexandros; Darr, Christopher; Kahl, T.; Püllen, Lukas; Jentzen, Walter; Kersting, David; Hadaschik, Boris; Herrmann, Ken; Fendler, Wolfgang; Costa, Pedro Fragoso;
    Performance Evaluation of 18F-PSMA and 68Ga-PSMA in a Novel MicroPET/CT System Dedicated to Radioguided Surgery
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023, Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S131
  • Schuler, Martin; Bölükbas, Servet; Darwiche, Kaid; Theegarten, Dirk; Herrmann, Ken; Stuschke, Martin
    Personalized Treatment for Patients With Lung Cancer
    In: Deutsches Ärzteblatt international Jg. 120 (2023) Nr. 17, S. 300 - 310
  • Sartor, O.; Castellano Gauna, D.E.; Herrmann, Ken; de Bono, J.S.; Shore, N.D.; Chi, K.N.N.; Crosby, M.; Piulats Rodriguez, J.M.; Flechon, A.; Wei, X.X.; Mahammedi, H.; Roubaud, G.; Ova, H.; Ghebremariam, S.; Kpamegan, E.; Kreisl, T.N.; Delgoshaie, N.; Lehnhoff, K.; Morris, M.J.; Fizazi, K.;
    Phase III trial of [177Lu]Lu-PSMA-617 in taxane-naive patients with metastatic castration-resistant prostate cancer (PSMAfore)
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology Jg. 34 (2023) Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S1324 - S1325
  • Pomykala, Kelsey L.; Herrmann, Ken; Lalumera, Elisabetta; Fanti, Stefano
    Positive Prostate-specific Membrane Antigen Findings : How To Interpret Them
    In: European Urology Oncology Jg. 6 (2023) Nr. 2, S. 113 - 115
  • Gafita, Andrei; Djaileb, Loic; Rauscher, Isabel; Fendler, Wolfgang; Hadaschik, Boris; Herrmann, Ken; Calais, Jeremie; Rowe, Steven; Rettig, Matthew; Eiber, Matthias; Weber, Manuel; Benz, Matthias; Farolfi, Andrea;
    Practical RECIP : Visual assessment of Response Evaluation Criteria In PSMA-PET/CT in metastatic castration-resistant prostate cancer
    55th Annual Conference of the Society-of-Nuclear-Medicine (SNMICON); NOV 16-19, 2023; Jodhpur, India,
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P1619
  • Djaileb, Loic; Armstrong, Wesley; Gafita, Andrei; Herrmann, Ken; Fendler, Wolfgang; Carroll, Peter;
    Pre-surgical 68Ga-PSMA-11 PET for biochemical recurrence risk assessment: a surrogate of Pelvic Lymph Node Dissection? : Follow-up analysis of a Multicenter Prospective Phase 3 Imaging Trial
    55th Annual Conference of the Society-of-Nuclear-Medicine (SNMICON); NOV 16-19, 2023; Jodhpur, India,
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. Suppl. 1, P440
  • Lazaridis, Lazaros; Schmidt, Teresa; Oster, Christoph; Blau, Tobias; Pierscianek, Daniela; Siveke, Jens T.; Bauer, Sebastian; Schildhaus, Hans-Ulrich; Sure, Ulrich; Keyvani, Kathy; Kleinschnitz, Christoph; Stuschke, Martin; Herrmann, Ken; Deuschl, Cornelius; Scheffler, Björn; Kebir, Sied; Glas, Martin
    Precision neuro-oncology : A pilot analysis of personalized treatment in recurrent glioma
    In: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 7, S. 3513 - 3526
  • Pabst, Kim Magaly; Seifert, Robert; Hirmas, Nader; Bröcker-Preuß, Martina; Weber, Manuel; Fendler, Wolfgang Peter; Bartel, Timo; Theurer, Sarah; Herrmann, Ken; Görges, Rainer
    Predictive value of highly sensitive basal versus stimulated thyroglobulin measurement in long-term follow-up of thyroid cancer
    In: Endocrine Connections Jg. 12 (2023) Nr. 2, e220312
  • Okumus, Özlem; Mardanzai, Khaled; Plönes, Till; Theegarten, Dirk; Darwiche, Kaid; Schuler, Martin; Nensa, Felix; Hautzel, Hubertus; Herrmann, Ken; Stuschke, Martin; Hegedus, Balazs; Aigner, Clemens
    Preoperative PET-SUVmax and volume based PET parameters of the primary tumor fail to predict nodal upstaging in early-stage lung cancer
    In: Lung Cancer Jg. 176 (2023) S. 82 - 88
  • Djaïleb, Loïc; Armstrong, Wesley R.; Thompson, Daniel; Gafita, Andrei; Farolfi, Andrea; Rajagopal, Abhejit; Grogan, Tristan R.; Nguyen, Kathleen; Benz, Matthias R.; Hotta, Masatoshi; Barbato, Francesco; Ceci, Francesco; Schwarzenböck, Sarah M.; Unterrainer, Marcus; Zacho, Helle D.; Juarez, Roxanna; Cooperberg, Matthew; Carroll, Peter; Washington, Samuel; Reiter, Robert E.; Eiber, Matthias; Herrmann, Ken; Fendler, Wolfgang P.; Czernin, Johannes; Hope, Thomas A.; Calais, Jeremie
    Presurgical ⁶⁸Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment : A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial
    In: European Urology Jg. 84 (2023) Nr. 6, S. 588 - 596
  • Giovanella, Luca; Garo, Maria Luisa; Cuzzocrea, Marco; Paone, Gaetano; Herrmann, Ken
    Prognostic role of early prostate specific antigen changes after [¹⁷⁷Lu]Lu-PSMA radioligand therapy of metastasized prostate cancer : A meta-analysis
    In: European Journal of Clinical Investigation Jg. 53 (2023) Nr. 9, e14014
  • Wei, X.X.; Chi, K.N.N.; de Bono, J.S.; Fizazi, K.; Krause, B.; Herrmann, Ken; Rahbar, K.; Tagawa, S.T.; Morris, M.J.; Meisel, A.; Holder, G.; Mirante, O.; Wu, J.; Sartor, O.;
    Prognostic value of neutrophil-to-lymphocyte ratio and lymphopenia in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with [177Lu]Lu-PSMA-617 : VISION post hoc analysis
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology Jg. 34 (2023) Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S995 - S996
  • Leyser, Stephan; Lanzafame, Helena; Kersting, David; Seifert, Robert; Zarrad, Fadi; Lahner, Harald; Unger, Nicole; Fendler, Wolfgang; Herrmann, Ken; Weber, Manuel;
    Prognostic value of the post-treatment 177Lu-DOTATOC scintigraphy in NET patients undergoing PRRT
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023, Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S134
  • Fendler, Wolfgang; Seifert, Robert; Emmett, Louise; Herrmann, Ken; Hadaschik, Boris; Eiber, Matthias
    Prostate Cancer Molecular Imaging Standardized Evaluation : The PROMISE V2 Framework Including Response Evaluation for Clinical Trials
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 199 (2023) Nr. Suppl. 1, S. S150
  • Esen, Barış; Herrmann, Ken; Bavbek, Sevil; Kordan, Yakup; Tilki, Derya; Esen, Tarık
    Prostate-specific Membrane Antigen Positron Emission Tomography as a Biomarker to Assess Treatment Response in Patients with Advanced Prostate Cancer
    In: European Urology Focus Jg. 9 (2023) Nr. 4, S. 596 - 605
  • Kersting, David; Moraitis, Alexandros; Sraieb, Miriam; Zarrad, Fadi; Umutlu, Lale; Rischpler, Christoph; Fendler, Wolfgang; Herrmann, Ken; Weber, Manuel; Conti, Maurizio; Fragoso Costa, Pedro; Jentzen, Walter
    Quantification performance of silicon photomultiplier-based PET for small ¹⁸F-, ⁶⁸Ga- and ¹²⁴I-avid lesions in the context of radionuclide therapy planning
    In: Physica Medica: European Journal of Medical Physics Jg. 114 (2023) 103149
  • Storey, Claire M.; Altai, Mohamed; Bicak, Mesude; Veach, Darren R.; Lückerath, Katharina; Adrian, Gabriel; McDevitt, Michael R.; Kalidindi, Teja; Park, Julie E.; Herrmann, Ken; Abou, Diane; Zedan, Wahed; Peekhaus, Norbert; Klein, Robert J.; Damoiseaux, Robert; Larson, Steven M.; Lilja, Hans; Thorek, Daniel; Ulmert, David
    Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response
    In: Molecular Cancer Research Jg. 21 (2023) Nr. 4, S. 307 - 315
  • Kessler, Lukas; Fragoso Costa, Pedro; Kersting, David; Jentzen, Walter; Weber, Manuel; Lüdike, Peter; Carpinteiro, Alexander; Oubari, Sara; Hagenacker, Tim; Thimm, Andreas; Rassaf, Tienush; Herrmann, Ken; Papathanasiou, Maria; Rischpler, Christoph
    Quantitative ⁹⁹mTc-DPD-SPECT/CT assessment of cardiac amyloidosis
    In: Journal of Nuclear Cardiology Jg. 30 (2023) Nr. 1, S. 101 - 111
  • Meetschen, Mathias; Sandach, Patrick; Darwiche, Kaid; Theegarten, Dirk; Moter, Annette; Schaarschmidt, Benedikt Michael; Herrmann, Ken; Fendler, Wolfgang; Hautzel, Hubertus; Opitz, Marcel
    Rabbit fever : granulomatous inflammation by Francisella tularensis mimics lung cancer in dual tracer ¹⁸FDG and ⁶⁸Ga-FAPI PET/CT
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 8, S. 2567 - 2569
  • Oeverhaus, Michael; Koenen, Jana; Bechrakis, Nikolaos; Stöhr, Mareile; Herrmann, Ken; Fendler, Wolfgang; Eckstein, Anja; Weber, Manuel
    Radioiodine Ablation of Thyroid Remnants in Patients with Graves' Orbitopathy
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 4, S. 561 - 566
  • Bugani, Valentina; Battistelli, Luca; Sansovini, Maddalena; Monti, Manuela; Paganelli, Giovanni; Gich, Ignasi; Flotats, Albert; Erba, Paola Anna; Blay, Jean-Yves; la Fougère, Christian; Van Poppel, Hendrik; Charalambous, Andreas; Herrmann, Ken; Giordano, Alessandro; Györke, Tamás; Deroose, Christophe; Matteucci, Federica; Carrió, Ignasi
    Radioligand therapies in cancer : Mapping the educational landscape in Europe
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 9, S. 2692 - 2698
  • Klümper, Niklas; Eckstein, Markus; Hölzel, Michael; Herrmann, Ken; Hadaschik, Boris; Grünwald, Viktor
    Re: First-in-Human Study of the Radioligand ⁶⁸Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma : Navigating Metastatic Urothelial Cancer with Nectin-4 PET/CT
    In: European Urology Jg. 84 (2023) Nr. 5, S. 514 - 515
  • Fragoso Costa, Pedro; Jentzen, Walter; Süßelbeck, Finja; Fendler, Wolfgang; Rischpler, Christoph; Herrmann, Ken; Conti, Maurizio; Kersting, David; Weber, Manuel
    Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision : A phantom study
    In: The Quarterly Journal of Nuclear Medicine and Molecular Imaging Jg. 67 (2023) Nr. 1, S. 57 - 68
  • Papathanasiou, Maria; Kessler, Lukas; Bengel, Frank M.; Jakstaite, Aiste-Monika; Kersting, David; Varasteh, Zohreh; Lüdike, Peter; Carpinteiro, Alexander; Herrmann, Ken; Rassaf, Tienush; Rischpler, Christoph
    Regression of Myocardial ⁹⁹mTc-DPD Uptake After Tafamidis Treatment of Cardiac Transthyretin Amyloidosis
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 7, S. 1083 - 1086
  • Gafita, Andrei; Djaileb, Loïc; Rauscher, Isabel; Fendler, Wolfgang P.; Hadaschik, Boris; Rowe, Steven P.; Herrmann, Ken; Calais, Jeremie; Rettig, Matthew; Eiber, Matthias; Weber, Manuel; Benz, Matthias R.; Farolfi, Andrea
    Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer
    In: Radiology Jg. 308 (2023) Nr. 1, e222148
  • Hope, Thomas A.; Allen-Auerbach, Martin; Bodei, Lisa; Calais, Jeremie; Dahlbom, Magnus; Dunnwald, Lisa K.; Graham, Michael M.; Jacene, Heather A.; Heath, Courtney Lawhn; Mittra, Erik S.; Wright, Chadwick L.; Fendler, Wolfgang; Herrmann, Ken; Taïeb, David; Kjaer, Andreas
    SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET : Imaging Neuroendocrine Tumors
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 2, S. 204 - 210
  • Zaun, Gregor; Weber, Manuel; Metzenmacher, Martin; Wiesweg, Marcel; Hilser, Thomas; Zaun, Yasmin; Liffers, Sven; Pogorzelski, Michael; Virchow, Isabel; Eberhardt, Wilfried; Theurer, Sarah; Sabbah, Tanja Abu; Reissig, Timm M.; Stuschke, Martin; Kürten, Cornelius; Hussain, Timon; Lang, Stephan; Kasper, Stefan; Fendler, Wolfgang; Herrmann, Ken; Schuler, Martin
    SUVmₐₓ Above 20 in ¹⁸F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown Primary
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 8, S. 1191 - 1194
  • Telli, Tugce; Seifert, Robert; Lapa, Constantin; Hekimsoy, T.; Weber, W.; Pfob, C.; Herrmann, Ken; Rahbar, K.; Eiber, M.; Fendler, Wolfgang;
    Safety and Efficacy of Extended 177Lu-PSMA Therapy: Multi-Center Retrospective Analysis
    Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S152
  • Jakstaite, A. Aiste Monika; Lüdike, Peter; Janosi, Rolf Alexander; Al-Rashid, Fadi; Carpinteiro, Alexander; Kersting, David; Kessler, Lukas; Rischpler, Christoph; Herrmann, Ken; Rassaf, Tienush; Papathanasiou, Maria
    Screening for occult transthyretin amyloidosis in patients with degenerative aortic stenosis and amyloid red-flags
    In: European Journal of Heart Failure Jg. 25 (2023) Nr. Suppl. 2, S. 359 - 359
  • Seifert, Robert; Emmett, Louise; Rowe, Steven P.; Herrmann, Ken; Hadaschik, Boris; Calais, Jeremie; Giesel, Frederik L.; Reiter, Robert; Maurer, Tobias; Heck, Matthias; Gafita, Andrei; Morris, Michael J.; Fanti, Stefano; Weber, Wolfgang A.; Hope, Thomas A.; Hofman, Michael S.; Fendler, Wolfgang; Eiber, Matthias
    Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)
    In: European Urology Jg. 83 (2023) Nr. 5, S. 405 - 412
  • Seifert, Robert; Gafita, Andrei; Telli, Tugce; Voter, Andrew; Herrmann, Ken; Pomper, Martin; Hadaschik, Boris; Rowe, Steven P.; Fendler, Wolfgang
    Standardized PSMA-PET Imaging of Advanced Prostate Cancer
    In: Seminars in Nuclear Medicine Jg. 54 (2023) Nr. 1, S. 60 - 68
  • Allie, Rayjanah; Kayani, Irfan; Gnanasegaran, Gopinath; Vinjamuri, Sobhan; Chiti, Arturo; Paez, Diana; Giammarile, Francesco; Herrmann, Ken; Bomanji, Jamshed
    Strategy planning for turbulent times in nuclear medicine : Time to begin at the beginning?
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 51 (2023) Nr. 1, S. 12 - 19
  • Pabst, Kim M.; Trajkovic-Arsic, Marija; Cheung, Phyllis F Y; Ballke, Simone; Steiger, Katja; Bartel, Timo; Schaarschmidt, Benedikt M.; Milosevic, Aleksandar; Seifert, Robert; Nader, Michael; Kessler, Lukas; Siveke, Jens; Lückerath, Katharina; Kasper, Stefan; Herrmann, Ken; Hirmas, Nader; Schmidt, Hartmut; Hamacher, Rainer; Fendler, Wolfgang
    Superior Tumor Detection for ⁶⁸Ga-FAPI-46 Versus ¹⁸F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 7, S. 1049 - 1055
  • Pomykala, Kelsey L.; Würker, Marcus; Herrmann, Ken
    Tackling the Last Mile : A Major Component to Successfully Establish Radioligand Therapy
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 3, S. 347 - 348
  • Lazaridis, Lazaros; Mönninghoff, Christoph; Bumes, Elisabeth; Spille, Dorothee Cäcilia; Müther, Michael; Schulz, Tim; Heider, Sina; Agkatsev, Sarina; Schmidt, Teresa; Blau, Tobias; Oster, Christoph; Stummer, Walter; Kessler, Almuth Friederike; Seidel, Clemens; Grauer, Oliver; Hau, Peter; Sure, Ulrich; Keyvani, Kathy; Herrlinger, Ulrich; Kleinschnitz, Christoph; Stuschke, Martin; Herrmann, Ken; Deuschl, Cornelius; Scheffler, Björn; Kebir, Sied; Glas, Martin
    Temporal muscle thickness as a prognostic marker in a real-life cohort of newly diagnosed MGMT promoter methylated glioblastoma patients : a multicentric imaging analysis
    In: Neuro-Oncology Jg. 25 (2023) Nr. Suppl. 5, S. v192 - v193
  • Strosberg, Jonathan; Herrmann, Ken; Bodei, Lisa
    The Future of Targeted α-Therapy Is Bright, but Rigorous Studies Are Necessary to Advance the Field
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 2, S. 219 - 220
  • Seifert, Robert; Emmett, L.; Herrmann, Ken; Hadaschik, Boris; Fendler, Wolfgang;
    The Updated Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE V2.0) Framework for Standardized Reporting of PSMA-PET
    Annual Congress of the European Association of Nuclear Medicine, 19-13 September 2023, Vienna, Austria,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S177
  • Jannusch, Kai; Lindemann, Maike E.; Bruckmann, Nils Martin; Morawitz, Janna; Dietzel, Frederic; Pomykala, Kelsey L.; Herrmann, Ken; Bittner, Ann-Kathrin; Hoffmann, Oliver; Mohrmann, Svjetlana; Umutlu, Lale; Antoch, Gerald; Quick, Harald H.; Kirchner, Julian
    Towards a fast PET/MRI protocol for breast cancer imaging : maintaining diagnostic confidence while reducing PET and MRI acquisition times
    In: European Radiology Jg. 33 (2023) Nr. 9, S. 6179 - 6188
  • Seifert, Robert; Telli, Tugce; Opitz, Marcel; Barbato, Francesco; Berliner, Christoph; Nader, Michael; Umutlu, Lale; Stuschke, Martin; Hadaschik, Boris; Herrmann, Ken; Fendler, Wolfgang
    Unspecific ¹⁸F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 5, S. 738 - 743
  • Bröcker-Preuß, Martina; Simon, Dietmar; Fries, Mirka; Kornely, Elisabeth; Weber, Manuel; Vardarli, Irfan; Gilman, Elena; Herrmann, Ken; Görges, Rainer
    Update on Calcitonin Screening for Medullary Thyroid Carcinoma and the Results of a Retrospective Analysis of 12,984 Patients with Thyroid Nodules
    In: Cancers Jg. 15 (2023) Nr. 8, 2333
  • Kupusovic, Jana; Kessler, Lukas; Bruns, Florian; Bohnen, Jan-Eric; Nekolla, Stephan G.; Weber, Manuel; Lauenroth, Anna; Rattka, Manuel; Herrmann, Ken; Dobrev, Dobromir; Rassaf, Tienush; Wakili, Reza; Rischpler, Christoph; Siebermair, Johannes
    Visualization of fibroblast activation using ⁶⁸Ga-FAPI PET/CT after pulmonary vein isolation with pulsed field compared with cryoballoon ablation
    In: Journal of Nuclear Cardiology Jg. 30 (2023) Nr. 5, S. 2018 - 2028
  • Watanabe, Masao; Grafe, Hong; Theysohn, Jens; Schaarschmidt, Benedikt; Ludwig, Johannes; Jochheim, Leonie; Jeschke, Matthias; Schmidt, Hartmut; Fendler, Wolfgang; Moraitis, Alexandros; Herrmann, Ken; Pomykala, Kelsey L.; Weber, Manuel
    Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with ⁹⁰Y Glass Microspheres
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 7, S. 1102 - 1108
  • Weber, Wolfgang A.; Barthel, Henryk; Bengel, Frank; Eiber, Matthias; Herrmann, Ken; Schäfers, Michael
    What Is Theranostics?
    In: Journal of Nuclear Medicine (JNM) Jg. 64 (2023) Nr. 5, S. 669 - 670
  • Jannusch, Kai; Morawitz, Janna; Schweiger, Bernd; Weiss, Daniel; Schimmöller, Lars; Minko, Peter; Herrmann, Ken; Fendler, Wolfgang; Quick, Harald H.; Antoch, Gerald; Umutlu, Lale; Kirchner, Julian; Bruckmann, Nils-Martin
    [¹⁸F]FDG PET/MRI in children suffering from lymphoma : does MRI contrast media make a difference?
    In: European Radiology Jg. 33 (2023) Nr. 11, S. 8366 - 8375
  • Benz, Matthias R.; Armstrong, Wesley R.; Ceci, Francesco; Polverari, Giulia; Donahue, Timothy R.; Wainberg, Zev A.; Quon, Andrew; Auerbach, Martin; Girgis, Mark D.; Herrmann, Ken; Czernin, Johannes; Calais, Jeremie
    18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 2, S. 199 - 204
  • Lanzafame, H.; Hirmas, N.; Schuler, Martin; Darwiche, Kaid; Eberhardt, Wilfried E. E.; Aigner, Clemens; Stuschke, Martin; Kessler, Lukas; Pabst, K. M.; Barbato, F.; Rischpler, Christoph; Hautzel, H.; Herrmann, Ken; Fendler, Wolfgang;
    68GA-FAPI PET/CT in the evaluation of Non-Small Cell Lung Cancer (NSCLC)
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S107
  • Halfdanarson, T.R.; Halperin, D.; Reidy-Lagunes, D.; Kong, G.; Mailman, J.; Herrmann, Ken; Sri Rajaskanthan, R.; Leyden, S.; Capdevila Castillon, J.; Sierras, C.; Harris, P.;
    902TiP COMPOSE : Pivotal phase III trial to compare 177Lu-edotreotide with best standard of care for well-differentiated aggressive grade 2 and grade 3 gastroenteropancreatic neuroendocrine tumours
    Annual Meeting of the European-Society-for-Medical-Oncology (ESMO),
    In: Annals of Oncology Jg. 33 (2022) Nr. Suppl. 7, S. S960
  • Vardarli, Irfan; Brandenburg, Tim; Hegedüs, Laszlo; Attanasio, Roberto; Nagy, EndreV.; Papini, Enrico; Perros, Petros; Weidemann, Frank; Herrmann, Ken; Führer, Dagmar
    A Questionnaire Survey of German Thyroidologists on the Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients : The THESIS (Treatment of Hypothyroidism in Europe by Specialists: An International Survey) Collaborative
    In: Experimental and Clinical Endocrinology & Diabetes Jg. 130 (2022) Nr. 9, S. 577 - 586
  • Sandach, Patrick; Seifert, Robert; Fendler, Wolfgang; Hautzel, Hubertus; Herrmann, Ken; Maier, Sandra; Plönes, Till; Metzenmacher, Martin; Ferdinandus, Justin
    A Role for PET/CT in response assessment of malignant pleural mesothelioma
    In: Seminars in Nuclear Medicine Jg. 52 (2022) Nr. 6, S. 816 - 823
  • Bruckmann, Nils Martin; Morawitz, Janna; Fendler, Wolfgang P.; Ruckhäberle, Eugen; Bittner, Ann-Kathrin; Giesel, Frederik L.; Herrmann, Ken; Antoch, Gerald; Umutlu, Lale; Kirchner, Julian
    A Role of PET/MR in Breast Cancer?
    In: Seminars in Nuclear Medicine Jg. 52 (2022) Nr. 5, S. 611 - 618
  • Lam, Marnix; Garin, Etienne; Maccauro, Marco; Kappadath, S. Cheenu; Sze, Daniel Y.; Turkmen, Cuneyt; Cantasdemir, Murat; Haste, Paul; Herrmann, Ken; Alsuhaibani, Hamad Saleh; Dreher, Matthew; Fowers, Kirk D.; Salem, Riad
    A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90 : The TARGET study
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. 10, S. 3340 - 3352
  • Zehnder, A.; Castillo, J.; Bouterfa, H.; Reis, H.; Kaufmann, J.; Keller, U.; Gotthardt, M.; Weber, W.; Ferreri, A.; Kraeber-Bodéré, F.; Madsen, J.; Herrmann, Ken;
    A planned, prospective, international, multi-center, open-label, single-arm phase II study investigating the predictive value of [68Ga]GaPentixaFor PET imaging in primary and isolated secondary CNS lymphoma patients
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S415
  • Klose, Jasmin M.; Wosniack, Jasmin; Iking, Janette; Staniszewska, Magdalena; Zarrad, Fadi; Trajkovic-Arsic, Marija; Herrmann, Ken; Costa, Pedro Fragoso; Lückerath, Katharina; Fendler, Wolfgang
    Administration Routes for SSTR-/PSMA- and FAP-Directed Theranostic Radioligands in Mice
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 9, S. 1357 - 1363
  • Veit-Haibach, Patrick; Herrmann, Ken
    Artificial Intelligence/Machine Learning in Nuclear Medicine and Hybrid Imaging
    Cham (2022) XIV, 210 Seiten
  • Hosch, René; Weber, Manuel; Sraieb, Miriam; Flaschel, Nils; Haubold, Johannes; Kim, Moon-Sung; Umutlu, Lale; Kleesiek, Jens; Herrmann, Ken; Nensa, Felix; Rischpler, Christoph; Koitka, Sven; Seifert, Robert; Kersting, David
    Artificial intelligence guided enhancement of digital PET : Scans as fast as CT?
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. 13, S. 4503 - 4515
  • Freudenberg, Lutz; Pomykala, Kelsey L.; Herrmann, Ken
    COVID-19 Pandemic : What Have We Learned and What to Expect in the Future?
    In: Seminars in Nuclear Medicine Jg. 52 (2022) Nr. 1, S. 86 - 89
  • Weber, Manuel; Pettersson, O.; Seifert, R.; Schaarschmidt, B. M.; Fendler, Wolfgang P.; Rischpler, Christoph; Lahner, Harald; Herrmann, Ken; Sundin, A.;
    Changes in Tumor-Blood Ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S80
  • Weidemann, Frank; Jovanovic, Ana; Herrmann, Ken; Vardarli, Irfan
    Chaperone Therapy in Fabry Disease
    In: International Journal of Molecular Sciences (IJMS) Jg. 23 (2022) Nr. 3, 1887
  • Seifert, Robert; Kersting, David; Rischpler, Christoph; Opitz, Marcel; Kirchner, Julian; Pabst, Kim M.; Mavroeidi, Ilektra-Antonia; Laschinsky, Christina; Grueneisen, Johannes; Schaarschmidt, Benedikt; Catalano, Onofrio Antonio; Herrmann, Ken; Umutlu, Lale
    Clinical Use of PET/MR in Oncology : An Update
    In: Seminars in Nuclear Medicine Jg. 52 (2022) Nr. 3, S. 356 - 364
  • Schmidt, T; Agkatsev, S; Feldheim, J; Oster, C; Blau, T; Sure, Ulrich; Keyvani, Kathy; Kleinschnitz, Christoph; Stuschke, Martin; Herrmann, Ken; Deuschl, C; Scheffler, Björn; Kebir, S; Glas, M; Lazaridis, L
    Combination of Trofosfamide and Etoposide in Recurrent Glioma
    In: Neuro-Oncology Jg. 24 (2022) Nr. Suppl. 2, S. ii89 - ii89
  • Nagel, Isabel; Herrmann, Ken; Lahner, Harald; Rischpler, Christoph; Weber, Frank
    Combined medical therapy, nuclear medicine therapy and other therapies in metastatic neuroendocrine tumor
    In: Nuclear Medicine and Molecular Imaging: Volume 4: Nuclear Medicine Therapy / Signore, Alberto / Sathekge, Mike; Luster, Markus (Hrsg.) (2022) S. 145 - 156
  • Morawitz, Janna; Bruckmann, Nils-Martin; Dietzel, Frederic; Ullrich, Tim; Bittner, Ann-Kathrin; Hoffmann, Oliver; Ruckhäberle, Eugen; Mohrmann, Svjetlana; Häberle, Lena; Ingenwerth, Marc; Abrar, Daniel Benjamin; Sawicki, Lino Morris; Breuckmann, Katharina; Fendler, Wolfgang; Herrmann, Ken; Buchbender, Christian; Antoch, Gerald; Umutlu, Lale; Kirchner, Julian
    Comparison of nodal staging between CT, MRI, and [¹⁸F]-FDG PET/MRI in patients with newly diagnosed breast cancer
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) S. 992 - 1001
  • Sraieb, Miriam; Coelho, M.; Himmen, Stefan; Pabst, K. M.; Kazek, S.; Rischpler, Christoph; Fendler, Wolfgang P.; Herrmann, Ken; Costa, P.; Jentzen, Walter;
    Comparison of the Safety and Tolerability of Paraaminohippurate (PAH) and Amino Acid (AA) Co-Infusion in Patients with Neuroendocrine Tumours Receiving Peptide Receptor Radionuclide Therapy (PRRT) : A Case Series of Eight Patients
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine October ; 15-19, 2022 Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S579
  • Thimm, Andreas; Carpinteiro, Alexander; Oubari, Sara; Papathanasiou, Maria; Kessler, Lukas; Rischpler, Christoph; Malik, Rayaz Ahmed; Reinhardt, Christian; Rassaf, Tienush; Herrmann, Ken; Kleinschnitz, Christoph; Stettner, Mark; Hagenacker, Tim
    Corneal confocal microscopy to detect early immune-mediated small nerve fibre loss in AL amyloidosis
    In: Annals of Clinical and Translational Neurology Jg. 9 (2022) Nr. 6, S. 853 - 863
  • Vaz, Sofia C.; Adam, Judit A.; Delgado Bolton, Roberto C.; Vera, Pierre; van Elmpt, Wouter; Herrmann, Ken; Hicks, Rodney J.; Lievens, Yolande; Santos, Andrea; Schöder, Heiko; Dubray, Bernard; Visvikis, Dimitris; Troost, Esther G. C.; de Geus-Oei, Lioe-Fee
    Correction to: Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[¹⁸F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0 (European Journal of Nuclear Medicine and Molecular Imaging, (2022), 49, 4, (1386-1406), 10.1007/s00259-021-05624-5)
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. 9, S. 3300 - 3301
  • Schmidt, Matthias; Bartenstein, Peter; Bucerius, Jan; Dietlein, Markus; Drzezga, Alexander; Herrmann, Ken; Lapa, Constantin; Lorenz, Kerstin; Musholt, Thomas J.; Nagarajah, James; Reiners, Christoph; Sahlmann, Carsten O.; Kreissl, Michael C.
    Correction: Individualized treatment of differentiated thyroid cancer : The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear Medicine
    In: Nuklearmedizin = Nuclear Medicine (2022) in press
  • Hautzel, H.; Bartel, T.; Darwiche, Kaid; Aigner, Clemens; Taube, Christian; Herrmann, Ken;
    Determination of the Efficiency of Filter Pads in expiratory Filters with 99mTc-labelled Graphite Eerosol
    62. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.; 25.–28.05.2022; Leipzig,
    In: Pneumologie Jg. 76 (2022) Nr. Supplement 1, S. S68
  • Weber, Manuel; Schmitz, Jochen; Maric, Ines; Pabst, Kim; Umutlu, Lale; Walz, Martin; Herrmann, Ken; Rischpler, Christoph; Weber, Frank; Jentzen, Walter; Theurer, Sarah; Poeppel, Thorsten D.; Unger, Nicole; Fendler, Wolfgang
    Diagnostic Performance of ¹²⁴I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 6, S. 869 - 874
  • Schenke, Simone Agnes; Kreissl, Michael C.; Grunert, Michael; Hach, Anja; Haghghi, Sarvar; Kandror, Tatjana; Peppert, Eckhard; Rosenbaum-Krumme, Sandra; Ruhlmann, Verena; Stahl, Alexander; Wanjura, Dieter; Zaplatnikov, Konstantin; Zimny, Michael; Gilman, Elena; Herrmann, Ken; Görges, Rainer
    Distribution of Functional Status of Thyroid Nodules and Malignancy Rates of Hyperfunctioning and Hypofunctioning Thyroid Nodules in Germany
    In: Nuklearmedizin = Nuclear Medicine Jg. 61 (2022) Nr. 5, S. 376 - 384
  • Herrmann, Ken; Rahbar, Kambiz; Eiber, Matthias; Krause, Bernd J.; Lassmann, Michael; Jentzen, Walter; Blumenstein, Lars; Klein, Patrick; Basque, Jean-René; Kurth, Jens
    Dosimetry of 177Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer : Results from the VISION trial sub-study
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. Suppl. 6, 97
  • Weber, Manuel; Lam, Marnix; Chiesa, Carlo; Konijnenberg, Mark W.; Cremonesi, Marta; Flamen, Patrick B.; Gnesin, Silvano; Bodei, Lisa; Kracmerova, T.; Luster, Markus; Garin, Etienne; Herrmann, Ken
    EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. 5, S. 1682 - 1699
  • Fanti, Stefano; Briganti, Alberto; Emmett, Louise; Fizazi, Karim; Gillessen, Silke; Goffin, Karolien; Hadaschik, Boris; Herrmann, Ken; Kunikowska, Jolanta; Maurer, Tobias; MacLennan, Steven; Mottet, Nicolas; Murphy, Declan G.; Oprea-Lager, Daniela E.; O'Sullivan, Joe M.; Oyen, Wim J G; Rouvière, Olivier; Sartor, Oliver; Stenzl, Arnulf; Van Poppel, Hendrik; Walz, Jochen; Witjes, Wim; Bjartell, Anders
    EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [¹⁷⁷Lu]Lu-PSMA Radioligand Therapy
    In: European Urology Oncology Jg. 5 (2022) Nr. 5, S. 530 - 536
  • Sandach, Patrick; Seifert, R.; Darwiche, Kaid; Funke, Faustina; Maier, S. C.; Herrmann, Ken; Hautzel, H.;
    EBUS-TBNA within 8 days prior to (18)FDG PET/CT affects (18)FDG uptake in mediastinal and hilar lymph nodes of patients during staging for lung cancer
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S166
  • Guberina, Maja; Guberina, Nika; Pöttgen, Christoph; Gauler, Thomas; Richlitzki, Cedric; Metzenmacher, Martin; Wiesweg, Marcel; Plönes, Till; Forsting, Michael; Wetter, Axel; Herrmann, Ken; Hautzel, Hubertus; Darwiche, Kaid; Theegarten, Dirk; Aigner, Clemens; Schuler, Martin; Stuschke, Martin; Eberhardt, Wilfried
    Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer : focus on treatment selection and prognostic factors
    In: Immunotherapy Jg. 14 (2022) Nr. 12, S. 927 - 944
  • Bruckmann, Nils Martin; Rischpler, Christoph; Tsiami, Styliani; Kirchner, Julian; Abrar, Daniel B.; Bartel, Timo; Theysohn, Jens; Umutlu, Lale; Herrmann, Ken; Fendler, Wolfgang; Buchbender, Christian; Antoch, Gerald; Sawicki, Lino M.; Tsobanelis, Athanasios; Braun, Juergen; Baraliakos, Xenofon
    Effects of Anti-Tumor Necrosis Factor Therapy on Osteoblastic Activity at Sites of Inflammatory and Structural Lesions in Radiographic Axial Spondyloarthritis : A Prospective Proof-of-Concept Study Using Positron Emission Tomography/Magnetic Resonance Imaging of the Sacroiliac Joints and Spine
    In: Arthritis & Rheumatology Jg. 74 (2022) Nr. 9, S. 1497 - 1505
  • Hautzel, H; Bartel, T; Darwiche, Kaid; Aigner, Clemens; Taube, Christian; Herrmann, Ken
    Efficacy estimation of filter pads in expiratory filter/valve sets by means of Tc-99m-labeled graphite aerosol
    In: European Respiratory Journal (ERJ) Jg. 60 (2022) Nr. Suppl. 66, 1793
  • Weber, Manuel; Kersting, David; Riemann, Burkhard; Brandenburg, Tim; Führer, Dagmar; Grünwald, Frank; Kreissl, Michael C.; Dralle, Henning; Weber, Frank; Schmid, Kurt Werner; Herrmann, Ken; Jentzen, Walter; Grafe, Hong; Rischpler, Christoph; Theurer, Sarah; Bockisch, Andreas; Nagarajah, James; Fendler, Wolfgang
    Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI) : A Single-Center Prospective Two-Arm Study
    In: Clinical Cancer Research Jg. 28 (2022) Nr. 19, S. 4194 - 4202
  • Dierckx, Rudi; Herrmann, Ken; Hustinx, Roland; Lassman, Michael; Wadsak, Wolfgang; Kunikowska, Jolanta
    European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2022) Nr. 1, S. 1 - 3
  • Hautzel, H.; Bartel, T.; Darwiche, Kaid; Aigner, Clemens; Taube, Christian; Herrmann, Ken;
    Expiratory filter sets substantially reduce exhaled small bioaerosol particles and potential COVID-19 virus load
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S318
  • Pabst, K. M.; Fendler, Wolfgang P.; Hadaschik, Boris; Kesch, C.; Hirmas, N.; Kessler, Lukas; Gruenwald, V.; Hamacher, R.; Nader, M.; Berliner, C.; Umutlu, Lale; Püllen, Lukas; Herrmann, Ken; Lückerath, Katharina; Castellucci, P.; Fanti, S.; Mei, R.;
    FAPI, PSMA and FDG PET/CT in patients with advanced metastatic castration-resistant prostate cancer (mCRPC) : a triple tracer comparison
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine October ; 15-19, 2022 Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S118 - S119
  • Sandach, Patrick; Kleibrink, Björn; Maier, Sandra; Herrmann, Ken; Hautzel, Hubertus
    False Positive Ventilation/Perfusion SPECT/CT Mismatch Mimicking Pulmonary Embolism in a Patient With Bilateral Lung Transplant
    In: Clinical Nuclear Medicine Jg. 47 (2022) Nr. 11, S. e718 - e721
  • Kersting, David; Sraieb, Miriam; Seifert, Robert; Costa, Pedro Fragoso; Kazek, Sandra; Kessler, Lukas; Umutlu, Lale; Fendler, Wolfgang; Jentzen, Walter; Herrmann, Ken; Büther, Florian; Nader, Michael; Rischpler, Christoph
    First experiences with dynamic renal [⁶⁸Ga]Ga-DOTA PET/CT : A comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rate
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. 10, S. 3373 - 3386
  • Lazaridis, Lazaros; Bumes, Elisabeth; Cäcilia Spille, Dorothee; Schulz, Tim; Heider, Sina; Agkatsev, Sarina; Schmidt, Teresa; Blau, Tobias; Oster, Christoph; Feldheim, Jonas; Stummer, Walter; Kessler, Almuth Friederike; Seidel, Clemens; Grauer, Oliver; Hau, Peter; Sure, Ulrich; Keyvani, Kathy; Herrlinger, Ulrich; Kleinschnitz, Christoph; Stuschke, Martin; Herrmann, Ken; Deuschl, Cornelius; Breuer, Stella; Hattingen, Elke; Scheffler, Björn; Kebir, Sied; Glas, Martin
    First multicentric real-life experience with the combination of CCNU and temozolomide in newly diagnosed MGMT promoter methylated IDH wildtype glioblastoma
    In: Neuro-Oncology Advances Jg. 4 (2022) Nr. 1, S. vdac137
  • Bruckmann, Nils Martin; Kirchner, Julian; Morawitz, Janna; Umutlu, Lale; Fendler, Wolfgang; Herrmann, Ken; Bittner, Ann-Kathrin; Hoffmann, Oliver; Fehm, Tanja; Lindemann, Maike E.; Buchbender, Christian; Antoch, Gerald; Sawicki, Lino M.
    Free-breathing 3D Stack of Stars GRE (StarVIBE) sequence for detecting pulmonary nodules in 18F-FDG PET/MRI
    In: EJNMMI Physics Jg. 9 (2022) Nr. 1, 11
  • Pacelli, Anna; Zarrad, Fadi; Fendler, Wolfgang; Herrmann, Ken; Nader, Michael
    Fully Automated, High-Dose Radiosynthesis of [18F]PARPi
    In: Pharmaceuticals Jg. 15 (2022) Nr. 7, 865
  • Herrmann, Ken; Krause, B. J.; Rahbar, K.; Chi, K. N.; Morris, M. J.; Sartor, O.; Tagawa, S. T.; Kendi, A. T.; Vogelzang, N.; Calais, J.; Nagarajah, James; Wei, X. X.; Koshkin, V.; Beauregard, J.; Chang, B.; DeSilvio, M.; Messmann, R. A.; de Bono, J.; Fizazi, K.;
    Health-related quality of life (HRQoL), pain and safety outcomes in the phase 3 VISION study of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine October ; 15-19, 2022 Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S55 - S56
  • Nadig, Vanessa; Herrmann, Ken; Mottaghy, Felix M.; Schulz, Volkmar
    Hybrid total-body pet scanners : current status and future perspectives
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) S. 445 - 459
  • Unterrainer, Marcus; Deroose, Christophe M.; Herrmann, Ken; Moehler, Markus; Blomqvist, Lennart; Cannella, Roberto; Caramella, Caroline; Caruso, Damiano; Chouhan, Manil D.; Denecke, Timm; De la Pinta, Carolina; De Geus-Oei, Lioe-Fee; Dulskas, Audrius; Eisenblätter, Michel; Foley, Kieran G.; Gourtsoyianni, Sofia; Lecouvet, Frederic E.; Lopci, Egesta; Maas, Monique; Obmann, Markus M.; Oprea-Lager, Daniela E.; Verhoeff, Joost J.C.; Santiago, Ines; Terraz, Sylvain; D'Anastasi, Melvin; Regge, Daniele; Laghi, Andrea; Beets-Tan, Regina G.H.; Heinemann, Volker; Lordick, Florian; Smyth, Elizabeth C.; Ricke, Jens; Kunz, Wolfgang G.
    Imaging standardisation in metastatic colorectal cancer : A joint EORTC-ESOI-ESGAR expert consensus recommendation
    In: European Journal of Cancer (EJC) Jg. 176 (2022) S. 193 - 206
  • Rischpler, Christoph; Rassaf, Tienush; Umutlu, Lale; Herrmann, Ken; Schlosser, Thomas Wilfried; Totzeck, Matthias
    Imaging the Inflammatory Response in Checkpoint Inhibition Myocarditis
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 1, S. 14 - 16
  • Pogorzelski, M.; Fendler, Wolfgang; Berliner, C.; Hussain, T.; Lang, Stephan; Ting, Saskia; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Gauler, Thomas; Stuschke, Martin; Laue, K.; Herrmann, Ken; Grünwald, V.; Schuler, Martin; Kasper-Virchow, S.;
    Immuntherapie eines Mikrosatelliten-instabilen metastasierten Talgdrüsenkarzinoms der Glandula submandibularis mit Pembrolizumab
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,
    In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 230 - 231
  • Nader, M.; Herrmann, Ken; Kunkel, F.; Zarrad, F.; Pacelli, A.; Fendler, Wolfgang; Koplin, S.
    Improved production of ⁶⁸Ga-Pentixafor using cartridge mediated cation exchange purification
    In: Applied Radiation and Isotopes Jg. 189 (2022) 110447
  • Schmidt, Matthias; Bartenstein, Peter; Bucerius, Jan; Dietlein, Markus; Drzezga, Alexander; Herrmann, Ken; Lapa, Constantin; Lorenz, Kerstin; Musholt, Thomas J.; Nagarajah, James; Reiners, Christoph; Sahlmann, Carsten O.; Kreissl, Michael C.
    Individualized treatment of differentiated thyroid cancer : The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear Medicine
    In: Nuklearmedizin = Nuclear Medicine Jg. 61 (2022) Nr. 02, S. 87 - 96
  • Ferdinandus, Justin; Costa, Pedro Fragoso; Kessler, Lukas; Weber, Manuel; Hirmas, Nader; Kostbade, Karina; Bauer, Sebastian; Schuler, Martin; Ahrens, Marit; Schildhaus, Hans-Ulrich; Rischpler, Christoph; Grafe, Hong; Siveke, Jens; Herrmann, Ken; Fendler, Wolfgang; Hamacher, Rainer
    Initial Clinical Experience with ⁹⁰Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors : A Case Series of 9 Patients
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 5, S. 727 - 734
  • Seifert, Robert; Kersting, David; Rischpler, Christoph; Sandach, Patrick; Ferdinandus, Justin; Fendler, Wolfgang; Rahbar, Kambiz; Weckesser, Matthias; Umutlu, Lale; Hanoun, Christine; Hüttmann, Andreas; Reinhardt, Hans Christian; von Tresckow, Bastian; Herrmann, Ken; Dührsen, Ulrich; Schäfers, Michael
    Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification : A post-hoc analysis of the PETAL trial
    In: Leukemia Jg. 36 (2022) Nr. 12, S. 2845 - 2852
  • Grafe, Hong; Lindemann, Maike E.; Weber, Manuel; Kirchner, Julian; Binse, Ina; Umutlu, Lale; Herrmann, Ken; Quick, Harald H.
    Intra-Individual Comparison of 124I-PET/CT and 124I-PET/MR Hybrid Imaging of Patients with Resected Differentiated Thyroid Carcinoma : Aspects of Attenuation Correction
    In: Cancers Jg. 14 (2022) Nr. 13, 3040
  • Herrmann, Ken; Giovanella, Luca; Santos, Andrea; Gear, Jonathan; Kiratli, Pinar Ozgen; Kurth, Jens; Denis-Bacelar, Ana M.; Hustinx, Roland; Patt, Marianne; Wahl, Richard L.; Paez, Diana; Giammarile, Francesco; Jadvar, Hossein; Pandit-Taskar, Neeta; Ghesani, Munir; Kunikowska, Jolanta
    Joint EANM, SNMMI and IAEA enabling guide : How to set up a theranostics centre
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. 7, S. 2300 - 2309
  • Herrmann, Ken; Giovanella, Luca; Santos, Andrea; Gear, Jonathan; Ozgen Kiratli, Pinar; Kurth, Jens; Denis-Bacelar, Ana M.; Hustinx, Roland; Patt, Marianne; Wahl, Richard L.; Paez, Diana; Giammarile, Francesco; Jadvar, Hossein; Pandit-Taskar, Neeta; Ghesani, Munir; Kunikowska, Jolanta
    Joint EANM, SNMMI, and IAEA Enabling Guide : How to Set up a Theranostics Center
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 12, S. 1836 - 1843
  • Vaz, Sofia C.; Adam, Judit A.; Bolton, Roberto C. Delgado; Vera, Pierre; van Elmpt, Wouter; Herrmann, Ken; Hicks, Rodney J.; Lievens, Yolande; Santos, Andrea; Schöder, Heiko; Dubray, Bernard; Visvikis, Dimitris; Troost, Esther G. C.; de Geus-Oei, Lioe-Fee
    Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. 4, S. 1386 - 1406
  • Murphy, Declan; Herrmann, Ken; Hofman, Michael
    Leading in Urology and Pioneering in Social Media Outreach : A Conversation Among Declan Murphy, Ken Herrmann, and Michael Hofman
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 12, S. 1783 - 1785
  • Kersting, David; Jentzen, Walter; Jeromin, D.; Mavroeidi, I.; Conti, M.; Büther, F.; Herrmann, Ken; Rischpler, Christoph; Hamacher, R.; Fendler, Wolfgang P.; Seifert, R.; Fragoso Costa, P.;
    Lesion Quantification Accuracy of Digital 90Y PET Imaging in the Context of Dosimetry in Systemic FAPI Radionuclide Therapy
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S636
  • Leyh, Catherine; Heucke, Niklas; Schotten, Clemens; Büchter, Matthias; Bechmann, Lars P.; Wichert, Marc; Dechene, Alexander; Herrmann, Ken; Heider, Dominik; Sydor, Svenja; Lemmer, Peter; Ludwig, Johannes M.; Pospiech, Josef; Theysohn, Jens; Damm, Robert; March, Christine; Powerski, Maciej; Pech, Maciej; Özcürümez, Mustafa; Weigt, Jochen; Keitel, Verena; Lange, Christian M.; Schmidt, Hartmut; Canbay, Aliekber; Best, Jan; Gerken, Guido; Manka, Paul
    LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver Cirrhosis
    In: Cancers Jg. 14 (2022) Nr. 19, 4584
  • Leyh, Catherine; Heucke, Niklas; Schotten, Clemens; Büchter, Matthias; Bechmann, Lars; Wichert, Marc; Dechene, Alexander; Herrmann, Ken; Katsounas, Antonios; Özcürümez, Mustafa; Heider, Dominik; Sydor, Svenja; Ludwig, Johannes M.; Theysohn, Jens; Damm, Robert; Powerski, Maciej; Pech, Maciej; Canbay, Ali; Weigt, Jochen; Keitel-Anselmino, Verena; Lange, Christian; Best, Jan; Manka, Paul;
    LiMAx faciliates patient selection prior radioembolization for patients with hepatocellular carcinoma in liver cirrhosis
    The International Liver Congress 2022 ; 22-26 June 2022, London, UK,
    In: Journal of Hepatology Jg. 77 (2022) Nr. Supplement 1: Abstracts of The International Liver CongressTM 2022, S. S378 - S379
  • Singh, Simron; Pavel, Marianne; Kunz, Pamela L.; de Herder, Wouter; Herrmann, Ken; D'Amelio, Anthony M., Jr.; Santoro, Paola; Folitar, Ilya; Ferone, Diego;
    Lu-DOTA-TATE as First-line Therapy for Patients With Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) : The NETTER-2 Study
    14th Annual Multidisciplinary Neuroendocrine Tumor Medical Virtual Symposium of the North American Neuroendocrine Tumor Society: 2021 Multidisciplinary NET Medical Symposium, November 4-6, 2021, Chicago, Virtual,
    In: Pancreas Jg. 51 (2022) Nr. 3, Abstracts Presented at the 14th Annual Multidisciplinary Neuroendocrine Tumor Medical Virtual Symposium of the North American Neuroendocrine Tumor Society, November 4-6, 2021, S. E58 - E58
  • Jannusch, Kai; Bruckmann, Nils Martin; Geuting, Charlotte Johanna; Morawitz, Janna; Dietzel, Frederic; Rischpler, Christoph; Herrmann, Ken; Bittner, Ann-Kathrin; Hoffmann, Oliver; Mohrmann, Svjetlana; Quick, Harald H.; Umutlu, Lale; Antoch, Gerald; Kirchner, Julian
    Lung Nodules Missed in Initial Staging of Breast Cancer Patients in PET/MRI : Clinically Relevant?
    In: Cancers Jg. 14 (2022) Nr. 14, 3454
  • Oprea-Lager, Daniela E.; Ceci, Francesco; Eiber, Matthias; Fanti, Stefano; Herrmann, Ken
    Lymph node classification in E‑PSMA reporting guidelines for PSMA‑PET
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2022) Nr. 1, S. 10 - 11
  • Gafita, A.; Rauscher, I.; Fendler, Wolfgang; Murthy, V.; Hui, W.; Armstrong, W.; Herrmann, Ken; Weber, W.; Calais, J.; Eiber, M.; Weber, Manuel; Benz, M.;
    Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT : Comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S267
  • Gafita, Andrei; Rauscher, Isabel; Fendler, Wolfgang; Murthy, Vishnu; Hui, Wang; Armstrong, Wesley R.; Herrmann, Ken; Weber, Wolfgang A.; Calais, Jeremie; Eiber, Matthias; Weber, Manuel; Benz, Matthias R.
    Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT : comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. 12, S. 4271 - 4281
  • Voltin, C.; Gödel, P.; Beckmann, L.; Heger, J.; Kobe, C.; Kutsch, N.; Borchmann, P.; Dietlein, M.; Herrmann, Ken; Stelljes, M.; Rahbar, K.; Lenz, G.; Reinhardt, H. C.; Teichert, M.; Noppeney, Richard; Albring, J. C.; Seifert, R.; von Tresckow, Bastian; Floßdorf, S.; Hanoun, C.;
    Metabolic Tumor Volume for Outcome Prediction in Patients with Large B-Cell Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Treatment
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S211
  • Ferdinandus, Justin; Zaremba-Montenari, Anne; Zimmer, Lisa; Umutlu, Lale; Seifert, Robert; Barbato, Francesco; Ugurel, Selma; Chorti, Eleftheria; Grünwald, Viktor; Herrmann, Ken; Schadendorf, Dirk; Fendler, Wolfgang; Livingstone, Elisabeth
    Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma
    In: Cancer Imaging Jg. 22 (2022) Nr. 1,
  • Kurth, J.; Rahbar, K.; Eiber, M.; Sparks, R.; Baca, N.; Krause, B. J.; Lassmann, M.; Jentzen, Walter; Chicco, D.; Klein, P.; Blumenstein, L.; Basque, J.; Herrmann, Ken;
    Multi-cycle dosimetry of [Lu-177]Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer : results from the VISION trial sub-study
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine October ; 15-19, 2022 Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S129
  • Umutlu, Lale; Kirchner, Julian; Bruckmann, Nils-Martin; Morawitz, Janna; Antoch, Gerald; Ting, Saskia; Bittner, Ann-Kathrin; Hoffmann, Oliver; Häberle, Lena; Ruckhäberle, Eugen; Catalano, Onofrio Antonio; Chodyla, Michal; Grueneisen, Johannes; Quick, Harald H.; Fendler, Wolfgang; Rischpler, Christoph; Herrmann, Ken; Gibbs, Peter; Pinker, Katja
    Multiparametric¹⁸F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
    In: Cancers Jg. 14 (2022) Nr. 7, 1727
  • Husseini, Jad S.; Balza, Rene; Jarraya, Mohamed; Cañamaque, Lina Garcia; Barbato, Francesco; Herrmann, Ken; Picchio, Maria; Catalano, Onofrio Antonio
    Musculoskeletal imaging
    In: Clinical PET/MRI / Catalano, Onofrio Antonio (Hrsg.) (2022) S. 199 - 224
  • Gafita, Andrei; Rauscher, Isabel; Weber, Manuel; Hadaschik, Boris; Wang, Hui; Armstrong, Wesley R.; Tauber, Robert; Grogan, Tristan R.; Czernin, Johannes; Rettig, Matthew B.; Herrmann, Ken; Calais, Jeremie; Weber, Wolfgang A.; Benz, Matthias R.; Fendler, Wolfgang; Eiber, Matthias
    Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0) : An International Multicenter Study
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 11, S. 1651 - 1658
  • Gafita, A.; Rauscher, I.; Weber, Manuel; Hadaschik, Boris; Wang, H.; Armstrong, W.R.; Tauber, R.; Grogan, T.R.; Czernin, J.; Rettig, M.B.; Herrmann, Ken; Calais, J.; Weber, W.; Benz, M.R.; Fendler, Wolfgang; Eiber, M.;
    Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0) : An international multicenter study
    EAU22: 37th Annual EAU Congress, 01.-04.07.2022, Amsterdam,
    In: European Urology Jg. 81 (2022) Nr. Supplement 1: Abstracts EAU22 - 37th Annual EAU Congress, S. S794 - S795
  • Gafita, Andrei; Rauscher, Isabel; Weber, Manuel; Hadaschik, Boris; Wang, Hui; Armstrong, Wesley Robert; Tauber, Robert; Grogan, Tristan R.; Czernin, Johannes; Rettig, Matthew B.; Herrmann, Ken; Calais, Jeremie; Weber, Wolfgang A.; Benz, Matthias; Fendler, Wolfgang; Eiber, Matthias;
    Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0) : an international multicenter study
    2022 ASCO Genitourinary Cancers Symposium, 17.-19.02.2022, San Fransisco,
    In: Journal of Nuclear Medicine (JNM) Jg. 40 (2022) Nr. 6, Supplement: 2022 ASCO Genitourinary Cancers Symposium, jnumed.121.263072
  • Gafita, A.; Rauscher, I.; Weber, Manuel; Hadaschik, Boris; Wang, H.; Armstrong, W.; Tauber, R.; Grogan, T.; Czernin, J.; Rettig, M.; Herrmann, Ken; Calais, J.; Weber, W.; Benz, M.; Fendler, Wolfgang; Eiber, M.;
    Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0) : an international multicenter study
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022 Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S269
  • Gafita, Andrei; Rauscher, Isabel; Weber, Manuel; Hadaschik, Boris; Wang, Hui; Armstrong, Wesley R.; Tauber, Robert; Grogan, Tristan; Czernin, Johannes; Rettig, Matthew; Herrmann, Ken; Calais, Jeremie; Weber, Wolfgang A.; Benz, Matthias R.; Fendler, Wolfgang; Eiber, Matthias
    Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP) : An international multicenter study
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. Suppl. 6, 42
  • Herrmann, Ken; Garin, E.; Fowers, K.; Salem, R.; Lam, M.;
    Observer Reproducibility in the Calculation of Yttrium-90 Absorbed Dose in Patients with Hepatocellular Carcinoma : The Round Robin Sub-Study of The Global Retrospective TARGET Study
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022 Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S62
  • Laschinsky, Christina; Herrmann, Ken; Fendler, Wolfgang; Nader, Michael; Lahner, Harald; Hadaschik, Boris; Sandach, Patrick
    Onkologische Theranostik in der Nuklearmedizin
    In: Die Radiologie Jg. 62 (2022) Nr. 10, S. 875 - 884
  • Laschinsky, Christina; Herrmann, Ken; Fendler, Wolfgang; Nader, Michael; Lahner, Harald; Hadaschik, Boris; Sandach, Patrick
    Onkologische Theranostik in der Nuklearmedizin
    In: Die Onkologie Jg. 28 (2022) Nr. 7, S. 612 - 622
  • Ferdinandus, Justin; Fendler, Wolfgang; Farolfi, Andrea; Washington, Samuel; Mohamad, Osama; Pampaloni, Miguel H.; Scott, Peter J.H.; Rodnick, Melissa; Viglianti, Benjamin L.; Eiber, Matthias; Herrmann, Ken; Czernin, Johannes; Armstrong, Wesley R.; Calais, Jeremie; Hope, Thomas A.; Piert, Morand; Mohammad, Osama
    PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups : An International Multicenter Study
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 1, S. 76 - 80
  • Fendler, Wolfgang; Ferdinandus, J.; Farolfi, A.; Washington, S.; Mohamad, O.; Pampaloni, M.; Scott, P.; Rodnick, M.; Viglianti, B.; Eiber, M.; Herrmann, Ken; Czernin, J.; Armstrong, W.; Calais, J.; Hope, T.; Piert, M.;
    PSMA PET disease extent for European Association of Urology biochemical recurrence risk groups : An international multicentre study
    EAU22: 37th Annual EAU Congress, 01.-04.07.2022, Amsterdam,
    In: European Urology Jg. 81 (2022) Nr. Supplement 1: Abstracts EAU22 - 37th Annual EAU Congress, S. S291
  • Mattoni, Susanna; Farolfi, Andrea; Formaggio, Fabio; Bruno, Gabriel; Caroli, Paola; Cerci, Juliano Julio; Eiber, Matthias; Fendler, Wolfgang; Golfieri, Rita; Herrmann, Ken; Matteucci, Federica; Mosconi, Cristina; Paolani, Giulia; Santoro, Miriam; Strigari, Lidia; Nanni, Cristina; Castellucci, Paolo; Fanti, Stefano
    PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients : A Multicenter Retrospective Study
    In: Cancers Jg. 14 (2022) Nr. 22, 5680
  • Civan, C.; Kasper, Stefan; Berliner, C.; Fragoso-Costa, P.; Grünwald, V.; Pogorzelski, M.; Schaarschmidt, B. M.; Lang, Stephan; Kersting, David; Nader, M.; Lückerath, Katharina; Herrmann, Ken; Fendler, Wolfgang P.; Weber, Manuel;
    PSMA-directed imaging and therapy of salivary gland tumors : a single-center retrospective study
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S229
  • Vaz, Sofia C.; Adam, Judit A.; Delgado Bolton, Roberto C.; Vera, Pierre; van Elmpt, Wouter; Herrmann, Ken; Hicks, Rodney J.; Lievens, Yolande; Santos, Andrea; Schöder, Heiko; Dubray, Bernard; Visvikis, Dimitris; Troost, Esther G.C.; de Geus-Oei, Lioe-Fee
    Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[¹⁸F]FDG-PET/CT external beam radiation treatment planning in lung cancer
    In: Radiotherapy and Oncology (The Green Journal) Jg. 168 (2022) S. 37 - 39
  • Fragoso Costa, Pedro; Jentzen, Walter; Brahmer, Alissa; Mavroeidi, Ilektra-Antonia; Zarrad, Fadi; Umutlu, Lale; Fendler, Wolfgang; Rischpler, Christoph; Herrmann, Ken; Conti, Maurizio; Seifert, Robert; Sraieb, Miriam; Weber, Manuel; Kersting, David
    Phantom-based acquisition time and image reconstruction parameter optimisation for oncologic FDG PET/CT examinations using a digital system
    In: BMC Cancer Jg. 22 (2022) Nr. 1, 899
  • Kmetyuk, Yaroslav; Czernin, Johannes; Herrmann, Ken
    Practicing Medicine in Wartime Ukraine : A Conversation Between Yaroslav Kmetyuk, Johannes Czernin, and Ken Herrmann
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 8, S. 1127 - 1130
  • Theysohn, Jens; Demircioglu, Aydin; Kleditzsch, Malte; Ludwig, Johannes M.; Weber, Manuel; Umutlu, Lale; Li, Yan; Kircher, Malte; Lapa, Constantin; Buck, Andreas; Koehler, Michael; Wildgruber, Moritz; Lange, Christian M.; Palard, Xavier; Garin, Etienne; Herrmann, Ken; Forsting, Michael; Nensa, Felix
    Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validation
    In: Scientific Reports Jg. 12 (2022) Nr. 1, 20718
  • Guberina, Maja; Herrmann, Ken; Pöttgen, Christoph; Guberina, Nika; Hautzel, Hubertus; Gauler, Thomas; Ploenes, Till; Umutlu, Lale; Wetter, Axel; Theegarten, Dirk; Aigner, Clemens; Eberhardt, Wilfried; Metzenmacher, Martin; Wiesweg, Marcel; Schuler, Martin; Karpf-Wissel, Rüdiger; Santiago Garcia, Alina; Darwiche, Kaid; Stuschke, Martin
    Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT
    In: Scientific Reports Jg. 12 (2022) Nr. 1, 17511
  • Sartor, Oliver; Herrmann, Ken
    Prostate Cancer Treatment : 177Lu-PSMA-617 Considerations, Concepts, and Limitations
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 6, S. 823 - 829
  • Coelho, M.; Fragoso Costa, P.; Herrmann, Ken; Hautzel, H.;
    Pulmonary right-to-left shunt estimation with (99)mTc-labeled macroaggregated albumin (MAA) : Establishing a normal range with correction for unbound (99)mTc
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S93 - S94
  • Moraitis, A.; Reiter, G.; Kersting, David; Weber, Manuel M.; Fendler, Wolfgang P.; Herrmann, Ken; Fragoso Costa, P.; Jentzen, Walter;
    Radiation Exposure of I-124-MIBG Imaging in Adult Patients with Neuroendocrine Tumours
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S36 - S37
  • Costa, Pedro Fragoso; Fendler, Wolfgang; Herrmann, Ken; Sandach, Patrick; Grafe, Hong; Grootendorst, Maarten R.; Püllen, Lukas; Kesch, Claudia; Krafft, Ulrich; Radtke, Jan P.; Tschirdewahn, Stephan; Hadaschik, Boris; Darr, Christopher
    Radiation Protection and Occupational Exposure on ⁶⁸Ga-PSMA-11-Based Cerenkov Luminescence Imaging Procedures in Robot-Assisted Prostatectomy
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 9, S. 1349 - 1356
  • Bodei, Lisa; Herrmann, Ken; Schöder, Heiko; Scott, Andrew M.; Lewis, Jason S.
    Radiotheranostics in oncology : current challenges and emerging opportunities
    In: Nature Reviews Clinical Oncology Jg. 19 (2022) Nr. 8, S. 534 - 550
  • Hope, T.A.; Eiber, M.; Armstrong, W.R.; Juarez, R.; Murthy, V.; Lawhn-Heath, C.; Behr, S.C.; Zhang, L.; Barbato, F.; Ceci, F.; Farolfi, A.; Schwarzenbock, S.M.; Unterrainer, M.; Zacho, H.D.; Nguyen, H.G.; Cooperberg, M.R.; Carroll, P.R.; Reiter, R.E.; Holden, S.; Herrmann, Ken; Zhu, S.; Fendler, Wolfgang; Czernin, J.; Calais, J.
    Re: Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection prior to Radical Prostatectomy and Pelvic Lymph Node Dissection : A Multicenter Prospective Phase 3 Imaging Trial
    In: The Journal of Urology Jg. 207 (2022) Nr. 4, S. 930
  • Sartor, O.; de Bono, J.; Chi, K.N.; Fizazi, K.; Herrmann, Ken; Rahbar, K.; Tagawa, S.T.; Nordquist, L.T.; Vaishampayan, N.; El-Haddad, G.; Park, C.H.; Beer, T.M.; Armour, A.; Perez-Contreras, W.J.; DeSilvio, M.; Kpamegan, E.; Gericke, G.; Messmann, R.A.; Morris, M.J.; Krause, B.J.
    Re: Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
    In: The Journal of Urology Jg. 207 (2022) Nr. 2, S. 467 - 468
  • Seifert, Robert; Sandach, Patrick; Kersting, David; Fendler, Wolfgang; Hadaschik, Boris; Herrmann, Ken; Sunderland, John J.; Pollard, Janet H.
    Repeatability of ⁶⁸Ga-PSMA-HBED-CC PET/CT-Derived Total Molecular Tumor Volume
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 5, S. 746 - 753
  • Ferdinandus, Justin; Fendler, Wolfgang; Lückerath, Katharina; Berliner, Christoph; Kurzidem, Sabine; Hadaschik, Eva; Klode, Joachim; Zimmer, Lisa; Livingstone, Elisabeth; Schadendorf, Dirk; Herrmann, Ken; Becker, Jürgen; Ugurel, Selma
    Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 3, S. 396 - 398
  • Guberina, M.; Pöttgen, Christoph; Guberina, N.; Gauler, Thomas; Metzenmacher, M.; Wiesweg, Marcel; Richlitzki, C.; Plönes, T.; Forsting, Michael; Wetter, Axel; Herrmann, Ken; Hautzel, H.; Darwiche, Kaid; Theegarten, Dirk; Aigner, Clemens; Schuler, Martin; Eberhardt, Wilfried E. E.; Stuschke, Martin;
    Robuste und lang-andauernde Wirksamkeit der Durvalumab-Konsolidierung bei NSCLC im Stadium III nach Induktionschemotherapie und definitiver Radiochemotherapie : Fokus auf Behandlungsauswahl und prognostische Faktoren
    28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 198 (2022) Nr. Supplement 1, S. S15
  • Pomykala, Kelsey L.; Herrmann, Ken; Padhani, Anwar R.; Hofman, Michael S.; Lalumera, Elisabetta; Fanti, Stefano
    Role of Prostate-Specific Membrane Antigen PET in Metastatic Prostate Cancer : We Have the Answers
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 10, S. 1480 - 1481
  • Fendler, Wolfgang; Pabst, Kim M.; Kessler, Lukas; Fragoso Costa, Pedro; Ferdinandus, Justin; Weber, Manuel; Lippert, Maria; Lückerath, Katharina; Umutlu, Lale; Kostbade, Karina; Mavroeidi, Ilektra A.; Schuler, Martin; Ahrens, Marit; Rischpler, Christoph; Bauer, Sebastian; Herrmann, Ken; Siveke, Jens; Hamacher, Rainer
    Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities
    In: Clinical Cancer Research Jg. 28 (2022) Nr. 19, S. 4346 - 4353
  • Hamacher, R.W.; Pabst, K.M.; Kessler, Lukas; Costa, Pedro Fragoso; Ferdinandus, J.; Weber, Manuel; Lippert, M.; Lückerath, Katharina; Hirmas, N.; Kostbade, K.; Mavroeidi, I.A.; Schuler, Martin H. H.; Ahrens, M.; Rischpler, Christoph; Bauer, Sebastian; Herrmann, Ken; Siveke, Jens T.; Fendler, Wolfgang P.;
    Safety and efficacy of [90Y]Y-FAPI-46 radioligand therapy in patients with advanced sarcomas and other cancer entities
    ESMO Congress 2022, 9 - 13 September 2022, Paris, France,
    In: Annals of Oncology Jg. 33 (2022) Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S1231 - S1232
  • Kersting, David; Settelmeier, Stephan; Mavroeidi, Ilektra-Antonia; Herrmann, Ken; Seifert, Robert; Rischpler, Christoph
    Shining Damaged Hearts : Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear Cardiology
    In: International Journal of Molecular Sciences (IJMS) Jg. 23 (2022) Nr. 7, 3802
  • Lapa, Constantin; Herrmann, Ken; Troost, Esther G. C.
    Specific PET Tracers for Solid Tumors and for Definition of the Biological Target Volume
    In: Image-Guided High-Precision Radiotherapy / Troost, Esther G. C. (2022) S. 31 - 53
  • Lahner, Harald; Mathew, Annie; Klocker, Anna Lisa; Unger, Nicole; Theysohn, Jens; Rekowski, Jan; Jöckel, Karl-Heinz; Theurer, Sarah; Schmid, Kurt Werner; Herrmann, Ken; Führer, Dagmar
    Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapy
    In: Endocrine Jg. 75 (2022) Nr. 1, S. 293 - 302
  • Pabst, K. M.; Trajkovic-Arsic, M.; Cheung, P. F.; Kessler, Lukas; Hirmas, N.; Nader, M.; Bartel, T.; Schaarschmidt, B. M.; Kasper, Stefan; Siveke, Jens T.; Hamacher, R.; Schmidt, H. H. J.; Ingenwerth, M.; Herrmann, Ken; Fendler, Wolfgang P.;
    Superiority of [68Ga]Ga-FAPI-46 over [18F]F-FDG PET/CT for cholangiocarcinoma imaging
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022 Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S192 - S193
  • Hirmas, N.; Ingenwerth, M.; Sraieb, Miriam; Kessler, Lukas; Pabst, K. M.; Lanzafame, H.; Lückerath, Katharina; Kasper, Stefan; Nader, M.; Schildhaus, Hans-Ulrich; Hadaschik, Boris; Gruenwald, V.; von Tresckow, Bastian; Hanoun, C.; Aigner, Clemens; Glas, M.; Herrmann, Ken; Siveke, Jens T.; Hamacher, R.; Fendler, Wolfgang P.;
    Target Expression and FAP-Directed Tumour Imaging in a Large, Single-Centre PET Database of 324 Patients and 21 Tumour Entities
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S119 - S120
  • Michel, Lars; Helfrich, Iris; Hendgen-Cotta, Ulrike Barbara; Mincu, Raluca-Ileana; Korste, Sebastian; Mrotzek, Simone Maria; Spomer, Armin; Odersky, Andrea; Rischpler, Christoph; Herrmann, Ken; Umutlu, Lale; Coman, Cristina; Ahrends, Robert; Sickmann, Albert; Löffek, Stefanie; Livingstone, Elisabeth; Ugurel, Selma; Zimmer, Lisa; Gunzer, Matthias; Schadendorf, Dirk; Totzeck, Matthias; Rassaf, Tienush
    Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy
    In: European Heart Journal Jg. 43 (2022) Nr. 4, S. 316 - 329
  • Pabst, Kim M.; Decker, Thomas; Kersting, David; Bartel, Timo; Sraieb, Miriam; Herrmann, Ken; Seifert, Robert
    The Future Role of PET Imaging in Metastatic Breast Cancer
    In: Oncology Research and Treatment Jg. 45 (2022) Nr. 1-2, S. 18 - 25
  • Tagawa, Scott T.; Armstrong, Andrew J.; Krause, Bernd J.; Herrmann, Ken; Rahbar, Kambiz; De Bono, Johann S.; Adra, Nabil; Desilvio, Michelle; Messmann, Richard; Holder, Geoffrey; Chi, Kim N.
    Tolerability of [177Lu]Lu-PSMA-617 by treatment exposure in patients with metastatic castration-resistant prostate cancer (mCRPC) : A VISION study subgroup analysis
    In: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. 16_Suppl., S. 5047
  • Weich, Alexander; Higuchi, Takahiro; Bundschuh, Ralph A.; Lapa, Constantin; Serfling, Sebastian E.; Rowe, Steven P.; Pomper, Martin G.; Herrmann, Ken; Buck, Andreas K.; Derlin, Thorsten; Werner, Rudolf A.
    Training on Reporting and Data System (RADS) for Somatostatin-Receptor Targeted Molecular Imaging Can Reduce the Test Anxiety of Inexperienced Readers
    In: Molecular Imaging and Biology Jg. 24 (2022) Nr. 4, S. 631 - 640
  • Liu, S.; Planchard, D.; Herrmann, Ken; D'Amelio, A.; Folitar, I.; Ares, L. Paz
    Trial in Progress: [177Lu]Lu-DOTA-TATE Combination Therapy in Treatment-Naïve Extensive Stage Small Cell Lung Cancer
    In: Journal of Thoracic Oncology Jg. 17 (2022) Nr. 9, S. 534
  • Gafita, Andrei; Wang, Hui; Robertson, Andrew; Armstrong, Wesley R.; Zaum, Raphael; Weber, Manuel; Yagubbayli, Farid; Kratochwil, Clemens; Grogan, Tristan R.; Nguyen, Kathleen; Navarro, Fernando; Esfandiari, Rouzbeh; Rauscher, Isabel; Menze, Bjoern; Elashoff, David; Delpassand, Ebrahim S.; Herrmann, Ken; Czernin, Johannes; Hofman, Michael S.; Calais, Jeremie; Fendler, Wolfgang; Eiber, Matthias
    Tumor Sink Effect in ⁶⁸Ga-PSMA-11 PET : Myth or Reality?
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 2, S. 226 - 232
  • Chodyla, Michal; Barbato, Francesco; Dirksen, Uta; Kirchner, Julian; Schaarschmidt, Benedikt M.; Schweiger, Bernd; Forsting, Michael; Herrmann, Ken; Umutlu, Lale; Grueneisen, Johannes
    Utility of Integrated PET/MRI for the Primary Diagnostic Work-Up of Patients with Ewing Sarcoma : Preliminary Results
    In: Diagnostics Jg. 12 (2022) Nr. 10, 2278
  • Murray, Jacob M.; Wiegand, Bodo; Hadaschik, Boris; Herrmann, Ken; Kleesiek, Jens
    Virtual Biopsy : Just an AI Software or a Medical Procedure?
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 4, S. 511 - 513
  • Pomykala, Kelsey L.; Herrmann, Ken; Emmett, Louise; Lalumera, Elisabetta; Fanti, Stefano
    Virtual Prostate Biopsy with Prostate-specific Membrane Antigen and Magnetic Resonance Imaging : Closer to Reality in a Subgroup of Prostate Cancer Patients?
    In: European Urology Open Science Jg. 44 (2022) S. 11 - 12
  • Freudenberg, Lutz; Freudenberg, Ben J.; Klett, Rigobert; Herrmann, Ken
    Vom Aussterben bedroht? : Eine Demografie der Nuklearmedizin in Deutschland 1996–2021 anhand der Zahlen der Bundesärztekammer
    In: Nuklearmedizin = Nuclear Medicine Jg. 61 (2022) Nr. 05, S. 358 - 366
  • Myrehaug, Sten; Singh, Simron; Pavel, Marianne; Kunz, Pamela; de Herder, Wouter; Herrmann, Ken; D’Amelio, Anthony; Santoro, Paola; Folitar, Ilya; Ferone, Diego
    [177Lu]Lu-Dota-Tate as First-Line Therapy for Patients with Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETS) : The NETTER-2 Study
    In: Radiotherapy and Oncology (The Green Journal) Jg. 174 (2022) Nr. Suppl. 1, S. 40 - S41
  • Nader, Michael; Valla, D. F.; Vriamont, Charles; Masset, Julien; Pacelli, Anna; Herrmann, Ken; Zarrad, Fadi
    [⁶⁸Ga]/[⁹⁰Y]FAPI-46 : Automated production and analytical validation of a theranostic pair
    In: Nuclear Medicine and Biology Jg. 110-111 (2022) S. 37 - 44
  • Crompton, Joseph G.; Armstrong, Wesley R.; Eckardt, Mark A.; Seyedroudbari, Ameen; Tap, William D.; Dry, Sarah M.; Abt, Evan R.; Calais, Jeremie; Herrmann, Ken; Czernin, Johannes; Eilber, Fritz C.; Benz, Matthias R.
    ¹⁸F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue Sarcoma
    In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 5, S. 708 - 712
  • Papathanasiou, Maria; Kessler, Lukas; Carpinteiro, Alexander; Hagenacker, Tim; Nensa, Felix; Umutlu, Lale; Forsting, Michael; Brainman, Alexandra; Kleinschnitz, Christoph; Antoch, Gerald; Dührsen, Ulrich; Schlosser, Thomas Wilfried; Herrmann, Ken; Rassaf, Tienush; Lüdike, Peter; Rischpler, Christoph
    ¹⁸F-flutemetamol positron emission tomography in cardiac amyloidosis
    In: Journal of Nuclear Cardiology Jg. 29 (2022) Nr. 2, S. 779 - 789
  • Guberina, Nika; Kessler, Lukas; Pöttgen, Christoph; Guberina, Maja; Metzenmacher, Martin; Herrmann, Ken; Mucha, Maja; Rischpler, Christoph; Indenkämpen, Frank; Siveke, Jens; Treckmann, Jürgen-Walter; Umutlu, Lale; Kasper, Stefan; Fendler, Wolfgang; Stuschke, Martin
    ⁶⁸Ga]FAPI-PET/CT for radiation therapy planning in biliary tract, pancreatic ductal adeno-, and adenoidcystic carcinomas
    In: Scientific Reports Jg. 12 (2022) Nr. 1, 16261
  • Herrmann, Ken; Kratochwil, Clemens; Fendler, Wolfgang P.; Eiber, Matthias; Hustinx, Roland
    2021: the year [¹⁷⁷Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines? : Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands” by Dr. Germo Gericke
    In: European Journal of Nuclear Medicine and Molecular Imaging (2021)
  • Kessler, Lukas; Ferdinandus, J.; Costa, P. F.; Weber, Manuel; Hirmas, N.; Kostbade, K.; Bauer, Sebastian; Dirksen, U.; Zarrad, F.; Nader, M.; Grafe, Hong; Chodyla, M.; Milosevic, A.; Umutlu, Lale; Schuler, Martin; Ahrens, M.; Podleska, Lars E.; Schildhaus, Hans-Ulrich; Rischpler, Christoph; Siveke, Jens T.; Herrmann, Ken; Fendler, Wolfgang P.; Hamacher, R.;
    A novel theranostic approach for sarcoma : Insights on diagnostic and therapeutic use of FAP-radioligands
    Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,
    In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 11 - 12
  • Zaremba, Anne; Ferdinandus, J.; Zimmer, Lisa; Umutlu, Lale; Seifert, R.; Barbato, F.; Ugurel, Selma; Chorti, E.; Grünwald, V.; Herrmann, Ken; Schadendorf, Dirk; Fendler, Wolfgang; Livingstone, Elisabeth
    Additional Benefit of FDG-PET when Discontinuing Immune Checkpoint Inhibitor Therapy in Patients with metastatic Melanoma
    In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 75 - 76
  • Husseini, Jad S.; Amorim, Bárbara Juarez; Torrado-Carvajal, Angel; Prabhu, Vinay; Groshar, David; Umutlu, Lale; Herrmann, Ken; Cañamaque, Lina García; Garzón, José Ramón García; Palmer, William E.; Heidari, Pedram; Shih, Tiffany Ting-Fang; Sosna, Jacob; Matushita, Cristina; Cerci, Juliano; Queiroz, Marcelo; Muglia, Valdair Francisco; Nogueira-Barbosa, Marcello H.; Borra, Ronald J. H.; Kwee, Thomas C.; Glaudemans, Andor W. J. M.; Evangelista, Laura; Salvatore, Marco; Cuocolo, Alberto; Soricelli, Andrea; Herold, Christian; Laghi, Andrea; Mayerhoefer, Marius; Mahmood, Umar; Catana, Ciprian; Daldrup-Link, Heike E.; Rosen, Bruce; Catalano, Onofrio A.
    An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastases
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 5, S. 1522 - 1537
  • Weber, Manuel; Binse, Ina; Oebbecke, Karin; Brandenburg, Tim; Herrmann, Ken; Theurer, Sarah; Weber, Frank; Ehrlich, Ann-Kathrin; Schmid, Kurt Werner; Führer-Sakel, Dagmar; Vardarli, Irfan; Fendler, Wolfgang; Gilman, Elena; Görges, Rainer
    Analysis of risk factors and prognosis in differentiated thyroid cancer with focus on minimal extrathyroidal extension
    In: BMC Endocrine Disorders Jg. 21 (2021) Nr. 1, 161
  • Kersting, David; Rischpler, Christoph; Plönes, Till; Aigner, Clemens; Umutlu, Lale; Herrmann, Ken; Hautzel, Hubertus
    Atypical bilateral ventilation/perfusion mismatches in an asymptomatic patient suffering from metastatic thyroid cancer
    In: European Journal of Hybrid Imaging: EJNMMI Multimodality Journal Jg. 5 (2021) Nr. 1, 25
  • Freudenberg, Lutz; Essler, Markus; Herrmann, Ken
    Auswirkungen von COVID-19 auf nuklearmedizinische Untersuchungen und Therapien im Verlauf von 2020 : Ergebnisse einer nationalen Umfrage
    In: Nuklearmedizin = Nuclear Medicine Jg. 60 (2021) Nr. 3, S. 210 - 215
  • Oprea-Lager, Daniela E.; Cysouw, Matthijs C.F.; Boellaard, Ronald; Deroose, Christophe M.; de Geus-Oei, Lioe-Fee; Lopci, Egesta; Bidaut, Luc; Herrmann, Ken; Fournier, Laure S.; Bäuerle, Tobias; deSouza, Nandita M.; Lecouvet, Frederic E.
    Bone Metastases Are Measurable : The Role of Whole-Body MRI and Positron Emission Tomography
    In: Frontiers in Oncology Jg. 11 (2021) 772530
  • Bäumer, Christian; Bäcker, Markus; Conti, M; Fragoso Costa, P; Herrmann, Ken; Kazek, S L; Jentzen, Walter; Panin, V; Siegel, Steffen; Teimoorisichani, M; Wulff, J; Timmermann, Beate
    Can a ToF-PET photon attenuation reconstruction test stopping-power estimations in proton therapy? : A phantom study
    In: Physics in Medicine and Biology Jg. 66 (2021) Nr. 21, 215010
  • Giammarile, Francesco; Bolton, Roberto C. Delgado; El-Haj, Noura; Freudenberg, Lutz; Herrmann, Ken; Mikhail, Miriam; Morozova, Olga; Orellana, Pilar; Pellet, Olivier; Estrada L, Enrique; Vinjamuri, Sobhan; Gnanasegaran, Gopinath; Pynda, Yaroslav; Navarro-Marulanda, Maria C.; Choudhury, Partha S.; Paez, Diana
    Changes in the global impact of COVID-19 on nuclear medicine departments during 2020 : An international follow-up survey
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 13, S. 4318 - 4330
  • Kersting, David; Jentzen, Walter; Sraieb, Miriam; Costa, Pedro Fragoso; Conti, Maurizio; Umutlu, Lale; Antoch, Gerald; Nader, Michael; Herrmann, Ken; Fendler, Wolfgang Peter; Rischpler, Christoph; Weber, Manuel
    Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancer
    In: EJNMMI Physics Jg. 8 (2021) Nr. 1, 14
  • Bruckmann, Nils Martin; Lindemann, Maike E.; Grueneisen, Johannes; Grafe, Hong; Li, Yan; Sawicki, Lino M.; Rischpler, Christoph; Herrmann, Ken; Umutlu, Lale; Quick, Harald H.; Schaarschmidt, Benedikt Michael
    Comparison of pre- and post-contrast-enhanced attenuation correction using a CAIPI-accelerated T1-weighted Dixon 3D-VIBE sequence in ⁶⁸Ga-DOTATOC PET/MRI
    In: European Journal of Radiology Jg. 139 (2021) S. 109691
  • Christoph, Daniel; Ferdinandus, Justin; Metzenmacher, Martin; Kessler, Peter; Umutlu, Lale; Aigner, Clemens; Kambartel, Karl-Otto; Grünwald, Viktor; Eberhardt, Wilfried; Fendler, Wolfgang; Herrmann, Ken; Faehling, Martin
    Complete metabolic response in advanced non-small cell lung cancer patients with prolonged response to immune checkpoint inhibitor therapy
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 15_Suppl, S. 9050 - 9050
  • Ferdinandus, Justin; Metzenmacher, Martin; Kessler, Lukas; Umutlu, Lale; Aigner, Clemens; Karl, Kambartel Otto; Grünwald, Viktor; Eberhardt, Wilfried; Fendler, Wolfgang Peter; Herrmann, Ken; Faehling, Martin; Christoph, Daniel
    Complete metabolic response in patients with advanced nonsmall cell lung cancer with prolonged response to immune checkpoint inhibitor therapy
    In: Journal for ImmunoTherapy of Cancer Jg. 9 (2021) Nr. 3, S. 002262
  • Ambrosini, Valentina; Kunikowska, Jolanta; Baudin, Eric; Bodei, Lisa; Bouvier, Catherine; Capdevila, Jaume; Cremonesi, Marta; de Herder, Wouter W.; Dromain, Clarisse; Falconi, Massimo; Fani, Melpomeni; Fanti, Stefano; Hicks, Rodney J.; Kabasakal, Levent; Kaltsas, Gregory; Lewington, Val; Minozzi, Silvia; Cinquini, Michela; Öberg, Kjell; Oyen, Wim. J.G.; O'Toole, Dermot; Pavel, Marianne; Ruszniewski, Philippe; Scarpa, Aldo; Strosberg, Jonathan; Sundin, Anders; Taïeb, David; Virgolini, Irene; Wild, Damian; Herrmann, Ken; Yao, James
    Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
    In: European Journal of Cancer (EJC) Jg. 146 (2021) S. 56 - 73
  • Fanti, Stefano; Goffin, Karolien; Hadaschik, Boris; Herrmann, Ken; Maurer, Tobias; MacLennan, Steven; Oprea-Lager, Daniela E.; Oyen, Wim Jg; Rouvière, Olivier; Mottet, Nicolas; Bjartell, Anders
    Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 2, S. 469 - 476
  • Bruckmann, Nils Martin; Rischpler, Christoph; Kirchner, Julian; Umutlu, Lale; Herrmann, Ken; Ingenwerth, Marc; Theurer, Sarah; Lahner, Harald; Antoch, Gerald; Sawicki, Lino M.
    Correlation between contrast enhancement, standardized uptake value (SUV), and diffusion restriction (ADC) with tumor grading in patients with therapy-naive neuroendocrine neoplasms using hybrid ⁶⁸Ga-DOTATOC PET/MRI
    In: European Journal of Radiology Jg. 137 (2021) S. 109588
  • Bruckmann, Nils Martin; Kirchner, Julian; Grueneisen, Johannes; Li, Yan; McCutcheon, Angela; Aigner, Clemens; Rischpler, Christoph; Sawicki, Lino M.; Herrmann, Ken; Umutlu, Lale; Schaarschmidt, Benedikt Michael
    Correlation of the apparent diffusion coefficient (ADC) and standardized uptake values (SUV) with overall survival in patients with primary non-small cell lung cancer (NSCLC) using ¹⁸F-FDG PET/MRI
    In: European Journal of Radiology Jg. 134 (2021) S. 109422
  • Morawitz, Janna; Bruckmann, Nils-Martin; Dietzel, Frederic; Ullrich, Tim; Bittner, Ann-Kathrin; Hoffmann, Oliver; Mohrmann, Svjetlana; Häberle, Lena; Ingenwerth, Marc; Umutlu, Lale; Fendler, Wolfgang; Fehm, Tanja; Herrmann, Ken; Antoch, Gerald; Sawicki, Lino Morris; Kirchner, Julian
    Determining the Axillary Nodal Status with 4 Current Imaging Modalities, Including 18F-FDG PET/MRI, in Newly Diagnosed Breast Cancer : A Comparative Study Using Histopathology as the Reference Standard
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 12, S. 1677 - 1683
  • Gafita, A.; Rauscher, I.; Weber, Manuel; Hadaschik, Boris; Herrmann, Ken; Fendler, Wolfgang P.; Eiber, M.;
    Development of a novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP) : An international multicenter study
    EANM‘21 ; 34th Annual Congress of the European Association of Nuclear Medicine ; October 20-23, 2021, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. S311 - S312
  • Hope, Thomas A.; Eiber, Matthias; Armstrong, Wesley R.; Juarez, Roxanna; Murthy, Vishnu; Lawhn-Heath, Courtney; Behr, Spencer C.; Zhang, Li; Barbato, Francesco; Ceci, Francesco; Farolfi, Andrea; Schwarzenböck, Sarah M.; Unterrainer, Marcus; Zacho, Helle D.; Nguyen, Hao G.; Cooperberg, Matthew R.; Carroll, Peter R.; Reiter, Robert E.; Holden, Stuart; Herrmann, Ken; Zhu, Shaojun; Fendler, Wolfgang; Czernin, Johannes; Calais, Jeremie
    Diagnostic Accuracy of ⁶⁸Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection : A Multicenter Prospective Phase 3 Imaging Trial
    In: JAMA Oncology Jg. 7 (2021) Nr. 11, S. 1635 - 1642
  • Vardarli, Irfan; Weber, Manuel; Weidemann, Frank; Führer, Dagmar; Herrmann, Ken; Görges, Rainer
    Diagnostic accuracy of routine calcitonin measurement for the detection of medullary thyroid carcinoma in the management of patients with nodular thyroid disease : A meta-analysis
    In: Endocrine Connections Jg. 10 (2021) Nr. 3, S. 358 - 370
  • Seifert, Philipp; Schenke, Simone; Zimny, Michael; Stahl, Alexander; Grunert, Michael; Klemenz, Burkhard; Freesmeyer, Martin; Kreissl, Michael C.; Herrmann, Ken; Görges, Rainer
    Diagnostic performance of kwak, eu, acr, and korean tirads as well as ata guidelines for the ultrasound risk stratification of non-autonomously functioning thyroid nodules in a region with long history of iodine deficiency : A German multicenter trial
    In: Cancers Jg. 13 (2021) Nr. 17, 4467
  • Bartel, T.; Fendler, Wolfgang; Pabst, K.; Barbato, F.; Rischpler, Christoph; Herrmann, Ken; Hautzel, H.
    Digital and respiratory-gated FDG PET/CT for characterization of lung lesions
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 83
  • España, Samuel; Sánchez-Parcerisa, Daniel; Ibáñez, Paula; Sánchez-Tembleque, Víctor; Udías, Jose Manuel; Onecha, Víctor V.; Gutierrez-Uzquiza, Alvaro; Bäcker, Claus Maximilian; Bäumer, Christian; Herrmann, Ken; Fragoso Costa, Pedro; Timmermann, Beate; Fraile, Luis Mario
    Direct proton range verification using oxygen-18 enriched water as a contrast agent
    In: Radiation Physics and Chemistry Jg. 182 (2021) 109385
  • Pöttgen, Christoph; Gkika, E.; Stahl, Michael; Abu Jawad, Jehad; Gauler, Thomas; Kasper, Stefan; Trarbach, Tanja; Herrmann, Ken; Lehmann, Nils; Jöckel, Karl-Heinz; Lax, H.; Stuschke, Martin
    Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus : mature results of a phase I/II trial
    In: Radiation Oncology Jg. 16 (2021) Nr. 1, S. 59
  • Staniszewska, Magdalena; Iking, Janette; Lückerath, Katharina; Hadaschik, Boris; Herrmann, Ken; Ferdinandus, Justin; Fendler, Wolfgang
    Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancer
    In: Nuclear Medicine and Biology Jg. 96-97 (2021) S. 101 - 111
  • Kersting, David; Sraieb, Miriam; Seifert, Robert; Costa, Pedro Fragoso; Umutlu, Lale; Nader, Michael; Fendler, Wolfgang; Jentzen, Walter; Herrmann, Ken; Rischpler, Christoph
    Dynamic Ga-68-DOTA PET/CT and Compartmental Modelling to Non-invasively Estimate the Glomerular Filtration Rate
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. Suppl. 1, 88
  • Ceci, Francesco; Oprea-Lager, Daniela E.; Emmett, Louise; Adam, Judit A.; Bomanji, Jamshed; Czernin, Johannes; Eiber, Matthias; Haberkorn, Uwe; Hofman, Michael S.; Hope, Thomas A.; Kumar, Rakesh; Rowe, Steven P.; Schwarzenboeck, Sarah M.; Fanti, Stefano; Herrmann, Ken
    E-PSMA : The EANM standardized reporting guidelines v1.0 for PSMA-PET
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 5, S. 1626 - 1638
  • Kunikowska, Jolanta; Ambrosini, Valentina; Herrmann, Ken
    EANM Focus 3: The International Conference on Molecular Imaging and Theranostics in Neuroendocrine Tumours—the consensus in a nutshell
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) S. 1276 - 1277
  • Konijnenberg, Mark; Herrmann, Ken; Kobe, Carsten; Verburg, Frederik; Hindorf, Cecilia; Hustinx, Roland; Lassmann, Michael
    EANM position paper on article 56 of the Council Directive 2013/59/Euratom (basic safety standards) for nuclear medicine therapy
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) S. 67 - 72
  • Guberina, M.; Herrmann, Ken; Pöttgen, Christoph; Guberina, N.; Hoffmann, C.; Ploenes, T.; Gauler, Thomas; Wetter, Axel; Umutlu, Lale; Hautzel, H.; Theegarten, Dirk; Schuler, Martin; Eberhardt, Wilfried; Metzenmacher, M.; Wiesweg, Marcel; Aigner, Clemens; Darwiche, Kaid; Karpf-Wissel, Rüdiger; Stuschke, Martin
    EBUS-TBNA and [F-18] FDG-PET/CT for precise Target Volume Definition prior to Chemoradiotherapy : Lymphonodular Spreading Patterns in Stage III NSCLC
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 142
  • Maric, I.; Weber, Manuel; Jentzen, Walter; Schmitz, Jochen; Unger, Nicole; Poeppel, T. D.; Prochnow, A.; Herrmann, Ken; Fendler, Wolfgang
    Efficacy and safety of 124-I-MIBG guided high activity 131-I-MIBG therapy of metastatic pheochromocytoma and neuroblastoma
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 290 - S291
  • Staniszewska, Magdalena; Fragoso Costa, Pedro; Eiber, Matthias; Klose, Jasmin M.; Wosniack, Jasmin; Reis, Henning; Szarvas, Tibor; Hadaschik, Boris; Lückerath, Katharina; Herrmann, Ken; Fendler, Wolfgang; Iking, Janette
    Enzalutamide enhances psma expression of psma-low prostate cancer
    In: International Journal of Molecular Sciences (IJMS) Jg. 22 (2021) Nr. 14, 7431
  • Partelli, Stefano; Sclafani, Francesco; Barbu, Sorin Traian; Beishon, Marc; Bonomo, Pierluigi; Braz, Graça; de Braud, Filippo; Brunner, Thomas; Cavestro, Giulia Martina; Crul, Mirjam; Trill, Maria Die; Ferollà, Piero; Herrmann, Ken; Karamitopoulou, Eva; Neuzillet, Cindy; Orsi, Franco; Seppänen, Hanna; Torchio, Martina; Valenti, Danila; Zamboni, Giulia; Zins, Marc; Costa, Alberto; Poortmans, Philip
    European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC) : Pancreatic Cancer
    In: Cancer Treatment Reviews Jg. 99 (2021) 102208
  • Kersting, David; Sraieb, Miriam; Seifert, Robert; Fragoso Costa, Pedro; Kazek, S.; Umutlu, Lale; Nader, Michael; Fendler, Wolfgang; Jentzen, Walter; Herrmann, Ken; Rischpler, Christoph
    Evaluation of Dynamic Renal Ga-68-DOTA PET/CT to Monitor the Urinary Efflux and to Estimate the Glomerular Filtration Rate Using a Compartmental Kinetic Modelling Approach
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 340
  • Weber, Manuel; Jentzen, Walter; Hofferber, Regina; Herrmann, Ken; Fendler, Wolfgang Peter; Conti, Maurizio; Wetter, Axel; Kersting, David; Rischpler, Christoph; Fragoso Costa, Pedro
    Evaluation of [⁶⁸Ga]Ga-PSMA PET/CT images acquired with a reduced scan time duration in prostate cancer patients using the digital biograph vision
    In: EJNMMI Research Jg. 11 (2021) Nr. 1, S. 21
  • Bröcker-Preuß, Martina; Mehnert, Irina; Gilman, Elena; Herrmann, Ken; Weber, Manuel; Görges, Rainer
    Evaluation of a new automated assay for high-sensitivity thyroglobulin measurement and comparison with two established high-sensitivity thyroglobulin assays
    In: Practical Laboratory Medicine Jg. 26 (2021) e00250
  • Zhang, Caiyuan; O'Shea, Aileen; Parente, Chiara Anna; Amorim, Barbara Juarez; Caravan, Peter; Ferrone, Christina R.; Blaszkowsky, Lawrence S.; Soricelli, Andrea; Salvatore, Marco; Groshar, David; Bernstine, Hanna; Domachevsky, Liran; Canamaque, Lina Garcia; Umutlu, Lale; Herrmann, Ken; Catana, Ciprian; Mahmood, Umar; Catalano, Onofrio Antonio
    Evaluation of the Diagnostic Performance of Positron Emission Tomography/Magnetic Resonance for the Diagnosis of Liver Metastases
    In: Investigative Radiology Jg. 56 (2021) Nr. 10, S. 621 - 628
  • Chodyla, Michal; Demircioglu, Aydin; Schaarschmidt, Benedikt M.; Bertram, Stefanie; Morawitz, Janna; Bauer, Sebastian; Podleska, Lars; Rischpler, Christoph; Forsting, Michael; Herrmann, Ken; Umutlu, Lale; Grueneisen, Johannes
    Evaluation of the predictive potential of 18F-FDG PET and DWI data sets for relevant prognostic parameters of primary soft-tissue sarcomas
    In: Cancers Jg. 13 (2021) Nr. 11, 2753
  • Chodyla, Michal; Demircioglu, Aydin; Schaarschmidt, Benedikt M.; Bertram, Stefanie; Bruckmann, Nils Martin; Haferkamp, Jennifer; Li, Yan; Bauer, Sebastian; Podleska, Lars; Rischpler, Christoph; Forsting, Michael; Herrmann, Ken; Umutlu, Lale; Grüneisen, Johannes
    Evaluation of ¹⁸F-FDG PET and DWI Datasets for Predicting Therapy Response of Soft-Tissue Sarcomas Under Neoadjuvant Isolated Limb Perfusion
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 3, S. 348 - 353
  • Weber, Manuel; Jentzen, Walter; Hofferber, Regina; Herrmann, Ken; Fendler, Wolfgang Peter; Rischpler, Christoph; Umutlu, Lale; Conti, Maurizio; Costa, Pedro Fragoso; Sraieb, Miriam; Kersting, David
    Evaluation of ¹⁸F-FDG PET/CT images acquired with a reduced scan time duration in lymphoma patients using the digital biograph vision
    In: BMC Cancer Jg. 21 (2021) Nr. 1, 62
  • Kaddu-Mulindwa, Dominic; Altmann, Bettina; Held, Gerhard; Angel, Stephanie; Stilgenbauer, Stephan; Thurner, Lorenz; Bewarder, Moritz; Schwier, Maren; Pfreundschuh, Michael; Löffler, Markus; Menhart, Karin; Grosse, Jirka; Ziepert, Marita; Herrmann, Ken; Dührsen, Ulrich; Hüttmann, Andreas; Barbato, Francesco; Poeschel, Viola; Hellwig, Dirk
    FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma : Results from the prospective, multicenter PETAL and OPTIMAL>60 trials
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 11, S. 3550 - 3559
  • Kaddu-Mulindwa, Dominic; Altmann, Bettina; Held, Gerhard; Angel, Stephanie; Stilgenbauer, Stephan; Thurner, Lorenz; Bewarder, Moritz; Schwier, Maren; Pfreundschuh, Michael; Löffler, Markus; Menhart, Karin; Grosse, Jirka; Ziepert, Marita; Herrmann, Ken; Dührsen, Ulrich; Hüttmann, Andreas; Barbato, Francesco; Poeschel, Viola; Hellwig, Dirk
    FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma : Results from the prospective, multicenter PETAL and OPTIMAL>60 trials
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 11, S. 3550 - 3559
  • Ferdinandus, Justin; Maríc, Ines; Darr, Christopher; Kesch, Claudia; Hilser, Thomas; Fendler, Wolfgang; Herrmann, Ken; Hadaschik, Boris; Grünwald, Viktor;
    FDG-PET avidity as a prognostic biomarker for overall survival in renal cell carcinoma
    2021 ASCO Annual Meeting, 4. - 8. June 2021, virtuell,
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. Suppl. 15, S. e16564
  • Pilkington, Patrick; Lopci, Egesta; Adam, Judit A.; Kobe, Carsten; Goffin, Karolien; Herrmann, Ken
    FDG-PET/CT Variants and Pitfalls in Haematological Malignancies
    In: Seminars in Nuclear Medicine Jg. 51 (2021) Nr. 6, S. 554 - 571
  • Vardarli, Irfan; Weber, Manuel; Rischpler, Christoph; Führer, Dagmar; Herrmann, Ken; Weidemann, Frank
    Fabry Cardiomyopathy : Current Treatment and Future Options
    In: Journal of Clinical Medicine (JCM) Jg. 10 (2021) Nr. 14, 3026
  • Manafi-Farid, Reyhaneh; Harsini, Sara; Saidi, Bahare; Ahmadzadehfar, Hojat; Herrmann, Ken; Briganti, Alberto; Walz, Jochen; Beheshti, Mohsen
    Factors predicting biochemical response and survival benefits following radioligand therapy with [¹⁷⁷Lu]Lu-PSMA in metastatic castrate-resistant prostate cancer : A review
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 12, S. 4028 - 4041
  • Fendler, Wolfgang; Calais, Jeremie; Eiber, Matthias; Simko, Jeffrey P.; Kurhanewicz, John; Santos, Romelyn Delos; Feng, Felix Y.; Reiter, Robert E.; Rettig, Matthew B.; Nickols, Nicholas G.; Kishan, Amar U.; Shozo, Okamoto; Emmett, Louise; Zacho, Helle D.; Ilhan, Harun; Rischpler, Christoph; Wetter, Axel; Schoder, Heiko; Burger, Irene A.; Slavik, Roger; Carroll, Peter R.; Lawhn-Heath, Courtney; Herrmann, Ken; Czernin, Johannes; Hope, Thomas A.
    False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 2, S. 501 - 508
  • Kessler, Lukas; Hamacher, Rainer; Ferdinandus, Justin; Zarrad, Fadi; Hirmas, Nader; Schildhaus, Hans-Ulrich; Siveke, Jens; Herrmann, Ken; Fendler, Wolfgang
    Ga-68-FAPI for sarcoma imaging : Data from the FAPI-PET prospective observational trial
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. Suppl. 1, 126
  • Costa Fragoso, P.; Püllen, Lukas; Klose, J. M.; Iking, J.; Sandach, Patrick; Staniszewska, M.; Herrmann, Ken; Radtke, J. P.; Tschirdewahn, Stephan; Hadaschik, Boris; Fendler, Wolfgang; Darr, C.
    Ga-68-versus F-18-PSMA for Cerenkov Luminescence and autoradiography in a prostate cancer mouse model
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 17
  • Fizazi, K.; Herrmann, Ken; Krause, B.J.; Rahbar, K.; Chi, K.N.; Morris, M.J.; Sartor, O.; Tagawa, S.T.; Kendi, A.T.; Vogelzang, N.J.; Calais, J.; Nagarajah, James; Wei, X.X.; Koshkin, V.S.; Beauregard, J-M.; Chang, B.; DeSilvio, M.; Messmann, R.A.; de Bono, J.
    Health-related quality of life (HRQoL), pain and safety outcomes in the phase III VISION study of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 627 - S628
  • Farolfi, Andrea; Hirmas, Nader; Gafita, Andrei; Weber, Manuel; Barbato, Francesco; Wetter, Axel; Mei, Riccardo; Pianori, Davide; Hadaschik, Boris; Herrmann, Ken; Castellucci, Paolo; Fanti, Stefano; Eiber, Matthias; Fendler, Wolfgang
    Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging : A Multicenter Retrospective Study
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 5, S. 675 - 678
  • Iking, Janette; Staniszewska, Magdalena; Kessler, Lukas; Klose, Jasmin M.; Lückerath, Katharina; Fendler, Wolfgang; Herrmann, Ken; Rischpler, Christoph
    Imaging Inflammation with Positron Emission Tomography
    In: Biomedicines Jg. 9 (2021) Nr. 2, S. 212
  • Guberina, Maja; Darwiche, Kaid; Hautzel, Hubertus; Ploenes, Till; Pöttgen, Christoph; Guberina, Nika; Herrmann, Ken; Umutlu, Lale; Wetter, Axel; Theegarten, Dirk; Aigner, Clemens; Eberhardt, Wilfried; Schuler, Martin; Karpf-Wissel, Rüdiger; Stuschke, Martin
    Impact of EBUS-TBNA in addition to [¹⁸F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) S. 2894 - 2903
  • Schottelius, Margret; Herrmann, Ken; Lapa, Constantin
    In vivo targeting of cxcr4 : new horizons
    In: Cancers Jg. 13 (2021) Nr. 23, 5920
  • Ferdinandus, J.; Costa Fragoso, P.; Kessler, Lukas; Weber, Manuel; Hirmas, N.; Kostbade, K.; Bauer, Sebastian; Schuler, Martin; Ahrens, M.; Schildhaus, Hans-Ulrich; Rischpler, Christoph; Siveke, Jens; Herrmann, Ken; Fendler, Wolfgang; Hamacher, R.
    Initial clinical experience with [Y-90]Y-FAPI-46 radioligand therapy for advanced stage solid tumors
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 290
  • Dönmez, Tugba; Höhne, Kerstin; Zissel, Gernot; Herrmann, Ken; Hautzel, Hubertus; Aigner, Clemens; Hegedüs, Balazs; Ploenes, Till
    Insights into immunometabolism : A dataset correlating the ¹⁸FDG PET/CT maximum standard uptake value of the primary tumor with the CCL18 serum level in non-small cell lung cancer
    In: Data in Brief Jg. 35 (2021) 106859
  • Gafita, Andrei; Rauscher, Isabel; Weber, Manuel; Hadaschik, Boris; Wang, Hui; Armstrong, Wesley R; Tauber, Robert; Czernin, Johannes; Rettig, Matthew; Herrmann, Ken; Calais, Jeremie; Weber, Wolfgang A; Benz, Matthias R.; Fendler, Wolfgang; Eiber, Matthias
    Interim PSMA PET/CT for response evaluation during LuPSMA treatment in mCRPC (INTERIM PET) : An explorative, multicenter study
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 15_Suppl, S. 5066 - 5066
  • Buvat, Irène; Herrmann, Ken; Stremitzer, Alexander; Tobia, Kevin; Nielsen, Aileen
    Irène Buvat and Ken Herrmann Talk with Alexander Stremitzer, Kevin Tobia, and Aileen Nielsen
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 1, S. 3 - 5
  • Weber, Manuel; Kersting, David; Umutlu, Lale; Schäfers, Michael; Rischpler, Christoph; Fendler, Wolfgang; Buvat, Irène; Herrmann, Ken; Seifert, Robert
    Just another “Clever Hans”? : Neural networks and FDG PET-CT to predict the outcome of patients with breast cancer
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 10, S. 3141 - 3150
  • Patt, Marianne; Bengel, Frank; Essler, Markus; Krause, Bernd-Joachim; Kuwert, Torsten; Rahbar, Kambiz; Sabri, Osama; Schäfer, Wolfgang; Schreckenberger, Matthias; Weber, Wolfgang A.; Herrmann, Ken
    Kamingespräch § 13 (2b) AMG in der nuklearmedizinischen Therapie : Eine Follow-up-Veranstaltung der NuklearMedizin 2020 - Digital
    In: Nuklearmedizin = Nuclear Medicine Jg. 60 (2021) Nr. 4, S. 262 - 263
  • Sartor, Oliver; de Bono, Johann; Chi, Kim N; Fizazi, Karim; Herrmann, Ken; Rahbar, Kambiz; Tagawa, Scott T.; Nordquist, Luke T.; Vaishampayan, Nitin; El-Haddad, Ghassan; Park, Chandler H.; Beer, Tomasz M.; Armour, Alison; Pérez-Contreras, Wendy J.; DeSilvio, Michelle; Kpamegan, Euloge; Gericke, Germo; Messmann, Richard A.; Morris, Michael J.; Krause, Bernd J.; VISION Investigators
    Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
    In: The New England Journal of Medicine Jg. 385 (2021) S. 1091 - 1103
  • Kebir, Sied; Rauschenbach, Laurèl; Weber, Manuel; Lazaridis, Lazaros; Schmidt, Teresa; Keyvani, Kathy; Schäfer, Niklas; Milia, Asma; Umutlu, Lale; Pierscianek, Daniela; Stuschke, Martin; Forsting, Michael; Sure, Ulrich; Kleinschnitz, Christoph; Antoch, Gerald; Colletti, Patrick M.; Rubello, Domenico; Herrmann, Ken; Herrlinger, Ulrich; Scheffler, Björn; Bundschuh, Ralph A.; Glas, Martin
    Machine learning-based differentiation between multiple sclerosis and glioma WHO II°-IV° using O-(2-[18F] fluoroethyl)-L-tyrosine positron emission tomography
    In: Journal of Neuro-Oncology Jg. 152 (2021) S. 325 - 332
  • Bäuerle, Alexander; Musche, Venja; Schmidt, Kira; Schweda, Adam; Fink, Madeleine; Weismüller, Benjamin; Kohler, Hannah; Herrmann, Ken; Tewes, Mitra; Schadendorf, Dirk; Skoda, Eva-Maria; Teufel, Martin
    Mental health burden of german cancer patients before and after the outbreak of covid-19 : Predictors of mental health impairment
    In: International Journal of Environmental Research and Public Health = IJERPH Jg. 18 (2021) Nr. 5, 2318
  • Umutlu, Lale; Kirchner, Julian; Bruckmann, Nils Martin; Morawitz, Janna; Antoch, Gerald; Ingenwerth, Marc; Bittner, Ann-Kathrin; Hoffmann, Oliver; Haubold, Johannes; Grueneisen, Johannes; Quick, Harald H.; Rischpler, Christoph; Herrmann, Ken; Gibbs, Peter; Pinker-Domenig, Katja
    Multiparametric integrated¹⁸f-fdg pet/mri-based radiomics for breast cancer phenotyping and tumor decoding
    In: Cancers Jg. 13 (2021) Nr. 12, 2928
  • Hautzel, Hubertus; Alnajdawi, Yazan; Fendler, Wolfgang; Rischpler, Christoph; Darwiche, Kaid; Eberhardt, Wilfried; Umutlu, Lale; Theegarten, Dirk; Stuschke, Martin; Schuler, Martin; Aigner, Clemens; Herrmann, Ken; Plönes, Till
    N-staging in large cell neuroendocrine carcinoma of the lung : diagnostic value of [¹⁸F]FDG PET/CT compared to the histopathology reference standard
    In: EJNMMI Research Jg. 11 (2021) Nr. 1, 68
  • Aide, Nicolas; Lasnon, Charline; Kesner, Adam; Levin, Craig S.; Buvat, Irene; Iagaru, Andrei; Herrmann, Ken; Badawi, Ramsey D.; Cherry, Simon R.; Bradley, Kevin M.; McGowan, Daniel R.
    New PET technologies : embracing progress and pushing the limits
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) S. 2711 - 2726
  • Hadaschik, Boris; Weber, Manuel; Herrmann, Ken; Fendler, Wolfgang
    Nomograms to predict outcome after LuPSMA radionuclide therapy in men with metastatic castration-resistant prostate cancer : An international multicenter retrospective study
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 63 - S64
  • Gafita, Andrei; Calais, Jeremie; Grogan, Tristan R.; Hadaschik, Boris; Wang, Hui; Weber, Manuel; Sandhu, Shahneen; Kratochwil, Clemens; Esfandiari, Rouzbeh; Tauber, Robert; Zeldin, Anna; Rathke, Hendrik; Armstrong, Wesley R.; Robertson, Andrew; Thin, Pan; D'Alessandria, Calogero; Rettig, Matthew B.; Delpassand, Ebrahim S.; Haberkorn, Uwe; Elashoff, David; Herrmann, Ken; Czernin, Johannes; Hofman, Michael S.; Fendler, Wolfgang; Eiber, Matthias
    Nomograms to predict outcomes after ¹⁷⁷Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer : An international, multicentre, retrospective study
    In: The Lancet Oncology Jg. 22 (2021) Nr. 8, S. 1115 - 1125
  • Heinze, Britta; Schirbel, Andreas; Nannen, Lukas; Michelmann, David; Hartrampf, Philipp E.; Bluemel, Christina; Schneider, Magdalena; Herrmann, Ken; Haenscheid, Heribert; Fassnacht, Martin; Buck, Andreas K.; Hahner, Stefanie
    Novel CYP11B-ligand [¹²³/¹³¹I]IMAZA as promising theranostic tool for adrenocortical tumors : Comprehensive preclinical characterization and first clinical experience
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2021) S. 301 - 310
  • Fendler, Wolfgang; Herrmann, Ken; Eiber, Matthias
    Nuclear Medicine Beyond VISION
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 7, S. 916 - 917
  • Herrmann, Ken; Kraus, Bernd Joachim; Hadaschik, Boris; Kunikowska, Jolanta; van Poppel, Hendrik; N'Dow, James; Sartor, Oliver; Oyen, Wim J. G.
    Nuclear medicine theranostics comes of age
    In: The Lancet Oncology Jg. 22 (2021) Nr. 11, S. 1497 - 1498
  • Berliner, Christoph; Boss, Kristina; Pape, Anke; Kribben, Andreas; Fendler, Wolfgang; Herrmann, Ken
    Oldies (but Goldies) : Die Peritonealszintigrafie bei Peritonealdialyse
    In: Nuklearmedizin = Nuclear Medicine Jg. 60 (2021) Nr. 06, S. 450 - 453
  • Fendler, Wolfgang; Golfieri, R.; Herrmann, Ken
    PSMA PET and radiomics for the evaluation of liver metastases in castration-resistant prostate cancer patients : A multicenter retrospective study
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 234
  • Seifert, Robert; Kessel, Katharina; Schlack, Katrin; Weber, Manuel; Herrmann, Ken; Spanke, Maximilian; Fendler, Wolfgang; Hadaschik, Boris; Kleesiek, Jens; Schäfers, Michael; Weckesser, Matthias; Boegemann, Martin; Rahbar, Kambiz
    PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 4, S. 1200 - 1210
  • Barbato, Francesco; Fendler, Wolfgang; Rauscher, Isabel; Herrmann, Ken; Wetter, Axel; Ferdinandus, Justin; Seifert, Robert; Nader, Michael; Rahbar, Kambiz; Hadaschik, Boris; Eiber, Matthias; Gafita, Andrei; Weber, Manuel
    PSMA-PET for the assessment of metastatic hormone-sensitive prostate cancer volume of disease
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 12, S. 1747 - 1750
  • Weber, Manuel; Kurek, Claudia Ewa; Barbato, Francesco; Eiber, Matthias; Maurer, Tobias; Nader, Michael; Hadaschik, Boris; Grünwald, Viktor; Herrmann, Ken; Wetter, Axel; Fendler, Wolfgang Peter
    PSMA-ligand PET for early castration-resistant prostate cancer : a retrospective single-center study
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 1, S. 88 - 91
  • Palmedo, H.; Ahmadzadehfar, H.; Eschmann, S.; Selkinski, I.; Straube, F.; Niesen, A.; Schönberger, J.; Barsegian, V.; Liepe, K.; Mottaghy, F.M.; Guan, R.; Pinkert, J.; Buetikofer, S.; Herrmann, Ken
    Pain efficacy with radium-223 (Ra-223) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in the PARABO observational study
    In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 641
  • Herrmann, Ken
    Pain response and clinical outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) : Final results from a prospective, noninterventional study (PARABO)
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 313 - S314
  • Guberina, Maja; Darwiche, Kaid; Hautzel, Hubertus; Pöttgen, Christoph; Guberina, Nika; Gauler, Thomas; Ploenes, Till; Umutlu, Lale; Theegarten, Dirk; Aigner, Clemens; Eberhardt, Wilfried; Metzenmacher, Martin; Wiesweg, Marcel; Karpf-Wissel, Rüdiger; Schuler, Martin; Herrmann, Ken; Stuschke, Martin
    Patterns of nodal spread in stage III NSCLC : Importance of EBUS-TBNA and ¹⁸F-FDG PET/CT for radiotherapy target volume definition
    In: Radiation Oncology Jg. 16 (2021) Nr. 1, 176
  • Herrmann, Ken
    Phase 3 Study of Lu-177-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer (VISION)
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 63
  • Calais, Jeremie; Zhu, Shaojun; Hirmas, Nader; Eiber, Matthias; Hadaschik, Boris; Stuschke, Martin; Herrmann, Ken; Czernin, Johannes; Kishan, Amar U.; Nickols, Nicholas G.; Elashoff, David; Fendler, Wolfgang P.
    Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT] : study protocol
    In: BMC Cancer Jg. 21 (2021) 512
  • Calais, Jeremie; Zhu, Shaojun; Hrimas, Nader; Eiber, Matthias; Hadaschik, Boris; Stuschke, Martin; Herrmann, Ken; Czernin, Johannes; Kishan, Amar U.; Nickols, Nicholas G.; Elashoff, David; Fendler, Wolfgang
    Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT] : Study Protocol
    In: Cancer Research Jg. 81 (2021) Nr. 13, CT257
  • Calais, Jeremie; Zhu, Shaojun; Hirmas, Nader; Eiber, Matthias; Hadaschik, Boris; Stuschke, Martin; Herrmann, Ken; Czernin, Johannes; Kishan, Amar Upadhyaya; Nickols, Nicholas George; Elashoff, David; Fendler, Wolfgang;
    Phase III randomized trial of PSMA PET prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT] : Study protocol NCT04457245
    2021 Genitourinary Cancers Symposium, 11 - 13 Feb 2021, online,
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 6, Supplement, S. TPS172
  • Morris, Michael J.; De Bono, Johann S.; Chi, Kim N.; Fizazi, Karim; Herrmann, Ken; Rahbar, Kambiz; Tagawa, Scott T.; Nordquist, Luke T.; Vaishampayan, Nitin; El-Haddad, Ghassan; Park, Chandler H.; Beer, Tomasz M.; Pérez-Contreras, Wendy J; Desilvio, Michelle; Kpamegan, Euloge E.; Gericke, Germo; Messmann, Richard Adam; Krause, Bernd J.; Sartor, A. Oliver;
    Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION)
    2021 ASCO Annual Meeting, 4. - 8. June 2021, virtuell,
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 18_suppl, S. LBA4 - LBA4
  • Farolfi, Andrea; Hadaschik, Boris; Hamdy, Freddie C.; Herrmann, Ken; Hofman, Michael S.; Murphy, Declan G.; Ost, Piet; Padhani, Anwar R.; Fanti, Stefano
    Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment : A Systematic Review
    In: European Urology Oncology Jg. 4 (2021) Nr. 5, S. 714 - 730
  • Rodriguez-Freixinos, Víctor; Capdevila, Jaume; Pavel, Marianne; Thawer, Alia; Baudin, Eric; O'Toole, Dermot; Herrmann, Ken; Welin, Staffan; Grozinsky-Glasberg, Simona; de Herder, Wouter W.; Valle, Juan W.; Herman, Jackie; Kolarova, Teodora; Bouvier, Catherine; Falconi, Massimo; Ferone, Diego; Singh, Simron
    Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era
    In: European Journal of Cancer (EJC) Jg. 144 (2021) S. 200 - 214
  • Kersting, David; Seifert, Robert; Kessler, Lukas; Herrmann, Ken; Theurer, Sarah; Brandenburg, Tim; Dralle, Henning; Weber, Frank; Umutlu, Lale; Führer-Sakel, Dagmar; Görges, Rainer; Rischpler, Christoph; Weber, Manuel
    Predictive Factors for RAI-Refractory Disease and Short Overall Survival in PDTC
    In: Cancers Jg. 13 (2021) Nr. 7, S. 1728
  • Pöttgen, Christoph; Gkika, E.; Stahl, Michael; Abu Jawad, Jehad; Gauler, Thomas; Kasper, Stefan; Trarbach, Tanja; Herrmann, Ken; Lehmann, Nils; Jöckel, Karl-Heinz; Lax, H.; Stuschke, Martin
    Prognostic Significance of the metabolic Response during Induction Chemotherapy for the definitive Chemoradiotherapy of locally advanced Squamous Cell Carcinoma of the Esophagus
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 154 - S155
  • Guberina, Maja; Pöttgen, Christoph; Metzenmacher, Martin; Wiesweg, Marcel; Schuler, Martin; Aigner, Clemens; Ploenes, Till; Umutlu, Lale; Gauler, Thomas; Darwiche, Kaid; Stamatis, Georgios; Theegarten, Dirk; Hautzel, Hubertus; Jentzen, Walter; Guberina, Nika; Herrmann, Ken; Eberhardt, Wilfried E.E.; Stuschke, Martin
    Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non-Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 12, S. 1684 - 1691
  • Morawitz, Janna; Kirchner, Julian; Martin, Ole; Bruckmann, Nils-Martin; Dietzel, Frederic; Li, Yan; Rischpler, Christoph; Herrmann, Ken; Umutlu, Lale; Bittner, Ann-Kathrin; Mohrmann, Svjetlana; Ingenwerth, Marc; Häberle, Lena; Esposito, Irene; Antoch, Gerald; Buchbender, Christian; Sawicki, Lino M.
    Prospective Correlation of Prognostic Immunohistochemical Markers With SUV and ADC Derived From Dedicated Hybrid Breast 18F-FDG PET/MRI in Women With Newly Diagnosed Breast Cancer
    In: Clinical Nuclear Medicine Jg. 46 (2021) Nr. 3, S. 201 - 205
  • Bruckmann, Nils Martin; Kirchner, Julian; Morawitz, Janna; Umutlu, Lale; Herrmann, Ken; Bittner, Ann-Kathrin; Hoffmann, Oliver; Mohrmann, Svjetlana; Ingenwerth, Marc; Schaarschmidt, Benedikt M.; Li, Yan; Stang, Andreas; Antoch, Gerald; Sawicki, Lino M.; Buchbender, Christian
    Prospective comparison of CT and ¹⁸F-FDG PET/MRI in N and M staging of primary breast cancer patients : Initial results
    In: PLoS ONE Jg. 16 (2021) e0260804
  • Bruckmann, Nils Martin; Kirchner, Julian; Umutlu, Lale; Fendler, Wolfgang Peter; Seifert, Robert; Herrmann, Ken; Bittner, Ann-Kathrin; Hoffmann, Oliver; Mohrmann, Svjetlana; Antke, Christina; Schimmöller, Lars; Ingenwerth, Marc; Breuckmann, Katharina; Stang, Andreas; Buchbender, Christian; Antoch, Gerald; Sawicki, Lino M.
    Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients
    In: European Radiology Jg. 31 (2021) Nr. 11, S. 8714 - 8724
  • Calais, Jeremie; Gafita, Andrei; Eiber, Matthias; Armstrong, Wesley R.; Gartmann, Jeannine; Thin, Pan; Nguyen, Kathleen; Lok, Vincent; Gosa, Laura; Grogan, Tristan; Esfandiari, Rouzbeh; Allen-Auerbach, Martin; Quon, Andrew; Bahri, Shadfar; Gupta, Pawan; Gardner, Linda; Ranganathan, David; Slavik, Roger; Dahlbom, Magnus; Herrmann, Ken; Delpassand, Ebrahim; Fendler, Wolfgang; Czernin, Johannes
    Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC) : efficacy results of the UCLA cohort
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 10, S. 1440 - 1446
  • Darr, Christopher; Costa, Pedro Fragoso; Kesch, Claudia; Krafft, Ulrich; Püllen, Lukas; Harke, Nina; Heß, Jochen A.; Szarvas, Tibor; Haubold, Johannes; Reis, Henning; Fendler, Wolfgang; Herrmann, Ken; Radtke, Jan Philipp; Hadaschik, Boris; Tschirdewahn, Stephan
    Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging : Utilization of a short-pass filter to reduce technical pitfalls
    In: Translational Andrology and Urology Jg. 10 (2021) Nr. 10, S. 3972 - 3985
  • Weber, Manuel; Hadaschik, Boris; Ferdinandus, Justin; Rahbar, Kambiz; Bögemann, Martin; Herrmann, Ken; Fendler, Wolfgang; Kesch, Claudia
    Prostate-specific Membrane Antigen–based Imaging of Castration-resistant Prostate Cancer
    In: European Urology Focus Jg. 7 (2021) Nr. 2, S. 279 - 287
  • Mulcahy, Mary F.; Mahvash, Armeen; Pracht, Marc; Montazeri, Amir H.; Bandula, Steve; Martin, Robert C. G.; Herrmann, Ken; Brown, Ewan; Zuckerman, Darryl; Wilson, Gregory; Kim, Tae-You; Weaver, Andrew; Ross, Paul; Harris, William P.; Graham, Janet; Mills, Jamie; Yubero Esteban, Alfonso; Johnson, Matthew S.; Sofocleous, Constantinos T.; Padia, Siddharth A.; Lewandowski, Robert J.; Garin, Etienne; Sinclair, Philip; Salem, Riad
    Radioembolization With Chemotherapy for Colorectal Liver Metastases : A Randomized, Open-Label, International, Multicenter, Phase III Trial
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 35, S. 3897 - 3907
  • Mulcahy, M.F.; Salem, R.; Mahvash, A.; Pracht, M.; Montazeri, A.H.; Bandula, S.; Herrmann, Ken; Brown, E.; Zuckerman, D.; Wilson, G.; Kim, T-Y.; Weaver, A.; Ross, P.; Harris, W.P.; Johnson, M.S.; Sofocleous, C.T.; Padia, S.A.; Lewandowski, R.J.; Garin, E.; Sinclair, P.;
    Radioembolization with chemotherapy for colorectal liver metastases : A randomized, open-label, international, multicenter, phase III trial (EPOCH study)
    ESMO Congress 2021 ; 16 – 21 September 2021, online,
    In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. S1295
  • Hadaschik, Boris; Herrmann, Ken
    Re: Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
    In: European Urology Jg. 80 (2021) Nr. 4, S. 520 - 521
  • Bourla, Ariel B.; Herrmann, Ken
    Real-World Data as an Evidence Source in Nuclear Medicine
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 2, S. 156 - 157
  • Calais, Jeremie; Czernin, Johannes; Thin, Pan; Gartmann, Jeannine; Nguyen, Kathleen; Armstrong, Wesley R.; Allen-Auerbach, Martin; Quon, Andrew; Bahri, Shadfar; Gupta, Pawan; Gardner, Linda; Dahlbom, Magnus; He, Beilei; Esfandiari, Rouzbeh; Ranganathan, David; Herrmann, Ken; Eiber, Matthias; Fendler, Wolfgang; Delpassand, Ebrahim
    Safety of PSMA-Targeted Molecular Radioligand Therapy with 177Lu-PSMA-617 : Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312)
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 10, S. 1447 - 1456
  • Kersting, David; Jentzen, Walter; Fragoso Costa, P.; Sraieb, Miriam; Sandach, Patrick; Umutlu, Lale; Conti, Maurizio; Zarrad, Fadi; Rischpler, Christoph; Fendler, Wolfgang P.; Herrmann, Ken; Weber, Manuel
    Silicon-photomultiplier-based PET/CT reduces the minimum detectable activity of iodine-124
    In: Scientific Reports Jg. 11 (2021) Nr. 1, 17477
  • Johannes, Czernin; Herrmann, Ken
    The Disappearing Act of Nuclear Medicine in The Netherlands : Just a New Trick by the Great Harry Houdini?
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 7, S. 903 - 904
  • Al-Ibraheem, Akram; Abuhijla, Fawzi; Salah, Samer; Shahait, Mohamed; Khader, Jamal; Mohamad, Issa; Al-Rasheed, Ula; Pomykala, Kelsey L.; Herrmann, Ken; Abu-Hijlih, Ramiz
    The influence of ⁶⁸Ga-prostate-specific membrane antigen PET/computed tomography on prostate cancer staging and planning of definitive radiation therapy
    In: Nuclear Medicine Communications Jg. 42 (2021) Nr. 7, S. 811 - 817
  • Heynickx, Nathalie; Herrmann, Ken; Vermeulen, Koen; Baatout, Sarah; Aerts, An
    The salivary glands as a dose limiting organ of PSMA- targeted radionuclide therapy : A review of the lessons learnt so far
    In: Nuclear Medicine and Biology Jg. 98-99 (2021) S. 30 - 39
  • Sauerwein, Wolfgang; Sancey, Lucie; Hey-Hawkins, Evamarie; Kellert, Martin; Panza, Luigi; Imperio, Daniela; Balcerzyk, Marcin; Rizzo, Giovanna; Scalco, Elisa; Herrmann, Ken; Mauri, Pierluigi; Palma, Antonella De; Wittig, Andrea
    Theranostics in Boron neutron capture therapy
    In: Life Jg. 11 (2021) Nr. 4, S. 330
  • von Tresckow, Julia; von Tresckow, Bastian; Reinhardt, Christian; Herrmann, Ken; Berliner, Christoph; Herrmann, Ken
    Thymic hyperplasia after mRNA based Covid-19 vaccination
    In: Radiology Case Reports Jg. 16 (2021) Nr. 12, S. 3744 - 3745
  • Bäcker, Claus Maximilian; Bäumer, Christian; Bley, Aaron; Fragoso Costa, Pedro; Gerhardt, Marcel; Herrmann, Ken; Kauer, Samantha; Kröninger, Kevin; Nitsch, Christian; Siregar, Hilda Milani; Timmermann, Beate; Verbeek, Nico; Weingarten, Jens; Wulff, Jörg; Yazgan, Azad
    Towards using secondary gamma-rays from proton-induced radioactivation of titanium implants for off-line field verification
    In: Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms Jg. 492 (2021) S. 56 - 63
  • Kupusovic, J.; Kessler, Lukas; Ferdinandus, J.; Hirmas, N.; Fendler, Wolfgang; Totzeck, Matthias; Herrmann, Ken; Wakili, Reza; Rischpler, Christoph; Rassaf, Tienush; Siebermair, Johannes
    Visualization of fibroblast activation after myocardial infarction using 68Ga-FAPI-PET
    In: European Heart Journal Jg. 42 (2021) Nr. Supplement_1, ehab724.0255
  • Ferdinandus, Justin; Barbato, Francesco; Chodyla, Michal; Fendler, Wolfgang; Kessler, Lukas; Pomykala, Kelsey L.; Metzenmacher, Martin; Krefting, Frederik; Hager, Thomas; Umutlu, Lale; Herrmann, Ken; Christoph, Daniel
    Volumetric PET Response Assessment Outperforms Conventional Criteria in Patients Receiving High-Dose Pembrolizumab for Malignant Mesothelioma
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 2, S. 191 - 194
  • Seifert, Robert; Küper, Alina; Tewes, Mitra; Heuschmid, Martin; Welt, Anja; Fendler, Wolfgang P.; Herrmann, Ken; Decker, Thomas
    [18F]-Fluorodeoxyglucose Positron Emission Tomography/CT to Assess the Early Metabolic Response in Patients with Hormone Receptor-Positive HER2-Negative Metastasized Breast Cancer Treated with Cyclin-Dependent 4/6 Kinase Inhibitors
    In: Oncology Research and Treatment Jg. 44 (2021) Nr. 7-8, S. 400 - 407
  • Hirmas, Nader; Leyh, Catherine; Sraieb, Miriam; Barbato, Francesco; Schaarschmidt, Benedikt M.; Umutlu, Lale; Nader, Michael; Wedemeyer, Heiner; Ferdinandus, Justin; Rischpler, Christoph; Herrmann, Ken; Costa, Pedro Fragoso; Lange, Christian M.; Weber, Manuel; Fendler, Wolfgang
    [⁶⁸Ga]Ga-PSMA-11 PET/CT improves tumor detection and impacts management in patients with hepatocellular carcinoma
    In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 9, S. 1235 - 1241
  • Weber, M.; Koenen, J.; Deuschl, C.; Bechrakis, Nikolaos E.; Herrmann, Ken; Eckstein, Anja; Binse, Ina; Oeverhaus, M.;
    18F-FDG -PET/MRI in patients with Graves’ orbitopathy
    EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S251 - S252
  • Li, Yan; Mueller, Laura Isabel; Neuhaus, Jan Peter; Bertram, Stefanie; Schaarschmidt, Benedikt Michael; Demircioglu, Aydin; Ludwig, Johannes Maximilian; Kirchner, Julian; Rischpler, Christoph; Herrmann, Ken; Catalano, Onofrio Antonio; Umutlu, Lale
    18F-FDG PET/MR versus MR Alone in Whole-Body Primary Staging and Restaging of Patients with Rectal Cancer : What Is the Benefit of PET?
    In: Journal of Clinical Medicine (JCM) Jg. 9 (2020) Nr. 10, 3163
  • Lazaridis, Lazaros; Kebir, Sied; Weber, Manuel; Schmidt, Teresa; Keyvani, Kathy; Pierscianek, Daniela; Stuschke, Martin; Antoch, Gearald; Forsting, Michael; Sure, Ulrich; Kleinschnitz, Christoph; Herrmann, Ken; Umutlu, Lale; Deuschl, Cornelius; Glas, Martin
    18F-Fluorethyltyrosine positron emission tomography versus magnetic resonnace spectroscopy in preoperative detection of newly diagnosed gliomas by using machine learning
    In: Neuro-Oncology Jg. 22 (2020) Nr. Supplement 2, S. ii149
  • Herrmann, Ken;
    Zindel, Christoph (Interviewpartner)
    A Conversation Between Christoph Zindel and Ken Herrmann
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 8, S. 1088 - 1090
  • Carrió, Ignasi; Herrmann, Ken
    A conversation between Ignasi Carrió and Ken Herrmann
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 5, S. 638 - 640
  • Witjes, J. Alfred; Babjuk, Marek; Bellmunt, Joaquim; Maxim Bruins, H.; De Reijke, Theo M.; De Santis, Maria; Gillessen, Silke; James, Nicholas; Maclennan, Steven; Palou, Juan; Powles, Tom; Ribal, Maria J.; Shariat, Shahrokh F.; Van Der Kwast, Theo; Xylinas, Evanguelos; Agarwal, Neeraj; Arends, Tom; Bamias, Aristotle; Birtle, Alison; Black, Peter C.; Bochner, Bernard H.; Bolla, Michel; Boormans, Joost L.; Bossi, Alberto; Briganti, Alberto; Brummelhuis, Iris; Burger, Max; Castellano, Daniel; Cathomas, Richard; Chiti, Arturo; Choudhury, Ananya; Compérat, Eva; Crabb, Simon; Culine, Stephane; De Bari, Berardino; De Blok, Willem; De Visschere, Pieter J.L.; Decaestecker, Karel; Dimitropoulos, Konstantinos; Dominguez-Escrig, Jose L.; Fanti, Stefano; Fonteyne, Valerie; Frydenberg, Mark; Futterer, Jurgen J.; Gakis, Georgios; Geavlete, Bogdan; Gontero, Paolo; Grubmüller, Bernhard; Hafeez, Shaista; Hansel, Donna E.; Hartmann, Arndt; Hayne, Dickon; Henry, Ann M.; Hernandez, Virginia; Herr, Harry; Herrmann, Ken; Hoskin, Peter; Huguet, Jorge; Jereczek-Fossa, Barbara A.; Jones, Rob; Kamat, Ashish M.; Khoo, Vincent; Kiltie, Anne E.; Krege, Susanne; Ladoire, Sylvain; Lara, Pedro C.; Leliveld, Annemarie; Linares-Espinós, Estefania; Løgager, Vibeke; Lorch, Anja; Loriot, Yohann; Meijer, Richard; Carmen Mir, M.; Moschini, Marco; Mostafid, Hugh; Müller, Arndt-Christian; Müller, Christoph R.; N’dow, James; Necchi, Andrea; Neuzillet, Yann; Oddens, Jorg R.; Oldenburg, Jan; Osanto, Susanne; Oyen, Wim J.G.; Pacheco-Figueiredo, Luís; Pappot, Helle; Patel, Manish I.; Pieters, Bradley R.; Plass, Karin; Remzi, Mesut; Retz, Margitta; Richenberg, Jonathan; Rink, Michael; Roghmann, Florian; Rosenberg, Jonathan E.; Rouprêt, Morgan; Rouvière, Olivier; Salembier, Carl; Salminen, Antti; Sargos, Paul; Sengupta, Shomik; Sherif, Amir; Smeenk, Robert J.; Smits, Anita; Stenzl, Arnulf; Thalmann, George N.; Tombal, Bertrand; Turkbey, Baris; Lauridsen, Susanne Vahr; Valdagni, Riccardo; Van Der Heijden, Antoine G.; Van Poppel, Hein; Vartolomei, Mihai D.; Veskimäe, Erik; Vilaseca, Antoni; Vives Rivera, Franklin A.; Wiegel, Thomas; Wiklund, Peter; Williams, Andrew; Zigeuner, Richard; Horwich, Alan
    AU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort : Under the Auspices of the EAU-ESMO Guidelines Committees
    In: European Urology Jg. 77 (2020) Nr. 2, S. 223 - 250
  • Calais, Jeremie; Armstrong, Wesley R.; Murthy, Vishnu; Heath, Courtney Lawhn; Behr, Spencer; Barbato, Francesco; Ceci, Francesco; Farolfi, Andrea; Schwarzenboeck, Sarah; Unterrainer, Marcus; Zacho, Helle; Cooperberg, Matthew R.; Nguyen, Hao Gia; Reiter, Robert Evan; Holden, Stuart; Herrmann, Ken; Fendler, Wolfgang; Eiber, Matthias; Czernin, Johannes; Hope, Thomas A.;
    Accuracy of 68Ga-PSMA-11 for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection : A multicenter prospective phase III imaging study
    EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S209
  • Seifert, Robert; Seitzer, Konstantin; Herrmann, Ken; Kessel, Katharina; Schäfers, Michael; Kleesiek, Jens; Weckesser, Matthias; Boegemann, Martin; Rahbar, Kambiz
    Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving 177Lu-PSMA-617 Radioligand Therapy
    In: Theranostics Jg. 10 (2020) Nr. 17, S. 7812 - 7820
  • Sraieb, Miriam; Hirmas, Nader; Conrad, Rupert; Marinova, Milka; Essler, Markus; Herrmann, Ken; Ahmadzadehfar, Hojjat
    Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [223Ra]RaCl2 therapy
    In: Medicine Jg. 99 (2020) Nr. 38, e22287
  • Guberina, Nika; Gäckler, Anja; Grueneisen, Johannes; Wetter, Axel; Witzke, Oliver; Herrmann, Ken; Rischpler, Christoph; Fendler, Wolfgang; Umutlu, Lale; Sawicki, Lino Morris; Forsting, Michael; Rohn, Hana
    Assessment of Suspected Malignancy or Infection in Immunocompromised Patients After Solid Organ Transplantation by [¹⁸F]FDG PET/CT and [¹⁸F]FDG PET/MRI
    In: Nuclear Medicine and Molecular Imaging Jg. 54 (2020) Nr. 4, S. 183 - 191
  • Paez, D.; Gnanasegaran, G.; Fanti, S.; Bomanji, J.; Hacker, M.; Sathekge, M.; Bom, H.S.; Cerci, J.J.; Chiti, A.; Herrmann, Ken; Scott, A.M.; Czernin, J.; El-Haj, N.; Estrada, E.; Pellet, O.; Orellana, P.; Giammarile, F.; Abdel-Wahab, M.
    COVID-19 pandemic : guidance for nuclear medicine departments
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 7, S. 1615 - 1619
  • Musche, Venja; Bäuerle, Alexander; Steinbach, Jasmin; Schweda, Adam; Hetkamp, Madeleine; Weismüller, Benjamin; Kohler, Hannah; Beckmann, Mingo; Herrmann, Ken; Tewes, Mitra; Schadendorf, Dirk; Skoda, Eva-Maria; Teufel, Martin
    COVID-19-Related Fear and Health-Related Safety Behavior in Oncological Patients
    In: Frontiers in Psychology Jg. 11 (2020) S. 1984
  • Rauscher, Isabel; Fendler, Wolfgang P.; Hope, Thomas A.; Quon, Andrew; Nekolla, Stephan G.; Calais, Jeremie; Richter, Antonia; Haller, Bernhard; Herrmann, Ken; Weber, Wolfgang A.; Czernin, Johannes; Eiber, Matthias
    Can the injected dose be reduced in ⁶⁸Ga-PSMA-11 PET/CT while maintaining high image quality for lesion detection?
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 2, S. 189 - 193
  • Rischpler, Christoph; Siebermair, Johannes; Kessler, L.; Quick, Harald H.; Umutlu, Lale; Rassaf, Tienush; Antoch, G.; Herrmann, Ken; Nensa, Felix
    Cardiac PET/MRI : Current Clinical Status and Future Perspectives
    In: Seminars in Nuclear Medicine Jg. 50 (2020) Nr. 3, S. 260 - 269
  • Wiesweg, Marcel; Herold, Thomas; Metzenmacher, Martin; Eberhardt, Wilfried; Reis, Henning; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Herrmann, Ken; Nensa, Felix; Schildhaus, Hans-Ulrich; Schuler, Martin
    Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutation
    In: Lung Cancer Jg. 139 (2020) S. 165 - 168
  • Kersting, David; Weber, M.; Sraieb, Miriam; Fragoso Costa, P.; Umutlu, Lale; Rischpler, Christoph; Fendler, Wolfgang; Conti, M.; Herrmann, Ken; Jentzen, Walter;
    Comparison of Lesion Detectability and Image Quality among Digital and Analog PET Systems for Recurrence in Thyroid Cancer Patients Using I-124
    EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S429
  • Li, Yan; Langhorst, Jost; Koch, Anna K.; Demircioglu, Aydin; Schaarschmidt, Benedikt; Theysohn, Jens; Martin, Ole; Herrmann, Ken; Catalano, Onofrio; Umutlu, Lale
    Comparison of acceptance of PET/MR enterography and ileocolonoscopy in patients with inflammatory bowel diseases
    In: Clinical Imaging Jg. 64 (2020) S. 11 - 17
  • Li, Yan; Khamou, Michael; Schaarschmidt, Benedikt Michael; Umutlu, Lale; Forsting, Michael; Demircioglu, Aydin; Haubold, Johannes; Koch, Anna Katharina; Bruckmann, Nils-Martin; Sawicki, Lino Morris; Herrmann, Ken; Boone, James Hunter; Langhorst, Jost
    Comparison of ¹⁸F-FDG PET-MR and fecal biomarkers in the assessment of disease activity in patients with ulcerative colitis
    In: The British Journal of Radiology (BJR) Jg. 93 (2020) Nr. 1112, S. 20200167
  • Krause, Bernd Joachim; Bartenstein, Peter; Freudenberg, Lutz Stefan; Herrmann, Ken; Jonas, Götz; Luster, Markus; Moka, Detlef; Schäfer, Wolfgang; Schwarzenböck, Sarah Marie; Meyer, Philipp Tobias
    Coronavirus SARS-CoV-2 : Empfehlungen für die nuklearmedizinische Versorgung in nuklearmedizinischen Kliniken/Abteilungen mit Therapiestation und Praxen, Instituten sowie Ordinationen
    In: Nuklearmedizin = Nuclear Medicine Jg. 59 (2020) Nr. 2, S. E1 - E4
  • Happel, C.; Kranert, W.T.; Gröner, D.; Bockisch, B.; Sabet, A.; Vardarli, I.; Görges, Rainer; Herrmann, Ken; Grünwald, F.
    Correction for hyperfunctioning radiation-induced stunning (CHRIS) in benign thyroid diseases
    In: Endocrine Jg. 69 (2020) Nr. 2, S. 466 - 473
  • Huang, H.L.; Gnanasegaran, G.; Paez, D.; Fanti, S.; Hacker, M.; Sathekge, M.; Bom, H.S.; Cerci, J.J.; Chiti, A.; Lan, X.; Herrmann, Ken; Scott, A.M.; Vinjamuri, S.; Dorbala, S.; Estrada, E.; Pellet, O.; Orellana, P.; El-Haj, N.; Giammarile, F.; Abdel-Wahab, M.; Bomanji, Jamshed
    Correction to: Nuclear medicine services after COVID-19: gearing up back to normality
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 9, S. 2220
  • Witjes, J. Alfred; Babjuk, Marek; Bellmunt, Joaquim; Bruins, H. Maxim; De Reijke, Theo M.; De Santis, Maria; Gillessen, Silke; James, Nicholas; Maclennan, Steven; Palou, Juan; Powles, Tom; Ribal, Maria J.; Shariat, Shahrokh F.; Van Der Kwast, Theo; Xylinas, Evanguelos; Agarwal, Neeraj; Arends, Tom; Bamias, Aristotle; Birtle, Alison; Black, Peter C.; Bochner, Bernard H.; Bolla, Michel; Boormans, Joost L.; Bossi, Alberto; Briganti, Alberto; Brummelhuis, Iris; Burger, Max; Castellano, Daniel; Cathomas, Richard; Chiti, Arturo; Choudhury, Ananya; Compérat, Eva; Crabb, Simon; Culine, Stephane; De Bari, Berardino; De Blok, Willem; De Visschere, Pieter J.L.; Decaestecker, Karel; Dimitropoulos, Konstantinos; Dominguez-Escrig, Jose L.; Fanti, Stefano; Fonteyne, Valerie; Frydenberg, Mark; Futterer, Jurgen J.; Gakis, Georgios; Geavlete, Bogdan; Gontero, Paolo; Grubmüller, Bernhard; Hafeez, Shaista; Hansel, Donna E.; Hartmann, Arndt; Hayne, Dickon; Henry, Ann M.; Hernandez, Virginia; Herr, Harry; Herrmann, Ken; Hoskin, Peter; Huguet, Jorge; Jereczek-Fossa, Barbara A.; Jones, Rob; Kamat, Ashish M.; Khoo, Vincent; Kiltie, Anne E.; Krege, Susanne; Ladoire, Sylvain; Lara, Pedro C.; Leliveld, Annemarie; Linares-Espinós, Estefania; Løgager, Vibeke; Lorch, Anja; Loriot, Yohann; Meijer, Richard; Mir, M. Carmen; Moschini, Marco; Mostafid, Hugh; Müller, Arndt-Christian; Müller, Christoph R.; N'Dow, James; Necchi, Andrea; Neuzillet, Yann; Oddens, Jorg R.; Oldenburg, Jan; Osanto, Susanne; Oyen, Wim J.G.; Pacheco-Figueiredo, Luís; Pappot, Helle; Patel, Manish I.; Pieters, Bradley R.; Plass, Karin; Remzi, Mesut; Retz, Margitta; Richenberg, Jonathan; Rink, Michael; Roghmann, Florian; Rosenberg, Jonathan E.; Rouprêt, Morgan; Rouvière, Olivier; Salembier, Carl; Salminen, Antti; Sargos, Paul; Sengupta, Shomik; Sherif, Amir; Smeenk, Robert J.; Smits, Anita; Stenzl, Arnulf; Thalmann, George N.; Tombal, Bertrand; Turkbey, Baris; Lauridsen, Susanne Vahr; Valdagni, Riccardo; Van Der Heijden, Antoine G.; Van Poppel, Hein; Vartolomei, Mihai D.; Veskimäe, Erik; Vilaseca, Antoni; Rivera, Franklin A. Vives; Wiegel, Thomas; Wiklund, Peter; Willemse, Peter-Paul M.; Williams, Andrew; Zigeuner, Richard; Horwich, Alan
    Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees
    In: European Urology Jg. 78 (2020) Nr. 1, S. e48 - e50
  • Vardarli, Irfan; Herrmann, Ken; Weidemann, Frank
    Diagnosis and screening of patients with fabry disease
    In: Therapeutics and Clinical Risk Management Jg. 16 (2020) S. 551 - 558
  • Langhorst, Jost; Umutlu, Lale; Schaarschmidt, Benedikt Michael; Grueneisen, Johannes; Demircioglu, Aydin; Forsting, Michael; Beiderwellen, Karsten; Haubold, Johannes; Theysohn, Jens; Koch, Anna Katharina; Dobos, Gustav; Dechene, Alexander; Herrmann, Ken; Bruckmann, Nils Martin; Lauenstein, Thomas; Li, Yan
    Diagnostic Performance of Simultaneous [18F]-FDG PET/MR for Assessing Endoscopically Active Inflammation in Patients with Ulcerative Colitis : A Prospective Study
    In: Journal of Clinical Medicine (JCM) Jg. 9 (2020) Nr. 8, 2474
  • Kersting, David; Weber, Manuel; Berger, Alexander; Sraieb, Miriam; Costa, Pedro Fragoso; Umutlu, Lale; Rischpler, Christoph; Fendler, Wolfgang; Conti, Maurizio; Herrmann, Ken; Jentzen, Walter
    Digital high sensitivity I-124 PET/CT improves the detectability of thyroid cancer metastases
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 255
  • Decker, Thomas; Seifert, R.; Tewes, Mitra; Heuschmid, M.; Welt, Anja; Herrmann, Ken;
    Early metabolic evaluation using F-18-FDG PET/CT might help to identify patients who benefit from treatment with cdk4/6 inhibitors
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 121 - 122
  • Baraliakos, X.; Tsiami, S.; Rischpler, Christoph; Bruckmann, N. M.; Fendler, Wolfgang; Kirchner, J.; Herrmann, Ken; Sawicki, L.; Braun, J.;
    Effects of anti-TNF-therapy on osteoblastic activity in ankylosing spondylitis : Results from a prospective study using PET-MRI of SIJ and SPINE
    EULAR: Annual European Congress of Rheumatology, 2020, 03.-06.06.2020, Frankfurt,
    In: Annals of the Rheumatic Diseases (ARD) Jg. 79 (2020) Nr. Suppl. 1, S. 1125 - 1126
  • Gafita, Andrei; Fendler, Wolfgang P.; Hui, Wang; Sandhu, Shahneen; Weber, Manuel; Esfandiari, Rouzbeh; Calais, Jeremie; Rauscher, Isabel; Rathke, Hendrik; Tauber, Robert; Delpassand, Ebrahim S.; Weber, Wolfgang A.; Herrmann, Ken; Czernin, Johannes; Eiber, Matthias; Hofman, Michael S.
    Efficacy and Safety of ¹⁷⁷Lu-labeled Prostate-specific Membrane Antigen Radionuclide Treatment in Patients with Diffuse Bone Marrow Involvement : A Multicenter Retrospective Study
    In: European Urology Jg. 78 (2020) Nr. 2, S. 148 - 154
  • Gafita, A.; Fendler, Wolfgang; Wang, H.; Sandhu, S.; Weber, Manuel; Esfandiari, R.; Calais, J.; Rauscher, I.; Rathke, H.; Tauber, R.; Delpassand, E. S.; Weber, W.; Herrmann, Ken; Czernin, J.; Eiber, M.; Hofman, M. S.;
    Efficacy and safety of 177Lu-PSMA radionuclide treatment in patients with diffuse bone marrow involvement : a multicenter retrospective study
    EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S491
  • Gafita, Andrei; Fendler, Wolfgang Peter; Wang, Hui; Sandhu, Shahneen Kaur; Weber, Manuel; Esfandiari, Rouzbeh; Czernin, Johannes; Rathke, Hendrik; Rauscher, Isabel; Tauber, Robert; Desspahand, Ebrahim; Weber, Wolfgang A.; Herrmann, Ken; Calais, Jeremie; Eiber, Matthias; Hofman, Michael S.;
    Efficacy and safety of Lu ¹⁷⁷-PSMA radionuclide treatment in patients with diffuse bone marrow involvement : A multicenter retrospective study
    2020 ASCO Annual Meeting; 29.05.2020 - 02.06.2020; Chicago, USA,
    In: Journal of Clinical Oncology (JCO) Jg. 38 (2020) Nr. Suppl. 15, S. e17543
  • Fendler, Wolfgang; Weber, Manuel; Herrmann, Ken
    Efficacy and safety of Lu-177-PSMA radionuclide treatment in patients with diffuse bone marrow involvement : a multicenter retrospective study
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 1284
  • Costa, Pedro Fragoso; Jentzen, Walter; Süßelbeck, Florian; Fendler, Wolfgang; Rischpler, Christoph; Herrmann, Ken; Conti, M.; Kersting, David; Weber, Manuel;
    Emission time optimisation for [68Ga]Ga-PSMA-11 with a SiPM PET/CT based on phantom measurements
    EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S256
  • Costa, Pedro Fragoso; Bramer, A.; Weber, Manuel; Kersting, David; Conti, M.; Fendler, W. P.; Rischpler, Christoph; Herrmann, Ken; Jentzen, Walter;
    Emission time reduction for 2-[18F]FDG examinations in lymphoma patients with a PET/CT with SiPM - a feasibility phantom study
    EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S257 - S258
  • Weber, M.; Hofferber, R.; Herrmann, Ken; Fendler, Wolfgang; Conti, M.; Wetter, A.; Kersting, David; Rischpler, Christoph; Jentzen, Walter; Costa, Pedro Fragoso;
    Evaluation of 68Ga-PSMA PET/CT Images Acquired with a Reduced Scan Time Duration in Prostate Cancer Patients using a Digital PET/CT Scanner
    EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S27
  • Grafe, Hong; Lindemann, Maike E.; Ruhlmann, Verena; Oehmigen, Mark; Hirmas, Nader; Umutlu, Lale; Herrmann, Ken; Quick, Harald H.
    Evaluation of improved attenuation correction in whole-body PET/MR on patients with bone metastasis using various radiotracers
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 10, S. 2269 - 2279
  • Kaddu-Mulindwa, D.; Altmann, B.; Held, G.; Angel, S.; Stilgenbauer, S.; Thurner, L.; Bewarder, Moritz; Schwier, M.; Pfreundschuh, Michael; Löffler, Markus; Menhart, Karin; Grosse, Jirka; Ziepert, Marita; Herrmann, Ken; Dührsen, Ulrich; Hüttmann, Andreas; Barbato, Francesco; Pöschel, Viola; Hellwig, Dirk;
    FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma : results from the prospective, multicenter PETAL and OPTIMAL > 60 trials
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 55 - 56
  • Darr, Christopher; Krafft, Ulrich; Fendler, W.P.; Costa, P. Fragoso; Barbato, F.; Praus, C.; Reis, Henning; Hager, T.; Tschirdewahn, Stephan; Radtke, J.P.; Herrmann, Ken; Hadaschik, Boris
    First-in-man intraoperative Cerenkov luminescence imaging for oligometastatic prostate cancer using ⁶⁸Ga-PSMA-11
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 13, S. 3194 - 3195
  • Freudenberg, Lutz S.; Paez, Diana; Giammarile, Francesco; Cerci, Juliano; Modiselle, Moshe; Pascual, Thomas N.B.; El-Haj, Noura; Orellana, Pilar; Pynda, Yaroslav; Carrió, Ignasi; Fanti, Stefano; Matushita, Cristina; Herrmann, Ken
    Global impact of COVID-19 on nuclear medicine departments : An international survey in April 2020
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 9, S. 1278 - 1283
  • Umutlu, Lale; Herrmann, Ken; Herold, C.
    Hybridbildgebung
    In: Der Radiologe Jg. 60 (2020) Nr. 5, S. 375
  • Iking, Janette; Klose, Jasmin; Staniszewska, Magdalena; Fendler, Wolfgang P.; Herrmann, Ken; Rischpler, Christoph
    Imaging inflammation after myocardial infarction : implications for prognosis and therapeutic guidance
    In: The Quarterly Journal of Nuclear Medicine and Molecular Imaging Jg. 64 (2020) Nr. 1, S. 35 - 50
  • Theurer, Sarah; Ingenwerth, Marc; Herold, Thomas; Herrmann, Ken; Schmid, Kurt Werner
    Immunohistochemical Profile and 47-Gene Next-Generation Sequencing (NGS) Solid Tumor Panel Analysis of a Series of 13 Strumal Carcinoids
    In: Endocrine Pathology Jg. 31 (2020) S. 101 - 107
  • Fendler, Wolfgang P; Ferdinandus, Justin; Czernin, Johannes; Eiber, Matthias; Flavell, Robert R; Behr, Spencer C; Wu, I-Wei K; Lawhn-Heath, Courtney; Pampaloni, Miguel H; Reiter, Robert E; Rettig, Matthew B; Gartmann, Jeannine; Murthy, Vishnu; Slavik, Roger; Carroll, Peter R; Herrmann, Ken; Calais, Jeremie; Hope, Thomas A
    Impact of 68Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 12, S. 1793 - 1799
  • Freudenberg, Lutz; Dittmer, Ulf; Herrmann, Ken
    Impact of COVID-19 on Nuclear Medicine in Germany, Austria and Switzerland : An International Survey in April 2020
    In: Nuklearmedizin = Nuclear Medicine Jg. 59 (2020) Nr. 4, S. 294 - 299
  • Kirchner, Julian; Martin, Ole; Umutlu, Lale; Herrmann, Ken; Bittner, Ann-Kathrin; Hoffmann, Oliver; Mohrmann, Swetlana; Gauler, Thomas; Theurer, Sarah; Antke, Christina; Esposito, Irene; Kinner, Sonja; Schaarschmidt, Benedikt M.; Kowall, Bernd; Lütke-Brintrup, Diana; Stang, Andreas; Becker, Anton S.; Antoch, Gerald; Buchbender, Christian
    Impact of ¹⁸F-FDG PET/MR on therapeutic management in high risk primary breast cancer patients : A prospective evaluation of staging algorithms
    In: European Journal of Radiology Jg. 128 (2020) S. 108975
  • Ferdinandus, Justin; Herrmann, Ken
    Impact of(68)Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 43
  • Kollenda, Sebastian; Klose, Jasmin; Knuschke, Torben; Sokolova, Viktoriya; Schmitz, Jochen; Staniszewska, Magdalena; Costa, Pedro Fragoso; Herrmann, Ken; Westendorf, Astrid; Fendler, Wolfgang; Epple, Matthias
    In vivo biodistribution of calcium phosphate nanoparticles after intravascular, intramuscular, intratumoral, and soft tissue administration in mice investigated by small animal PET/CT
    In: Acta Biomaterialia Jg. 109 (2020) S. 244 - 253
  • Vaz, Sofia; Hadaschik, Boris; Gabriel, Michael; Herrmann, Ken; Eiber, Matthias; Costa, Durval
    Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patients
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 1, S. 9 - 15
  • Darr, Christopher; Harke, Nina; Radtke, Jan Philipp; Yirga, Leubet; Kesch, Claudia; Grootendorst, Maarten; Fendler, Wolfgang; Fragoso Costa, Pedro; Rischpler, Christoph; Praus, Christine; Haubold, Johannes; Reis, Henning; Hager, Thomas; Herrmann, Ken; Binse, Ina; Hadaschik, Boris
    Intraoperative 68Gallium-PSMA Cerenkov Luminescence Imaging for surgical margins in radical prostatectomy : A feasibility study
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 10, S. 1500 - 1506
  • Martin, Ole; Bruckmann, Nils-Martin; Kirchner, Julian; Ullrich, Tim; Ingenwerth, Marc; Bogner, Simon; Eze, Chukwuka; Nensa, Felix; Herrmann, Ken; Umutlu, Lale; Antoch, Gerald; Sawicki, Lino M.
    Is there a connection between immunohistochemical markers and grading of lung cancer with apparent diffusion coefficient (ADC) and standardised uptake values (SUV) of hybrid 18F-FDG-PET/MRI?
    In: Journal of Medical Imaging and Radiation Oncology Jg. 64 (2020) Nr. 6, S. 779 - 786
  • Scherer, Jonas; Nolden, Marco; Kleesiek, Jens; Metzger, Jasmin; Kades, Klaus; Schneider, Verena; Bach, Michael; Sedlaczek, Oliver; Bucher, Andreas M.; Vogl, Thomas J.; Grünwald, Frank; Kühn, Jens-Peter; Hoffmann, Ralf-Thorsten; Kotzerke, Jörg; Bethge, Oliver; Schimmöller, Lars; Antoch, Gerald; Müller, Hans-Wilhelm; Daul, Andreas; Nikolaou, Konstantin; la Fougère, Christian; Kunz, Wolfgang G.; Ingrisch, Michael; Schachtner, Balthasar; Ricke, Jens; Bartenstein, Peter; Nensa, Felix; Radbruch, Alexander; Umutlu, Lale; Forsting, Michael; Seifert, Robert; Herrmann, Ken; Mayer, Philipp; Kauczor, Hans-Ulrich; Penzkofer, Tobias; Hamm, Bernd; Brenner, Winfried; Kloeckner, Roman; Düber, Christoph; Schreckenberger, Mathias; Braren, Rickmer; Kaissis, Georgios; Makowski, Marcus; Eiber, Matthias; Gafita, Andrei; Trager, Rupert; Weber, Wolfgang A.; Neubauer, Jakob; Reisert, Marco; Bock, Michael; Bamberg, Fabian; Hennig, Jürgen; Meyer, Philipp Tobias; Ruf, Juri; Haberkorn, Uwe; Schoenberg, Stefan O.; Kuder, Tristan; Neher, Peter; Floca, Ralf; Schlemmer, Heinz-Peter; Maier-Hein, Klaus
    Joint Imaging Platform for Federated Clinical Data Analytics
    In: JCO Clinical Cancer Informatics (JCO CCI) Jg. 4 (2020) S. 1027 - 1038
  • Derlin, Thorsten; Gatidis, Sergios; Krause, Bernd Joachim; Antoch, Gerald; Kotzerke, Jörg; Pinto Dos Santos, Daniel; Eiber, Matthias; Weber, Marc-André; Giesel, Frederik; Pfannenberg, Christina; Schlemmer, Heinz-Peter; Persigehl, Thorsten; Herrmann, Ken; Umutlu, Lale
    Konsensusempfehlung zur strukturierten Befunderstellung onkologischer PET-Hybridbildgebung
    In: Nuklearmedizin = Nuclear Medicine Jg. 59 (2020) Nr. 4, S. 288 - 293
  • Derlin, Thorsten; Gatidis, Sergios; Krause, Bernd Joachim; Antoch, Gerald; Kotzerke, Jörg; Pinto Dos Santos, Daniel; Eiber, Matthias; Weber, Marc-André; Giesel, Frederik; Pfannenberg, Christina; Schlemmer, Heinz-Peter; Persigehl, Thorsten; Herrmann, Ken; Umutlu, Lale; Anton, Frank; Barkhausen, Jörg; Bartenstein, Peter; Luster, Markus; Neumann, Stefan; Schönberg, Stefan O.
    Konsensusempfehlung zur strukturierten Befunderstellung onkologischer PET-Hybridbildgebung*
    In: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren Jg. 192 (2020) Nr. 8, S. 739 - 744
  • Vardarli, I.; Weidemann, F.; Aboukoura, M.; Herrmann, Ken; Binse, Ina; Görges, Rainer
    Longer-term recurrence rate after low versus high dose radioiodine ablation for differentiated thyroid Cancer in low and intermediate risk patients : a meta-analysis
    In: BMC Cancer Jg. 20 (2020) Nr. 1, 550
  • Guberina, Marko; Pöttgen, Christoph; Guberina, Nika; Hautzel, Hubertus; Herrmann, Ken; Theegarten, Dirk; Aigner, Clemens; Plones, Till; Gauler, Thomas; Eberhardt, Wilfried; Schuler, Martin; Karpf-Wissel, Rüdiger; Darwiche, Kaid; Stuschke, Martin;
    Lymphknoten-Staging von lokal fortgeschrittenen, nicht kleinzelligen Lungenkarzinomen (NSCLC) : Wert von [18F] FDG-PET/CT und EBUS/TBNA zur Festlegung des Zielvolumens bei definitiver Radiotherapie in kurativer Intention
    26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 196 (2020) Nr. 1 Supplement: Abstracts DEGRO 2020, S. S143
  • Hautzel, H.; Plönes, T.; Darwiche, Kaid; Fendler, Wolfgang; Rischpler, Christoph; Theegarten, Dirk; Aigner, Clemens; Herrmann, Ken;
    Lymphonodular anthracosis in patients undergoing FDG PET/CT for initial lung cancer diagnostics and/or staging is a mayor pitfall : a comparison to the histological gold standard
    EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S565 - S566
  • Ferrone, Cristina; Goyal, Lipika; Qadan, Motaz; Gervais, Debra; Sahani, Dushyant V.; Zhu, Andrew X.; Hong, Theodore S.; Blaszkowsky, Lawrence S.; Tanabe, Kenneth K.; Vangel, Mark; Amorim, Barbara J.; Wo, Jennifer Y.; Mahmood, Umar; Pandharipande, Pari V.; Catana, Ciprian; Duenas, Virginia P.; Collazo, Yolanda Q.; Canamaque, Lina G.; Domachevsky, Liran; Bernstine, Hanna H.; Groshar, David; Shih, Tiffany Tsing-Fang; Li, Yan; Herrmann, Ken; Umutlu, Lale; Rosen, Bruce R.; Catalano, Onofrio A.
    Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinoma
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 8, S. 1871 - 1884
  • Farolfi, Andrea; Ilhan, Harun; Gafita, Andrei; Calais, Jeremie; Barbato, Francesco; Weber, Manuel; Afshar-Oromieh, Ali; Spohn, Fabian; Wetter, Axel; Rischpler, Christoph; Hadaschik, Boris; Pianori, Davide; Fanti, Stefano; Haberkorn, Uwe; Eiber, Matthias; Herrmann, Ken; Fendler, Wolfgang Peter
    Mapping Prostate Cancer Lesions Before and After Unsuccessful Salvage Lymph Node Dissection Using Repeat PSMA PET
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 7, S. 1037 - 1042
  • Farolfi, Andrea; Barbato, Francesco; Weber, Manuel; Ferdinandus, Justin; Wetter, Axel; Rischpler, Christoph; Hadaschik, Boris; Herrmann, Ken; Fendler, Wolfgang
    Mapping prostate cancer lesions pre/post unsuccessful salvage lymph node dissection employing PSMA-PET
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 1270
  • Lordick, F.; Herrmann, Ken
    Metabolic response assessment and PET-guided treatment of esophageal cancer
    In: Annals of Oncology Jg. 31 (2020) Nr. 2, S. 163 - 164
  • Sandach, Patrick; Kasper-Virchow, Stefan; Rischpler, Christoph; Herrmann, Ken
    Molecular Imaging and Therapy of Colorectal and Anal Cancer
    In: Seminars in Nuclear Medicine Jg. 50 (2020) Nr. 5, S. 465 - 470
  • Sandach, Patrick; Rischpler, Christoph; Herrmann, Ken
    Molecular imaging and theranostics
    In: Der Onkologe Jg. 26 (2020) Nr. 1, S. 14 - 21
  • Bodei, Lisa; Schöder, Heiko; Baum, Richard P; Herrmann, Ken; Strosberg, Jonathan; Caplin, Martyn; Öberg, Kjell; Modlin, Irvin M
    Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy
    In: The Lancet Oncology Jg. 21 (2020) Nr. 9, S. e431 - e443
  • Lahner, Harald; Fendler, Wolfgang P.; Theurer, Sarah; Unger, Nicole; Herrmann, Ken; Schmid, Kurt Werner; Führer, Dagmar
    Neuroendokrine Neoplasien des Verdauungstrakts
    In: Best Practice Onkologie Jg. 15 (2020) Nr. 7-8, S. 320 - 333
  • Haubold, Johannes; Demircioglu, Aydin; Gratz, Marcel; Glas, Martin; Wrede, Karsten; Sure, Ulrich; Antoch, Gerald; Keyvani, Kathy; Nittka, Mathias; Kannengiesser, Stephan; Gulani, Vikas; Griswold, Mark; Herrmann, Ken; Forsting, Michael; Nensa, Felix; Umutlu, Lale
    Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric ¹⁸F-FET PET-MRI and MR Fingerprinting
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 6, S. 1435 - 1445
  • Vaz, Sofia C.; Oliveira, Francisco; Herrmann, Ken; Veit-Haibach, Patrick
    Nuclear medicine and molecular imaging advances in the 21st century
    In: The British Journal of Radiology (BJR) Jg. 93 (2020) Nr. 1110, S. 20200095
  • Czernin, Johannes; Fanti, Stefano; Meyer, Philipp T.; Allen-Auerbach, Martin; Hacker, Marcus; Sathekge, Mike; Hicks, Rodney; Scott, Andrew M.; Hatazawa, Jun; Yun, Mijin; Schöder, Heiko; Bartenstein, Peter; Herrmann, Ken
    Nuclear medicine operations in the times of COVID-19: Strategies, precautions, and experiences
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 5, S. 626 - 629
  • Huang, H.L.; Gnanasegaran, G.; Paez, D.; Fanti, S.; Hacker, M.; Sathekge, M.; Bom, H.S.; Cerci, J.J.; Chiti, A.; Lan, X.; Herrmann, Ken; Scott, A.M.; Vinjamuri, S.; Dorbala, S.; Estrada, E.; Pellet, O.; Orellana, P.; El-Haj, N.; Giammarile, F.; Abdel-Wahab, M.; Bomanji, Jamshed
    Nuclear medicine services after COVID-19: gearing up back to normality
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 9, S. 2048 - 2053
  • Calais, J.; Armstrong, W. R.; Gartmann, J.; Thin, P.; Nguyen, K.; Lok, V.; Gosa, L.; Slavik, R.; Dalhbom, M.; Herrmann, Ken; Eiber, M.; Fendler, Wolfgang; Czernin, J.;
    Overall survival after177Lu-PSMA-617 molecular radiotherapy in patients with metastatic castrate-resistant prostate cancer : Post-hoc analysis of a prospective phase II trial
    EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S488
  • Calais, J.; Armstrong, W. R.; Gartmann, J.; Thin, P.; Nguyen, K.; Lok, V.; Gosa, L.; Slavik, R.; Dalhbom, M.; Herrmann, Ken; Eiber, M.; Fendler, W. P.; Czernin, J.;
    Overall survival after177Lu-PSMA-617 molecular radiotherapy in patients with metastatic castrateresistant prostate cancer : Post-hoc analysis of a prospective phase II trial
    EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S488
  • Ferdinandus, Justin; Barbato, Francesco; Chodyla, Michal; Fendler, Wolfgang; Kessler, Lukas; Metzenmacher, Martin; Krefting, Frederik; Hager, Thomas; Herrmann, Ken; Christoph, Daniel
    PERCIST-derived metabolic volume response predicts overall and progression-free survival in patients with malignant pleural mesothelioma treated with Pembrolizumab
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 243
  • Ferdinandus, Justin; Barbato, Francesco; Chodyla, Michal; Fendler, Wolfgang; Kessler, Lukas; Metzenmacher, Martin; Krefting, Frederik; Hager, Thomas; Herrmann, Ken; Christoph, Daniel;
    PERCIST-derived metabolic volume response predicts overall and progression-free survival in patients with malignant pleural mesothelioma treated with Pembrolizumab
    EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S353
  • Martin, Ole; Schaarschmidt, Benedikt M.; Kirchner, Julian; Suntharalingam, Saravanabavaan; Grueneisen, Johannes; Demircioglu, Aydin; Heusch, Philipp; Quick, Harald H.; Forsting, Michael; Antoch, Gerald; Herrmann, Ken; Umutlu, Lale
    PET/MRI Versus PET/CT for Whole-Body Staging : Results from a Single-Center Observational Study on 1,003 Sequential Examinations
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 8, S. 1131 - 1136
  • Farolfi, Andrea; Hirmas, Nader; Gafita, Andrei; Weber, Manuel; Barbato, Francesco; Wetter, Axel; Ferdinandus, Justin; Nader, Michael; Mei, Riccardo; Pianori, Davide; Hadaschik, Boris; Castellucci, Paolo; Fanti, Stefano; Eiber, Matthias; Herrmann, Ken; Fendler, Wolfgang
    PSMA-PET identifies PCWG3 target populations with high concordance however superior reproducibility when compared to conventional imaging
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 1260
  • Bodei, Lisa; Bergsland, Emily; de Herder, Wouter W.; Ferone, Diego; Hicks, Rodney J.; Hope, Thomas A.; Kunikowska, Jolanta; Pavel, Marianne; Reidy-Lagunes, Diane; Siveke, Jens; Strosberg, Jonathan; Dittmer, Ulf; Herrmann, Ken
    Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic : Are There Any Concerns?
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 8, S. 1094 - 1095
  • Michel, Lars; Hendgen-Cotta, Ulrike B.; Mincu, Raluca I.; Helfrich, Iris; Korste, S; Mrotzek, Simone; Rischpler, C; Herrmann, Ken; Ugurel, Selma; Zimmer, Lisa; Coman, C; Ahrends, R; Schadendorf, Dirk; Rassaf, Tienush; Totzeck, Matthias;
    Preclinical and clinical assessment of immune checkpoint inhibitor-associated left ventricular dysfunction
    ESC Congress 2020 – The Digital Experience 29 August – 1 September 2020,
    In: European Heart Journal Jg. 41 (2020) Nr. Supplement_2, S. 3260
  • Weber, Manuel; Herrmann, Ken; Fendler, Wolfgang
    Predictive factors and prediction nomograms for LuPSMA radioligand therapy in patients with metastatic castration-resistant prostate cancer : an international multicentre retrospective study
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 593
  • Fragoso Costa, P.; Sonnenschein, W.; Binse, Ina; Fendler, W. P.; Herrmann, Ken; Grootendorst, M. R.; Krafft, Ulrich; Radtke, J. P.; Hadaschik, Boris; Darr, C.;
    Preliminary Investigations on Radiation Exposure in [68Ga]Ga-PSMA-11 based Cerenkov Luminescence Imaging Procedures
    EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S212
  • Köhler, Michael; Harders, Fabian; Lohöfer, Fabian; Paprottka, Philipp M; Schaarschmidt, Benedikt M; Theysohn, Jens; Herrmann, Ken; Heindel, Walter; Schmidt, Hartmut H; Pascher, Andreas; Stegger, Lars; Rahbar, Kambiz; Wildgruber, Moritz
    Prognostic Factors for Overall Survival in Advanced Intrahepatic Cholangiocarcinoma Treated with Yttrium-90 Radioembolization
    In: Journal of Clinical Medicine (JCM) Jg. 9 (2020) Nr. 1, 56
  • Gafita, Andrei; Calais, Jeremie; Wang, Hui; Weber, Manuel; Rathke, Hendrik; Kratochwil, Clemens; Esfandiari, Rouzbeh; Armstrong, Wesley R; Sandhu, Shahneen Kaur; Tauber, Robert; Delpassand, Ebrahim; Haberkorn, Uwe; Weber, Wolfgang A; Herrmann, Ken; Czernin, Johannes; Hofman, Michael S; Fendler, Wolfgang Peter; Eiber, Matthias
    Prognostic markers for overall survival and outcome to LuPSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer
    In: Journal of Clinical Oncology (JCO) Jg. 38 (2020) Nr. 15_Suppl., S. 5548
  • Gafita, A.; Calais, J.; Wang, H.; Weber, Manuel; Rathke, H.; Kratochwil, C.; Esfandiari, R.; Armstrong, W. R.; Sandhu, S.; Tauber, R.; Delpassand, E. S.; Haberkorn, U.; Weber, W. A.; Herrmann, Ken; Czernin, J.; Hofman, M. S.; Fendler, Wolfgang; Eiber, M.;
    Prognostic markers for overall survival and outcome to LuPSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer
    EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S487
  • Fanti, Stefano; Hadaschik, Boris; Herrmann, Ken
    Proposal for Systemic-Therapy Response-Assessment Criteria at the Time of PSMA PET/CT Imaging : The PSMA PET Progression Criteria
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 5, S. 678 - 682
  • Bruckmann, Nils Martin; Sawicki, Lino M.; Kirchner, Julian; Martin, Ole; Umutlu, Lale; Herrmann, Ken; Fendler, Wolfgang; Bittner, Ann-Kathrin; Hoffmann, Oliver; Mohrmann, Svjetlana; Dietzel, Frederic; Ingenwerth, Marc; Schaarschmidt, Benedikt M.; Li, Yan; Kowall, Bernd; Stang, Andreas; Antoch, Gerald; Buchbender, Christian
    Prospective evaluation of whole-body MRI and ¹⁸F-FDG PET/MRI in N and M staging of primary breast cancer patients
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 12, S. 2816 - 2825
  • Ferdinandus, Justin; Fendler, Wolfgang Peter; Hadaschik, Boris; Herrmann, Ken
    Prostate-specific membrane antigen targeted PET imaging for prostate cancer recurrence
    In: Current Opinion in Urology Jg. 30 (2020) Nr. 5, S. 635 - 640
  • Papathanasiou, Maria; Carpinteiro, Alexander; Hagenacker, Tim; Herrmann, Ken; Rassaf, Tienush; Rischpler, Christoph; Lüdike, Peter
    Publisher Correction to: 18F-florbetaben positron emission tomography detects cardiac involvement in systemic AA amyloidosis
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 13, S. 3196
  • Umutlu, Lale; Nensa, Felix; Demircioglu, Aydin; Antoch, Gerald; Herrmann, Ken; Forsting, Michael; Grueneisen, Johannes Stefan
    Radiomics Analysis of Multiparametric PET/MRI for N- and M-Staging in Patients with Primary Cervical Cancer
    In: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren Jg. 192 (2020) Nr. 8, S. 754 - 763
  • Bögemann, M.; Herrmann, Ken; Radtke, J.P.; Rahbar, K.
    Radionuklidtherapie mit PSMA-Liganden bei fortgeschrittenem Prostatakarzinom
    In: Der Urologe Jg. 59 (2020) Nr. 6, S. 680 - 686
  • Herrmann, Ken; Schwaiger, Markus; Lewis, Jason S.; Solomon, Stephen B.; McNeil, Barbara J.; Baumann, Michael; Gambhir, Sanjiv S.; Hricak, Hedvig; Weissleder, Ralph
    Radiotheranostics : A roadmap for future development
    In: The Lancet Oncology Jg. 21 (2020) Nr. 3, S. e146 - e156
  • Hadaschik, Boris; Herrmann, Ken
    Re: Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Prostate Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA) : A Prospective, Randomised, Multi-centre Study
    In: European Urology Jg. 78 (2020) Nr. 3, S. 470 - 471
  • Merkel, C.; Whicher, C.H.; Bomanji, J.; Herrmann, Ken; Ćwikła, J.; Jervis, N.; Wait, S.; Chiti, A.
    Realising the potential of radioligand therapy: policy solutions for the barriers to implementation across Europe
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 6, S. 1335 - 1339
  • Seifert, Robert; Herrmann, Ken; Kleesiek, Jens; Schafers, Michael A.; Shah, Vijay; Xu, Zhoubing; Chabin, Guillaume; Grbic, Sasa; Spottiswoode, Bruce; Rahbar, Kambiz
    Semi-automatically quantified tumor volume using Ga-68-PSMA-11-PET as biomarker for survival in patients with advanced prostate cancer
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 12, S. 1786 - 1792
  • Weber, Manuel; Kessler, Lukas; Schaarschmidt, Benedikt; Fendler, Wolfgang Peter; Lahner, Harald; Antoch, Gerald; Umutlu, Lale; Herrmann, Ken; Rischpler, Christoph
    Textural analysis of hybrid DOTATOC-PET/MRI and its association with histological grading in patients with liver metastases from neuroendocrine tumors
    In: Nuclear Medicine Communications Jg. 41 (2020) Nr. 4, S. 363 - 369
  • Weber, Wolfgang A.; Czernin, Johannes; Anderson, Carolyn J.; Badawi, Ramsey D.; Barthel, Henryk; Bengel, Frank; Bodei, Lisa; Buvat, Irène; DiCarli, Marcelo; Graham, Michael M.; Grimm, Jan; Herrmann, Ken; Kostakoglu, Lale; Lewis, Jason S.; Mankoff, David A.; Peterson, Todd E.; Schelbert, Heinrich; Schöder, Heiko; Siegel, Barry A.; Strauss, H William
    The Future of Nuclear Medicine, Molecular Imaging, and Theranostics
    In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Supplement 2, S. 263S - 272S
  • Theruvath, Ashok J.; Siedek, Florian; Muehe, Anne M.; Garcia-Diaz, Jordi; Kirchner, Julian; Martin, Ole; Link, Michael P.; Spunt, Sheri; Pribnow, Allison; Rosenberg, Jarrett; Herrmann, Ken; Gatidis, Sergios; Schäfer, Jürgen F.; Moseley, Michael; Umutlu, Lale; Daldrup-Link, Heike E.
    Therapy Response Assessment of Pediatric Tumors with Whole-Body Diffusion-weighted MRI and FDG PET/MRI
    In: Radiology Jg. 296 (2020) Nr. 1, S. 143 - 151
  • Weber, Manuel; Kessler, Lukas; Schaarschmidt, Benedikt; Fendler, Wolfgang Peter; Lahner, Harald; Antoch, Gerald; Umutlu, Lale; Herrmann, Ken; Rischpler, Christoph
    Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from ⁶⁸Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient
    In: BMC Cancer Jg. 20 (2020) Nr. 1, 326
  • Christoph, Daniel; Barbato, Francesco; Chodyla, Michal; Fendler, Wolfgang P.; Kessler, Lukas; Pomykala, Kelsey L.; Metzenmacher, Martin; Krefting, Frederik; Hager, Thomas; Herrmann, Ken; Ferdinandus, Justin;
    Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma
    ESMO Virtual Congress 2020, 19.-21.09- und 16.-18.10.2020,
    In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. S1076 - S1077
  • Guberina, Nika; Hetkamp, Philipp; Rübben, Herbert; Fendler, W.; Grueneisen, J.; Suntharalingam, S.; Kirchner, J.; Püllen, Lukas; Harke, Nina; Radtke, J.P.; Umutlu, Lale; Hadaschik, Boris; Herrmann, Ken; Forsting, Michael; Wetter, Axel
    Whole-Body Integrated [⁶⁸Ga]PSMA-11-PET/MR Imaging in Patients with Recurrent Prostate Cancer : Comparison with Whole-Body PET/CT as the Standard of Reference
    In: Molecular Imaging and Biology Jg. 22 (2020) Nr. 3, S. 788 - 796
  • Li, Yan; Schaarschmidt, Benedikt; Umutlu, Lale; Forsting, Michael; Demircioglu, Aydin; Koch, Anna Katharina; Martin, Ole; Herrmann, Ken; Juette, Hendrik; Tannapfel, Andrea; Langhorst, Jost
    ¹⁸F-FDG PET-MR enterography in predicting histological active disease using the Nancy index in ulcerative colitis : A randomized controlled trial
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 4, S. 768 - 777
  • Deuschl, Cornelius; Rüber, Theodor; Ernst, Leon; Fendler, Wolfgang P.; Kirchner, Julian; Mönninghoff, Christoph; Herrmann, Ken; Quesada, Carlos M.; Forsting, Michael; Elger, Christian E.; Umutlu, Lale
    ¹⁸F-FDG-PET/MRI in the diagnostic work-up of limbic encephalitis
    In: PLoS ONE Jg. 15 (2020) Nr. 1, S. e0227906
  • Papathanasiou, Maria; Carpinteiro, Alexander; Hagenacker, Tim; Herrmann, Ken; Rassaf, Tienush; Rischpler, Christoph; Lüdike, Peter
    ¹⁸F-florbetaben positron computed tomography detects cardiac involvement in systemic AA amyloidosis
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 13, S. 3186 - 3187
  • Carrio, Ignasi; Essler, Markus; Freudenberg, Lutz; Herrmann, Ken
    “COVID-19 Pandemic as stimulator to Re-Establish Nuclear Medicine as Clinical Specialty” based on a report of Prof. Dr. Ignasi Carrio
    In: Nuklearmedizin = Nuclear Medicine Jg. 59 (2020) Nr. 6, S. 405 - 408
  • Grueneisen, Johannes; Schaarschmidt, Benedikt; Demircioglu, Aydin; Chodyla, Michal; Martin, Ole; Bertram, Stefanie; Wetter, Axel; Bauer, Sebastian; Fendler, Wolfgang Peter; Podleska, Lars; Forsting, Michael; Herrmann, Ken; Umutlu, Lale
    18F-FDG PET/MRI for Therapy Response Assessment of Isolated Limb Perfusion in Patients with Soft-Tissue Sarcomas
    In: Journal of Nuclear Medicine (JNM) Jg. 60 (2019) Nr. 11, S. 1537 - 1542
  • Buono, Stefano; Herrmann, Ken
    A conversation between Stefano Buono and Ken Herrmann
    In: Journal of Nuclear Medicine (JNM) Jg. 60 (2019) Nr. 12, S. 1659 - 1662
  • Schaffert, Susanne; Herrmann, Ken
    A conversation between Susanne Schaffert and Ken Herrmann
    In: Journal of Nuclear Medicine (JNM) Jg. 60 (2019) Nr. 7, S. 875 - 878
  • Li, Yan; Langhorst, Jost; Koch, Anna Katharina; Demircioglu, Aydin; Nensa, Felix; Kirchner, Julian; Beiderwellen, Karsten; Catalano, Onofrio; Forsting, Michael; Herrmann, Ken; Umutlu, Lale
    Assessment of ileocolonic inflammation in Crohn’s disease : Which surrogate marker is better—MAria, Clermont, or PET/MR index? Initial results of a feasibility trial
    In: Journal of Nuclear Medicine (JNM) Jg. 60 (2019) Nr. 6, S. 851 - 857
  • Fendler, Wolfgang P.; Calais, Jeremie; Eiber, Matthias; Flavell, Robert R.; Mishoe, Ashley; Feng, Felix Y.; Nguyen, Hao G.; Reiter, Robert E.; Rettig, Matthew B.; Okamoto, Shozo; Emmett, Louise; Zacho, Helle D.; Ilhan, Harun; Wetter, Axel; Rischpler, Christoph; Schoder, Heiko; Burger, Irene A.; Gartmann, Jeannine; Smith, Raven; Small, Eric J.; Slavik, Roger; Carroll, Peter R.; Herrmann, Ken; Czernin, Johannes; Hope, Thomas A.
    Assessment of ⁶⁸Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer : A Prospective Single-Arm Clinical Trial
    In: JAMA Oncology Jg. 5 (2019) Nr. 6, S. 856 - 863
  • Rischpler, Christoph; Nekolla, S.G.; Heusch, Gerd; Umutlu, Lale; Rassaf, Tienush; Heusch, P.; Herrmann, Ken; Nensa, Felix
    Cardiac PET/MRI—an update
    In: European Journal of Hybrid Imaging: EJNMMI Multimodality Journal Jg. 3 (2019) Nr. 1, 2
  • Bodei, Lisa; Herrmann, Ken; Baum, Richard P.; Kidd, Mark; Malczewska, Anna; Modlin, Irvin M.
    Caveat Emptor : Let our acclaim of the apotheosis of PRRT not blind us to the error of Prometheus
    In: Journal of Nuclear Medicine (JNM) Jg. 60 (2019) Nr. 1, S. 7 - 8
  • Farahati, Jamshid; Mäder, Uwe; Gilman, Elena; Görges, Rainer; Maric, Ines; Binse, Ina; Hänscheid, Heribert; Herrmann, Ken; Buck, Andreas; Bockisch, Andreas
    Changing trends of incidence and prognosis of thyroid carcinoma
    In: Nuklearmedizin = Nuclear Medicine Jg. 58 (2019) Nr. 2, S. 86 - 92
  • Kebir, Sied; Lazaridis, Lazaros; Weber, Manuel; Deuschl, Cornelius; Stoppek, Ann-Kathrin; Schmidt, Teresa; Mönninghoff, Christoph; Blau, Tobias; Keyvani, Kathy; Umutlu, Lale; Pierscianek, Daniela; Forsting, Michael; Stuschke, Martin; Antoch, Gerald; Sure, Ulrich; Kleinschnitz, Christoph; Scheffler, Björn; Colletti, Patrick M.; Rubello, Domenico; Herrmann, Ken; Glas, Martin
    Comparison of L-Methyl-11C-Methionine PET With Magnetic Resonance Spectroscopy in Detecting Newly Diagnosed Glioma
    In: Clinical Nuclear Medicine Jg. 44 (2019) Nr. 6, S. e375 - e381
  • Boerman, Otto C.; Heskamp, Sandra; Fracasso, Giulio; Colombatti, Marco; Franssen, Gerben M.; Frielink, Cathelijne; Kip, Annemarie; Gotthardt, Martin; Lütje, Susanne; Hekman, Marlène; Rijpkema, Mark; Herrmann, Ken
    Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors
    In: Theranostics Jg. 9 (2019) S. 2924 - 2938
  • Herrmann, Ken; Veit-Haibach, Patrick; Weber, Wolfgang A.
    Driving the Future of Nuclear Medicine
    In: Journal of Nuclear Medicine (JNM) Jg. 60 (2019) Nr. 9, S. 1S - 2S
  • Kratochwil, Clemens; Fendler, Wolfgang Peter; Eiber, Matthias; Baum, Richard; Bozkurt, Murat Fani; Czernin, Johannes; Delgado Bolton, Roberto C.; Ezziddin, Samer; Forrer, Flavio; Hicks, Rodney J.; Hope, Thomas A.; Kabasakal, Levant; Konijnenberg, Mark; Kopka, Klaus; Lassmann, Michael; Mottaghy, Felix M.; Oyen, Wim; Rahbar, Kambiz; Schöder, Heiko; Virgolini, Irene; Wester, Hans-Jürgen; Bodei, Lisa; Fanti, Stefano; Haberkorn, Uwe; Herrmann, Ken
    EANM procedure guidelines for radionuclide therapy with ¹⁷⁷Lu-labelled PSMA-ligands (¹⁷⁷Lu-PSMA-RLT)
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 46 (2019) Nr. 12, S. 2536 - 2544
  • Horwich, Alan; Babjuk, Marko; Bellmunt, Joaquim; Bruins, Harman M.; Reijke, Theo M. de; Santis, Maria C. de; Gillessen, S.; James, N.; Maclennan, S.; Palou, J.; Powles, T.; Ribal, M. J.; Shariat, S. F.; Kwast, Theodorus van der; Xylinas, E.; Agarwal, N.; Arends, T.; Bamias, A.; Birtle, A.; Black, P. C.; Bochner, B. H.; Bolla, M.; Boormans, J. L.; Bossi, A.; Briganti, A.; Brummelhuis, I.; Burger, M.; Castellano, D.; Cathomas, R.; Chiti, A.; Choudhury, A.; Compérat, E.; Crabb, S.; Culine, S.; De Bari, B.; DeBlok, W.; De Visschere, P. J. L.; Decaestecker, K.; Dimitropoulos, K.; Dominguez-Escrig, J. L.; Fanti, S.; Fonteyne, V.; Frydenberg, M.; Futterer, J. J.; Gakis, G.; Geavlete, B.; Gontero, P.; Grubmüller, B.; Hafeez, S.; Hansel, D. E.; Hartmann, A.; Hayne, D.; Henry, A. M.; Hernandez, V.; Herr, H.; Herrmann, Ken; Hoskin, P.; Huguet, J.; Jereczek-Fossa, B. A.; Jones, R.; Kamat, A. M.; Khoo, V.; Kiltie, A. E.; Krege, Susanne; Ladoire, S.; Lara, P. C.; Leliveld, A.; Linares-Espinós, E.; Løgager, V.; Lorch, A.; Loriot, Y.; Meijer, R.; Carmen Mir, M.; Moschini, M.; Mostafid, H.; Müller, A.-C.; Müller, C. R.; N'Dow, J.; Necchi, A.; Neuzillet, Y.; Oddens, J. R.; Oldenburg, J.; Osanto, S.; Oyen, W. J. G.; Pacheco-Figueiredo, L.; Pappot, H.; Patel, M. I.; Pieters, B.R.; Plass, K.; Remzi, M.; Retz, M.; Richenberg, J.; Rink, M.; Roghmann, F.; Rosenberg, J. E.; Rouprêt, M.; Rouvière, O.; Salembier, C.; Salminen, A.; Sargos, P.; Sengupta, S.; Sherif, A.; Smeenk, R. J.; Smits, A.; Stenzl, A.; Thalmann, G. N.; Tombal, B.; Turkbey, B.; Vahr Lauridsen, S.; Valdagni, R.; Heijden, A. G. van der; Poppel, H. van; Vartolomei, M. D.; Veskimäe, E.; Vilaseca, A.; Vives Rivera, F. A.; Wiegel, T.; Wiklund, P.; Williams, A.; Zigeuner, R.; Witjes, J. A.
    EAU–ESMO consensus statements on the management of advanced and variant bladder cancer - an international collaborative multi-stakeholder effort : under the auspices of the EAU and ESMO Guidelines Committees
    In: Annals of Oncology Jg. 30 (2019) Nr. 11, S. 1697 - 1727
  • Veit-Haibach, Patrick; Buvat, Irène; Herrmann, Ken
    EJNMMI supplement : bringing AI and radiomics to nuclear medicine
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 46 (2019) S. 2627 - 2629
  • Farolfi, Andrea; Gafita, Andrei; Calais, Jeremie; Eiber, Matthias; Afshar-Oromieh, Ali; Spohn, Fabian; Barbato, Francesco; Weber, Manuel; Ilhan, Harun; Cervati, Veronica; Wetter, Axel; Hadaschik, Boris; Briganti, Alberto; Walz, Jochen; Pianori, Davide; Fanti, Stefano; Haberkorn, Uwe; Herrmann, Ken; Fendler, Wolfgang Peter
    Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective Study
    In: The Journal of Urology Jg. 202 (2019) Nr. 6, S. 1174 - 1181
  • Lütje, Susanne; Franssen, Gerben M.; Herrmann, Ken; Boerman, Otto C.; Rijpkema, Mark; Gotthardt, Martin; Heskamp, Sandra
    In vitro and in vivo characterization of an ¹⁸F-ALF-labeled PSMA ligand for imaging of PSMA-expressing xenografts
    In: Journal of Nuclear Medicine (JNM) Jg. 60 (2019) Nr. 7, S. 1017 - 1022
  • Pomykala, Kelsey L.; Farolfi, Andrea; Hadaschik, Boris; Fendler, Wolfgang P.; Herrmann, Ken
    Molecular Imaging for Primary Staging of Prostate Cancer
    In: Seminars in Nuclear Medicine Jg. 49 (2019) Nr. 4, S. 271 - 279
  • Theurer, Sarah; Dralle, Henning; Führer, Dagmar; Herrmann, Ken; Schmid, Kurt Werner
    Morphologische Diagnosekriterien der nichtinvasiven follikulären Neoplasie mit PTC-äquivalenten Kernmerkmalen (NIFTP) : Eine diagnostische Herausforderung zum Nutzen des Patienten
    In: Der Pathologe Jg. 40 (2019) Nr. 3, S. 220 - 226
  • Schotten, Clemens; Bechmann, Lars Peter; Manka, Paul; Theysohn, Jens; Dechene, Alexander; El Fouly, Amr; Barbato, Francesco; Neumann, Ursula; Radünz, Sonia; Sydor, Svenja; Heider, Dominik; Venerito, Marino; Canbay, Aliekber; Gerken, Guido; Herrmann, Ken; Wedemeyer, Heiner; Best, Jan; Bechmann, Lars P.; El Fouly, Amr
    NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization
    In: Liver Cancer Jg. 8 (2019) Nr. 6, S. 491 - 504
  • Werner, Rudolf A.; Bundschuh, Ralph A.; Bundschuh, Lena; Fanti, Stefano; Javadi, Mehrbod S.; Higuchi, Takahiro; Weich, Alexander; Pienta, Kenneth J.; Buck, Andreas K.; Pomper, Martin G.; Gorin, Michael A.; Herrmann, Ken; Lapa, Constantin; Rowe, Steven P.
    Novel structured reporting systems for theranostic radiotracers
    In: Journal of Nuclear Medicine (JNM) Jg. 60 (2019) Nr. 5, S. 577 - 584
  • Kessler, L.; Hautzel, H.; Rassaf, Tienush; Herrmann, Ken; Nensa, Felix; Wessendorf, Thomas; Lüdike, Peter; Rischpler, Christoph
    Nuklearmedizinische Diagnostik der Sarkoidose
    In: Atemwegs- und Lungenkrankheiten Jg. 45 (2019) Nr. 12, S. 573 - 580
  • Umutlu, Lale; Antoch, Gerald; Herrmann, Ken; Grueneisen, Johannes
    PET/MR Imaging of the Female Pelvis
    In: Seminars in Nuclear Medicine Jg. 49 (2019) Nr. 6, S. 512 - 520
  • Maurer, Tobias; Hadaschik, Boris; Budäus, Lars Henrik; Steuber, Thomas; Salomon, Georg; Horn, Thomas; Herrmann, Ken; Weber, Manuel; Giesel, Frederik Lars; Berliner, C.; Eiber, Matthias J.
    PSA-Anstieg nach definitiver Therapie
    In: Der Urologe Jg. 58 (2019) Nr. 5, S. 569 - 582
  • Farahati, Jamshid; Kazek, Sandra; Maric, Ines; Soestwoehner, Thomas; Kalle, Patrick; Costa, Pedro Fragoso; Jentzen, Walter; Stein, Linda; Jalilian, Amirreza; Kumm, Dietmar; Bockisch, Andreas; Herrmann, Ken; Jalilian, Amir
    Post-radiosynovectomy imaging utilizing Erbium-169 citrate
    In: Applied Radiation and Isotopes Jg. 154 (2019) 108853
  • Guberina, Maja; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Aigner, Clemens; Schuler, Martin; Stamatis, Georgios; Theegarten, Dirk; Jentzen, Walter; Herrmann, Ken; Pöttgen, Christoph
    Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules : analysis of the ESPATUE randomized phase 3 trial
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 46 (2019) Nr. 7, S. 1439 - 1447
  • Nader, Michael; Oberdorfer, Franz; Herrmann, Ken
    Production of [¹¹C]Formaldehyde by the XeF2 mediated oxidation of [¹¹C]Methanol and its application in the labeling of α-(N-[¹¹C]Methylamino)isobutyric acid
    In: Applied Radiation and Isotopes Jg. 148 (2019) S. 178 - 183
  • Guberina, M.; Stuschke, Martin; Eberhardt, Wilfried; Gauler, Thomas; Aigner, Clemens; Schuler, Martin; Stamatis, Georgios; Dirk, T.; Jentzen, Walter; Herrmann, Ken; Pöttgen, Christoph;
    Prognostic Value of Metabolic Tumor Volume after Induction Chemotherapy in Stage IIIA/B Non-Small-Cell Lung Cancer : Secondary Analysis of a Randomized Phase 3 Trial
    61st Annual Meeting of the American Society for Radiation Oncology ; September 15-18, 2019, Chicago, IL, USA,
    In: International Journal of Radiation Oncology, Biology, Physics Jg. 105 (2019) Nr. 1, Supplement, S. S146 - S147
  • Kirchner, Julian; Sawicki, Lino M.; Nensa, Felix; Schaarschmidt, Benedikt M.; Reis, Henning; Ingenwerth, Marc; Bogner, Simon; Aigner, Clemens; Buchbender, Christian; Umutlu, Lale; Antoch, Gerald; Herrmann, Ken; Heusch, Philipp
    Prospective comparison of ¹⁸F-FDG PET/MRI and ¹⁸F-FDG PET/CT for thoracic staging of non-small cell lung cancer
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 46 (2019) Nr. 2, S. 437 - 445
  • Fendler, Wolfgang P.; Weber, Manuel; Iravani, Amir; Hofman, Michael S.; Calais, Jeremie; Czernin, Johannes; Ilhan, Harun; Saad, Fred; Small, Eric J.; Smith, Matthew R.; Perez, Paola M.; Hope, Thomas A.; Rauscher, Isabel; Londhe, Anil; Lopez-Gitlitz, Angela; Cheng, Shinta; Maurer, Tobias; Herrmann, Ken; Eiber, Matthias; Hadaschik, Boris
    Prostate-specific membrane antigen ligand positron emission tomography in men with nonmetastatic castration-resistant prostate cancer
    In: Clinical Cancer Research Jg. 25 (2019) Nr. 24, S. 7448 - 7454
  • Backer, Claus Maximilian; Baumer, Christian; Bley, Aaron; Costa, Pedro Fragoso; Gerhardt, Marcel; Herrmann, Ken; Kauer, Samantha; Kroninger, Kevin; Nitsch, Christian; Siregar, Hilda Milani; Timmermann, Beate; Yazgan, Azad
    Proton Beam Range Verification with Secondary Radiation from Titanium Implants
    In: 2019 IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2019 / IEEE Nuclear Science Symposium 2019 Manchester, 26 Oct.-2 Nov. 2019 (2019)
  • Calais, Jeremie; Fendler, Wolfgang P.; Eiber, Matthias; Lassmann, Michael; Dahlbom, Magnus; Esfandiari, Rouzbeh; Gartmann, Jeannine; Nguyen, Kathleen; Thin, Pan; Lok, Vincent; Herrmann, Ken; Czernin, Johannes; Delpassand, Ebrahim
    RESIST-PC phase 2 trial : 177Lu-PSMA-617 radionuclide therapy for metastatic castrate-resistant prostate cancer
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 15, S. 5028 - 5028
  • Barbato, Francesco; Weber, Manuel; Herrmann, Ken; Fendler, Wolfgang Peter
    Reply by Authors
    In: The Journal of Urology Jg. 202 (2019) Nr. 6, S. 1181
  • Kaddu-Mulindwa, Dominic; Altmann, Bettina; Held, Gerhard; Ziepert, Marita; Menhart, Karin; Grosse, Jirka; Angel, Stephanie; Stilgenbauer, Stephan; Pfreundschuh, Michael; Herrmann, Ken; Duehrsen, Ulrich; Hüttmann, Andreas; Barbato, Francesco; Hellwig, Dirk; Poeschel, Viola;
    Role of FDG PET/CT to Detect Bone Marrow Involvement in the Initial Staging of Aggressive Non-Hodgkin Lymphoma
    Konferenz 61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Orlando, USA,
    In: Blood Jg. 134 (2019) Nr. Supplement_1, S. 2892 - 2892
  • Stoffels, Ingo; Herrmann, Ken; Rekowski, Jan; Jansen, Philipp; Schadendorf, Dirk; Stang, Andreas; Klode, Joachim
    Sentinel lymph node excision with or without preoperative hybrid single-photon emission computed tomography/computed tomography (SPECT/CT) in melanoma : Study protocol for a multicentric randomized controlled trial
    In: Trials Jg. 20 (2019) Nr. 1, S. 99
  • Gerwing, Mirjam; Herrmann, Ken; Helfen, Anne; Schliemann, Christoph; Berdel, Wolfgang E.; Eisenblätter, Michel; Wildgruber, Moritz
    The beginning of the end for conventional RECIST — novel therapies require novel imaging approaches
    In: Nature Reviews Clinical Oncology Jg. 16 (2019) Nr. 7, S. 442 - 458
  • Weber, Manuel; Binse, Ina; Nagarajah, James; Bockisch, Andreas; Herrmann, Ken; Jentzen, Walter
    The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancer
    In: The Quarterly Journal of Nuclear Medicine and Molecular Imaging Jg. 63 (2019) Nr. 3, S. 235 - 252
  • Farolfi, Andrea; Fendler, Wolfgang; Iravani, Amir; Haberkorn, Uwe; Hicks, Rodney; Herrmann, Ken; Walz, Jochen; Fanti, Stefano
    Theranostics for Advanced Prostate Cancer : Current Indications and Future Developments
    In: European Urology Oncology Jg. 2 (2019) Nr. 2, S. 152 - 162
  • Sandach, P.; Fendler, W.P.; Herrmann, Ken
    Theranostik von soliden Tumoren : Renaissance eines alten Konzepts
    In: Best Practice Onkologie Jg. 14 (2019) Nr. 12, S. 526 - 534
  • Happel, Christian; Kranert, Wolfgang Tilman; Ackermann, Hanns; Binse, Ina; Bockisch, Benjamin; Gröner, Daniel; Herrmann, Ken; Grünwald, Frank
    Thyroid stunning in radioiodine-131 therapy of benign thyroid diseases
    In: Endocrine Jg. 63 (2019) Nr. 3, S. 537 - 544
  • Umutlu, Lale; Beyer, Thomas; Grüneisen, Johannes Stefan; Rischpler, Christoph; Quick, Harald H.; Veit-Haibach, Patrick; Eiber, Matthias; Purz, Sandra; Antoch, Gerald; Gatidis, Sergios; Nikolaou, Konstantin; Schäfer, Jürgen F.; Rausch, Ivo; Herrmann, Ken
    Whole-Body [18F]-FDG-PET/MRI for Oncology : A Consensus Recommendation
    In: Nuklearmedizin = Nuclear Medicine Jg. 191 (2019) Nr. 2, S. 68 - 76
  • Umutlu, Lale; Beyer, Thomas; Grüneisen, Johannes; Rischpler, Christoph; Quick, Harald H.; Veit-Haibach, Patrick; Eiber, Matthias; Purz, Sandra; Antoch, Gerald; Gatidis, Sergios; Nikolaou, Konstantin; Schäfer, Jürgen F.; Rausch, Yvo; Herrmann, Ken
    Whole-Body [18F]-FDG-PET/MRI for oncology : a consensus recommendation
    In: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren Jg. 191 (2019) Nr. 4, S. 289 - 297
  • Herrmann, Ken; Freudenberg, Lutz
    Zukunftsworkshop 1.0 : Aufbruch in die Zukunft oder ein Strohfeuer?
    In: Nuklearmedizin = Nuclear Medicine Jg. 58 (2019) Nr. 4, S. 297 - 300
  • Hirmas, Nader; Al-Ibraheem, Akram; Herrmann, Ken; Alsharif, Abedalatif; Muhsin, Haider; Khader, Jamal; Al-Daghmin, Ali; Salah, Samer
    [⁶⁸Ga]PSMA PET/CT Improves Initial Staging and Management Plan of Patients with High-Risk Prostate Cancer
    In: Molecular Imaging and Biology Jg. 21 (2019) Nr. 3, S. 574 - 581
  • Deutschl, Cornelius; Kirchner, Julian; Pöppel, Thorsten; Schaarschmidt, Benedikt Michael; Kebir, Sied; El Hindy, Nicolai; Hense, Jörg; Quick, Harald H.; Glas, Martin; Herrmann, Ken; Umutlu, Lale; Mönninghoff, Christoph; Radbruch, A.; Forsting, Michael; Schlamann, Marc
    11C-MET PET/MRI for detection of recurrent glioma
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 4, S. 593 - 601
  • Wieder, Hinrich; Beer, Ambros J.; Siveke, Jens; Schuster, Tibor; Buck, Andreas K.; Herrmann, Ken; Stollfuss, Jens C.
    18F-fluorothymidine PET for predicting survival in patients with resectable pancreatic cancer
    In: OncoTarget Jg. 9 (2018) Nr. 11, S. 10128 - 10134
  • Schreder, M.; Barrio, S. G.; Drozdov, I.; Matar, Samir; Herrmann, Ken; Einsele, H.; Kidd, M.; Modlin, I.; Kortüm, K. M.;
    A whole blood gene expression signature accurately diagnoses multiple myeloma and differentiates patients in remission from those with active and progressive disease
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 231
  • Fendler, Wolfgang; Calais, Jeremie; Gartmann, Jeannine; Nickols, Nicholas George; Reiter, Robert Evan; Rettig, Matthew; Hope, Thomas A.; Slavik, Roger; Gupta, Pawan; Quon, Andrew; Allen-Auerbach, Martin; Herrmann, Ken; Czernin, Johannes; Eiber, Matthias
    Accuracy of 68Ga-PSMA11 PET/CT on recurrent prostate cancer : Preliminary results from a phase 2/3 prospective trial
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. 5001 - 5001
  • Hope, Thomas A.; Bergsland, Emily K.; Bozkurt, Murat Fani; Graham, Michael; Heaney, Anthony P.; Herrmann, Ken; Howe, James R.; Kulke, Matthew H.; Kunz, Pamela L.; Mailman, Josh; May, Lawrence; Metz, David C.; Millo, Corina; O’Dorisio, Sue; Reidy-Lagunes, Diane L.; Soulen, Michael C.; Strosberg, Jonathan R.
    Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors
    In: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 1, S. 66 - 74
  • Weber, M.M.; Kebir, S.; Lazaridis, L.; Deuschl, C.; Stoppek, A.; Schmidt, T.; Boehm, J.; Christoph, M.; Scheffler, B.; Keyvani, Kathy; Sure, Ulrich; Kleinschnitz, Christoph; Pierscanek, D.; Glas, M.; Herrmann, Ken
    Ascertaining F18 positron-emission tomography skill in glioma classification pursuant to the revised WHO classification 2016
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 354 - S355
  • Binse, Ina; Pokladek, J.; Weber, M.; Theurer, S.; Jentzen, Walter; Nagarajah, James; Herrmann, Ken; Görges, Rainer
    BRAF Mutation Analysis for Initial Risk Stratification in High Risk Papillary Thyroid Carcinoma
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 551
  • Zaun, Gregor; Schuler, Martin; Herrmann, Ken; Tannapfel, Andrea
    CUP syndrome : Metastatic malignancy with unknown primary tumor
    In: Deutsches Ärzteblatt international Jg. 115 (2018) Nr. 10, S. 157 - 162
  • Lapa, Constantin; Kortüm, K. Martin; Herrmann, Ken
    CXCR4-Directed Endoradiotherapy as New Treatment Option in Advanced Multiple Myeloma
    In: Clinical Applications of Nuclear Medicine Targeted Therapy / Bombardieri, Emilio; Seregni, Ettore; Evangelista, Laura; Chiesa, Carlo; Chiti, Arturo (2018) S. 475 - 481
  • Lutje, Susanne; Gerrits, Danny; Molkenboer-Kuenen, Janneke D.; Herrmann, Ken; Fracasso, Giulio; Colombatti, Marco; Boerman, Otto C.; Heskamp, Sandra
    Characterization of site-specifically conjugated monomethyl auristatin E-and duocarmycin-based anti-PSMA antibody-drug conjugates for treatment of PSMA-expressing tumors
    In: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 3, S. 494 - 501
  • Oernek, A.; Jentzen, Walter; Umutlu, Lale; Unger, Nicole; Kirchner, J.; Ruhlmann, Marcus; Herrmann, Ken; Ruhlmann, Verena
    Comparison evaluation of the diagnostic potential of PET/MRI and PET/CT using mIBG-Iod-124 in neuroendocrine and neuroectodermal tumors
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 65
  • Ceci, F.; Polverari, G.; Gartmann, J.; Fendler, W.; Eiber, M.; Herrmann, Ken; Czernin, J.; Calais, J,
    Comparison of 68Ga-PSMA-11 PET/CT and F-18-Fluciclovine PET/CT in recurrent Prostate Cancer
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 150
  • Catalano, Onofrio A.; Umutlu, Lale; Fuin, Niccolo; Hibert, Matthew Louis; Scipioni, Michele; Pedemonte, Stefano; Vangel, Mark; Catana, Andreea Maria; Herrmann, Ken; Nensa, Felix; Groshar, David; Mahmood, Umar; Rosen, Bruce R.; Catana, Ciprian
    Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo)
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 12, S. 2147 - 2154
  • Sarabhai, Theresia; Schaarschmidt, Benedikt M.; Wetter, Axel; Kirchner, Julian; Aktas, Bahriye; Forsting, Michael; Ruhlmann, Verena; Herrmann, Ken; Umutlu, Lale; Grueneisen, Johannes
    Comparison of ¹⁸F-FDG PET/MRI and MRI for pre-therapeutic tumor staging of patients with primary cancer of the uterine cervix
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 1, S. 67 - 76
  • Sawicki, Lino M.; Kirchner, Julian; Grueneisen, Johannes; Ruhlmann, Verena; Aktas, Bahriye; Schaarschmidt, Benedikt M.; Forsting, Michael; Herrmann, Ken; Antoch, Gerald; Umutlu, Lale
    Comparison of ¹⁸F–FDG PET/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer : a follow-up study
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 4, S. 622 - 629
  • Calais, Jeremie; Fendler, Wolfgang P.; Herrmann, Ken; Eiber, Matthias; Ceci, Francesco
    Comparison of ⁶⁸Ga-PSMA-11 and ¹⁸F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence
    In: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 5, S. 789 - 794
  • Fanti, Stefano; Minozzi, Silvia; Antoch, Gerald; Banks, Ian; Briganti, Alberto; Carrio, Ignasi; Chiti, Arturo; Clarke, Noel; Eiber, Matthias; De Bono, Johann; Fizazi, Karim; Gillessen, Silke; Gledhill, Sam; Haberkorn, Uwe; Herrmann, Ken; Hicks, Rodney J.; Lecouvet, Frederic; Montironi, Rodolfo; Ost, Piet; O'Sullivan, Joe M.; Padhani, Anwar R.; Schalken, Jack A.; Scher, Howard I.; Tombal, Bertrand; van Moorselaar, Reindert Jeroen A.; Van Poppel, Heindrik; Vargas, Hebert Alberto; Walz, Jochen; Weber, Wolfgang A.; Wester, Hans-Jürgen; Oyen, Wim J.G.
    Consensus on molecular imaging and theranostics in prostate cancer
    In: The Lancet Oncology Jg. 19 (2018) Nr. 12, S. e696 - e708
  • Happel, C.; Bockisch, Andreas; Sabet, A.; Kranert, W.T.; Grünwald, F.; Herrmann, Ken
    Correction of radiation induced stunning (CRIS) in pretherapeutic radioiodine-131 uptake test of patients suffering from goiter
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 420
  • Martin, O.; Kirchner, J.; Heusch, P.; Antoch, G.; Herrmann, Ken; Umutlu, Lale; Sawicki, L.
    Correlation of immunohistochemical parameters, apparent diffusion coefficient (ADC) and standardized uptake value (SUV) in lung cancer using hybrid PET/MRI
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 176
  • Martin, O.; Kirchner, J.; Heusch, P.; Antoch, G.; Herrmann, Ken; Umutlu, Lale; Sawicki, L.
    Correlation of immunohistochemical parameters, apparent diffusion coefficient (ADC) and standardized uptake value (SUV) in lung cancer using hybrid PET/MRI
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 176
  • Umutlu, Lale; Herrmann, Ken
    Current and emerging applications
    In: PET/MR Imaging: Current and Emerging Applications / Umutlu, Lale; Herrmann, Ken (Hrsg.) (2018) S. 1 - 8
  • Lückerath, Katharina; Stuparu, Andreea D.; Wei, Liu; Kim, Woosuk; Radu, Caius G.; Mona, Christine E.; Calais, Jeremie; Rettig, Matthew; Reiter, Robert E.; Czernin, Johannes; Slavik, Roger; Herrmann, Ken; Eiber, Matthias; Fendler, Wolfgang P.
    Detection Threshold and Reproducibility of ⁶⁸Ga-PSMA11 PET/CT in a Mouse Model of Prostate Cancer
    In: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 9, S. 1392 - 1397
  • Kip, A.; Heskamp, S.; Franssen, G. M.; Frielink, C.; Fracasso, G.; Herrmann, Ken; Gotthardt, M.; Rijpkema, M.; Lutje, S.
    Development and Characterization of a PSMA-targeting Antibody for SPECT/CT, Fluorescence Imaging and Targeted Photodynamic Therapy of PSMA-expressing Tumors
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 39 - S40
  • Bogner, Simon; Schmid, Kurt Werner; Metzenmacher, Martin; Hager, Thomas; Herrmann, Ken; Walter, Robert; Hegedues, Balazs; Herold, Thomas; Eberhardt, Wilfried; Reis, Henning; Goetz, Moritz; Mairinger, Fabian Dominik; Wiesweg, Marcel; Darwiche, Kaid; Aigner, Clemens; Schuler, Martin
    Development of predictors for PD-1/PD-L1-directed therapy of non-small cell lung cancer (NSCLC) by gene expression profiling of small diagnostic biopsies (DBX)
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 15 Suppl., S. e15121
  • Sawicki, Lino M; Lütje, Susanne; Baraliakos, Xenofon; Braun, Jürgen; Kirchner, Julian; Boos, Johannes; Heusch, Philipp; Ruhlmann, Verena; Herrmann, Ken; Umutlu, Lale; Quick, Harald H.; Antoch, Gerald; Buchbender, Christian
    Dual‐phase hybrid 18F‐Fluoride Positron emission tomography/MRI in ankylosing spondylitis : Investigating the link between MRI bone changes, regional hyperaemia and increased osteoblastic activity
    In: Journal of Medical Imaging and Radiation Oncology Jg. 62 (2018) Nr. 3, S. 313 - 319
  • Schotten, Clemens; Bechmann, Lars Peter; Manka, Paul; Theysohn, Jens; Dechene, Alexander; El Fouly, Amr; Müller, Stefan; Schulze, Maren; Neumann, Ursula; Raduenz, Sonia; Heider, Dominik; Canbay, Aliekber; Gerken, Guido; Herrmann, Ken; Wedemeyer, Heiner; Best, Jan
    Extrahepatic Comorbidities Do Not Alter the Safety and Efficacy of Radioembolization of NAFLD-Associated HCC
    In: Hepatology Jg. 68 (2018) Nr. S1, S. 852A - 853A
  • Schotten, C.; Bechmann, Lars Peter; Manka, Paul; Theysohn, Jens; Dechene, Alexander; El Fouly, A.; Muller, S.; Schulze, Maren; Neumann, U.; Radunz, S.; Heider, Dominik; Canbay, Aliekber; Gerken, Guido; Herrmann, Ken; Wedemeyer, Heiner; Best, Jan
    Extrahepatic Comorbidities Do Not Alter the Safety and Efficacy of Radioembolization of NAFLD-Associated HCC
    In: Hepatology Jg. 68 (2018) Nr. Suppl. 1, S. 852A - 853A
  • Calais, Jérémie; Fendler, Wolfgang P; Eiber, Matthias; Gartmann, Jeannine; Chu, Fang-I; Nickols, Nicholas G; Reiter, Robert R; Rettig, Matthew B; Marks, Leonard S; Ahlering, Thomas E; Huynh, Lynda; Slavik, Roger; Gupta, Pawan; Quon, Andrew; Allen-Auerbach, Martin S; Czernin, Johannes; Herrmann, Ken
    Impact of Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence
    In: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 3, S. 434 - 441
  • Wierts, Roel; Conti, Maurizio; Claessen, Anouk G.G.; Herrmann, Ken; Kemerink, Gerrit J.; Binse, Ina; Wildberger, Joachim E.; Mottaghy, Felix M.; Backes, Walter H.; Jentzen, Walter
    Impact of prompt gamma coincidence correction on absorbed dose estimation in differentiated thyroid cancer using 124 i PET/CT imaging
    In: Nuclear Medicine Communications Jg. 39 (2018) Nr. 12, S. 1156 - 1164
  • Oernek, A.; Umutlu, Lale; Li, Y.; Kirchner, J.; Herrmann, Ken; Ruhlmann, Verena
    Inflammation focus search with 18F-FDG-PET/MRI: comparative or additive value of PET and MRI
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 259 - S260
  • Al-Bayati, Mohammad; Grueneisen, Johannes; Lütje, Susanne; Sawicki, Lino M.; Suntharalingam, Saravanabavaan; Tschirdewahn, Stephan; Forsting, Michael; Rübben, Herbert; Herrmann, Ken; Umutlu, Lale; Wetter, Axel
    Integrated ⁶⁸Gallium Labelled Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Magnetic Resonance Imaging Enhances Discriminatory Power of Multi-Parametric Prostate Magnetic Resonance Imaging
    In: Urologia Internationalis Jg. 100 (2018) Nr. 2, S. 164 - 171
  • Martin, O.; Kirchner, J.; Buchbender, C.; Antoch, G.; Herrmann, Ken; Suntharalingam, S.; Forsting, Michael; Umutlu, Lale
    Intraindividual comparison of subsequently performed PET/MRI to PET/CT for whole-body staging : Results of a unicenter trial in 1000 patients
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 210 - S211
  • Kirchner, J.; Grueneisen, J.; Sawicki, L. M.; Oehmigen, M.; Quick, Harald H.; Antoch, G.; Herrmann, Ken; Umutlu, Lale
    Local and whole-body staging in patients with primary breast cancer : A comparison of one-step to two-step-staging utilizing F-18-FDG-PET/MRI
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 456
  • Kirchner, Julian; Grueneisen, Johannes; Martin, Ole; Oehmigen, Mark; Quick, Harald H.; Bittner, Ann-Kathrin; Hoffmann, Oliver; Ingenwerth, Marc; Catalano, Onofrio Antonio; Heusch, Philipp; Buchbender, Christian; Forsting, Michael; Antoch, Gerald; Herrmann, Ken; Umutlu, Lale
    Local and whole-body staging in patients with primary breast cancer : a comparison of one-step to two-step staging utilizing ¹⁸F-FDG-PET/MRI
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 13, S. 2328 - 2337
  • Rezaee, Alireza; Herrmann, Ken; Raderer, Markus; Langsteger, Werner; Beheshti, Mohsen
    Lung Cancer
    In: PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging / Beheshti, Mohsen; Langsteger, Werner; Rezaee, Alireza (Hrsg.) (2018) S. 23 - 42
  • Ahmadzadehfar, H.; Albers, P.; Bockisch, Andreas; Boegemann, M.; Böhme, C.; Burchert, W.; Dietlein, M.; Drzezga, A.; Fabry, U.; Feldmann, G.; Heidenreich, A.; Heinzel, A.; Herrmann, Ken; Heyll, A.; Höhling, C.; Kreuzer, C.; Laufer, D.; Mengel, R.; Mottaghy, F.M.; Müller, H.-W.; Müller, S.C.; Ost, E.; Rahbar, K.; Reifenhäuser, W.; Schäfers, M.; Schlenkhoff, C.; Schmidt, M.; Schmidt-Wolf, I.; Wildenhain, C.; Zimmer, B.; Essler, M.
    Lutetium-177-PSMA-Radioligandentherapie : Konsensus im Rahmen der GKV-finanzierten Versorgung zwischen den Hochschulkliniken in Aachen, Bonn, Düsseldorf, Essen und Köln und dem MDK Nordrhein
    In: Der Urologe Jg. 57 (2018) Nr. 6, S. 709 - 713
  • Reis, Henning; Metzenmacher, Martin; Goetz, Moritz; Savvidou, Nikoleta; Darwiche, Kaid; Aigner, Clemens; Herold, Thomas; Eberhardt, Wilfried; Skiba, Charlotte; Hense, Jörg; Virchow, Isabel; Westerwick, Daniela; Bogner, Simon; Ting, Saskia; Kasper, Stefan; Stuschke, Martin; Nensa, Felix; Herrmann, Ken; Hager, Thomas; Schmid, Kurt Werner; Schuler, Martin; Wiesweg, Marcel
    MET Expression in Advanced Non–Small-Cell Lung Cancer : Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy
    In: Clinical Lung Cancer Jg. 19 (2018) Nr. 4, S. e441 - e463
  • Lisova, Ksenia; Sergeev, Maxim; Evans-Axelsson, Susan; Stuparu, Andreea D.; Beykan, Seval; Collins, Jeffrey; Jones, Jason; Lassmann, Michael; Herrmann, Ken; Perrin, David; Lee, Jason T.; Slavik, Roger; van Dam, R. Michael
    Microscale radiosynthesis, preclinical imaging and dosimetry study of [¹⁸F]AMBF₃-TATE : A potential PET tracer for clinical imaging of somatostatin receptors
    In: Nuclear Medicine and Biology Jg. 61 (2018) S. 36 - 44
  • Kebir, Sied; Lazaridis, Lazaros; Weber, Manuel; Deuschl, Cornelius; Stoppek, Ann-Kathrin; Schmidt, Teresa; Boehm, Judith; Mönninghoff, Christoph; Scheffler, Björn; Keyvani, Kathy; Pierscianek, Daniela; Sure, Ulrich; Kleinschnitz, Christoph; Herrmann, Ken; Glas, Martin;
    NIMG-32. COMPARISON OF L-METHYL-11C-METHIONINE POSITRON EMISSION TOMOGRAPHY WITH MAGNETIC RESONANCE SPECTROSCOPY IN DETECTING NEWLY DIAGNOSED GLIOMA
    23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology November 15 – 18, 2018 New Orleans, USA,
    In: Neuro-Oncology Jg. 20 (2018) Nr. suppl_6, S. vi182 - vi183
  • Umutlu, Lale; Herrmann, Ken (Hrsg.)
    PET/MR Imaging : Current and Emerging Applications
    Cham (2018)
  • Calais, Jeremie; Kishan, Amar U.; Cao, Minsong; Fendler, Wolfgang P.; Eiber, Matthias; Herrmann, Ken; Ceci, Francesco; Reiter, Robert E.; Rettig, Matthew B.; Hegde, John V.; Shaverdian, Narek; King, Chris R.; Steinberg, Michael L.; Czernin, Johannes; Nickols, Nicholas G.
    Potential impact of ⁶⁸Ga-PSMA-11 PET/CT on the planning of definitive radiation therapy for prostate cancer
    In: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 11, S. 1714 - 1721
  • Lückerath, Katharina; Wei, Liu; Fendler, Wolfgang; Evans-Axelsson, Susan; Stuparu, Andreea D.; Slavik, Roger; Mona, Christine E.; Calais, Jeremie; Rettig, Matthew; Reiter, Robert E.; Herrmann, Ken; Radu, Caius G.; Czernin, Johannes; Eiber, Matthias
    Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
    In: EJNMMI Research Jg. 8 (2018) Nr. 1, 96
  • Umutlu, Lale; Herrmann, Ken
    Preface
    In: PET/MR Imaging: Current and Emerging Applications / Umutlu, Lale; Herrmann, Ken (Hrsg.) (2018) S. vii
  • Ruhlmann, Marcus; Sonnenschein, Wilfried; Nagarajah, James; Binse, Ina; Herrmann, Ken; Jentzen, Walter
    Pretherapeutic 124 i dosimetry reliably predicts intratherapeutic blood kinetics of 131 i in patients with differentiated thyroid carcinoma receiving high therapeutic activities
    In: Nuclear Medicine Communications Jg. 39 (2018) Nr. 5, S. 457 - 464
  • Kirchner, J.; Sawicki, L. M.; Schaarschmidt, B. M.; Umutlu, Lale; Herrmann, Ken; Buchbender, C.; Antoch, G.; Heusch, P.
    Prospective comparison of F-18-FDG PET/MRI and F-18-FDG PET/CT for thoracic staging of non-small cell lung cancer
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. S502 Abstract EP-0517
  • Eiber, Matthias; Herrmann, Ken; Calais, Jeremie; Hadaschik, Boris; Giesel, Frederik L.; Hartenbach, Markus; Hope, Thomas; Reiter, Robert; Maurer, Tobias; Weber, Wolfgang A.; Fendler, Wolfgang P.
    Prostate cancer molecular imaging standardized evaluation (PROMISE) : Proposed miTNM classification for the interpretation of PSMA-ligand PET/CT
    In: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 3, S. 469 - 478
  • Wierts, Roel; Jentzen, Walter; Quick, Harald H.; Wisselink, Hendrik J.; Pooters, Ivo N.A.; Wildberger, Joachim E.; Herrmann, Ken; Kemerink, Gerrit J.; Backes, Walter H.; Mottaghy, Felix M.
    Quantitative performance evaluation of I PET/MRI lesion dosimetry in differentiated thyroid cancer
    In: Physics in Medicine and Biology Jg. 63 (2018) Nr. 1, S. 015014
  • Jentzen, Walter; Phaosricharoen, Jinda; Gomez, Benedikt; Hetkamp, Philipp; Stebner, Vanessa; Binse, Ina; Kinner, Sonja; Herrmann, Ken; Sabet, Amir; Nagarajah, James
    Quantitative performance of ¹²⁴I PET/MR of neck lesions in thyroid cancer patients using ¹²⁴I PET/CT as reference
    In: EJNMMI Physics Jg. 5 (2018) Nr. 1, 13
  • Happel, C.; Kranert, W.T.; Gruenwald, F.; Herrmann, Ken
    Radiation induced stunning in patients suffering from benign thyroid diseases due to pre-therapeutic radioiodine-131 uptake test
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 351 - S352
  • Calais, Jeremie; Fendler, Wolfgang Peter; Herrmann, Ken; Eiber, Matthias; Ceci, Francesco
    Reply : Comparison of Ga-PSMA-11 and F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its Way
    In: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 5, S. 861
  • Sarabhai, Theresia; Tschischka, Alexander; Stebner, Vanessa; Nensa, Felix; Wetter, Axel; Kimmig, Rainer; Forsting, Michael; Herrmann, Ken; Umutlu, Lale; Grüneisen, Johannes
    Simultaneous multiparametric PET/MRI for the assessment of therapeutic response to chemotherapy or concurrent chemoradiotherapy of cervical cancer patients : preliminary results
    In: Clinical Imaging Jg. 49 (2018) S. 163 - 168
  • deSouza, Nandita M.; Liu, Yan; Chiti, Arturo; Oprea-Lager, Daniela; Gebhart, Géraldine; Van Beers, Bernard E.; Herrmann, Ken; Lecouvet, Frederic E.
    Strategies and technical challenges for imaging oligometastatic disease : Recommendations from the European Organisation for Research and Treatment of Cancer imaging group
    In: European Journal of Cancer (EJC) Jg. 91 (2018) S. 153 - 163
  • Heinze, Britta; Fuss, Carmina T.; Mulatero, Paolo; Beuschlein, Felix; Reincke, Martin; Mustafa, Mona; Schirbel, Andreas; Deutschbein, Timo; Williams, Tracy Ann; Rhayem, Yara; Quinkler, Marcus; Rayes, Nada; Monticone, Silvia; Wild, Vanessa; Gomez-Sanchez, Celso E.; Reis, Anna-Carinna; Petersenn, Stephan; Wester, Hans-Juergen; Kropf, Saskia; Fassnacht, Martin; Lang, Katharina; Herrmann, Ken; Buck, Andreas K.; Bluemel, Christina; Hahner, Stefanie
    Targeting CXCR4 (CXC Chemokine Receptor Type 4) for molecular imaging of aldosterone-producing adenoma
    In: Hypertension Jg. 71 (2018) Nr. 2, S. 317 - 325
  • Ceccon, Garry; Lazaridis, Lazaros; Stoffels, Gabriele; Rapp, Marion; Weber, Manuel; Blau, Tobias; Lohmann, Phillip; Kebir, Sied; Herrmann, Ken; Fink, Gereon R.; Langen, Karl-Josef; Glas, Martin; Galldiks, Norbert
    Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields : initial experience
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 9, S. 1626 - 1635
  • Lecouvet, Frédéric E.; Oprea-Lager, Daniela E.; Liu, Yan; Ost, Piet; Bidaut, Luc; Collette, Laurence; Deroose, Christophe M.; Goffin, Karolien; Herrmann, Ken; Hoekstra, Otto S.; Kramer, Gem; Lievens, Yolande; Lopci, Egesta; Pasquier, David; Petersen, Lars J.; Talbot, Jean-Noël; Zacho, Helle; Tombal, Bertrand; deSouza, Nandita M.
    Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer : a consensus recommendation from the EORTC Imaging Group
    In: The Lancet Oncology Jg. 19 (2018) Nr. 10, S. e534 - e545
  • Li, Yan; Beiderwellen, Karsten; Nensa, Felix; Grüneisen, Johannes; Dobos, Gustav; Herrmann, Ken; Lauenstein, Thomas; Umutlu, Lale; Langhorst, Jost
    [¹⁸F]FDG PET/MR enterography for the assessment of inflammatory activity in Crohn’s disease: comparison of different MRI and PET parameters
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 8, S. 1382 - 1393
  • Calais, Jeremie; Czernin, Johannes; Cao, Minsong; Kishan, Amar U.; Hegde, John V.; Shaverdian, Narek; Sandler, Kiri; Chu, Fang-I; King, Chris R.; Steinberg, Michael L.; Rauscher, Isabel; Schmidt-Hegemann, Nina-Sophie; Pöppel, Thorsten; Hetkamp, Philipp; Ceci, Francesco; Herrmann, Ken; Fendler, Wolfgang P.; Eiber, Matthias; Nickols, Nicholas G.
    ⁶⁸Ga-PSMA-11 PET/CT mapping of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a PSA level of less than 1.0 ng/mL : Impact on salvage radiotherapy planning
    In: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 2, S. 230 - 237
  • Kirchner, Julian; Deuschl, Cornelius; Grueneisen, Johannes; Herrmann, Ken; Forsting, Michael; Heusch, Philipp; Antoch, Gerald; Umutlu, Lale
    (18)F-FDG PET/MRI in patients suffering from lymphoma : how much MRI information is really needed?
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 44 (2017) Nr. 6, S. 1005 - 1013
  • Fendler, Wolfgang Peter; Rahbar, Kambiz; Herrmann, Ken; Kratochwil, Clemens; Eiber, Matthias J.
    177Lu-PSMA Radioligand Therapy for Prostate Cancer
    In: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 8, S. 1196 - 1200
  • Kirchner, Julian; Sawicki, Lino M; Deuschl, Cornelius; Grüneisen, Johannes; Beiderwellen, Karsten; Lauenstein, Thomas; Herrmann, Ken; Forsting, Michael; Heusch, Philipp; Umutlu, Lale
    18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
    In: PLoS ONE Jg. 12 (2017) Nr. 7, S. e0180349
  • Ruhlmann, Marcus; Ruhlmann, Jürgen; Görges, Rainer; Herrmann, Ken; Antoch, Gerald; Keller, Hans Wilhelm; Ruhlmann, Verena
    18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography May Exclude Malignancy in Sonographically Suspicious and Scintigraphically Hypofunctional Thyroid Nodules and Reduce Unnecessary Thyroid Surgeries
    In: Thyroid Jg. 27 (2017) Nr. 10, S. 1300 - 1306
  • Fendler, Wolfgang Peter; Barrio, Martin; Spick, Claudio; Allen-Auerbach, Martin; Ambrosini, Valentina; Benz, Matthias; Bluemel, Christina; Grewal, Ravinder Kaur; Lapa, Constantin; Miederer, Matthias; Nicolas, Guillaume; Schuster, Tibor; Czernin, Johannes; Herrmann, Ken
    68Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment : Results of a Prospective Study on 50 Patients
    In: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 2, S. 307 - 311
  • Fendler, Wolfgang P.; Eiber, Matthias; Beheshti, Mohsen; Bomanji, Jamshed; Ceci, Francesco; Cho, Steven; Giesel, Frederik; Haberkorn, Uwe; Hope, Thomas A.; Kopka, Klaus; Krause, Bernd J.; Mottaghy, Felix M.; Schöder, Heiko; Sunderland, John; Wan, Simon; Wester, Hans-Jürgen; Fanti, Stefano; Herrmann, Ken
    68Ga-PSMA PET/CT : Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 44 (2017) Nr. 6, S. 1014 - 1024
  • Fendler, Wolfgang Peter; Calais, Jérémie; Allen-Auerbach, Martin S.; Bluemel, Christina; Eberhardt, Nina; Emmett, Louise M.; Gupta, Pawan K.; Hartenbach, Markus; Hope, Thomas A.; Okamoto, Shozo; Pfob, Christian H.; Pöppel, Thorsten; Rischpler, Christoph; Schwarzenböck, Sarah Marie; Stebner, Vanessa; Unterrainer, Marcus; Zacho, Helle Damgaard; Maurer, Tobias; Gratzke, Christian; Crispin, Alexander A.; Czernin, Johannes G.; Herrmann, Ken; Eiber, Matthias J.
    68Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments : An International Multicenter Prospective Study
    In: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 10, S. 1617 - 1623
  • Fendler, Wolfgang P.; Eiber, Matthias; Stief, Christian G.; Herrmann, Ken
    A PET for All Seasons : 18F-Fluorodeoxyglucose to Characterize Inflammation and Malignancy in Retroperitoneal Fibrosis?
    In: European Urology Jg. 71 (2017) Nr. 6, S. 934 - 935
  • Walenkamp, Annemiek M.E.; Lapa, Constantin; Herrmann, Ken; Wester, Hans-Jürgen
    CXCR4 ligands : The next big hit?
    In: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. Suppl. 2, S. 77S - 82S
  • Lapa, Constantin; Herrmann, Ken; Schirbel, Andreas; Hänscheid, Heribert; Lückerath, Katharina; Schottelius, Margret; Kircher, Malte; Werner, Rudolf A.; Schreder, Martin; Samnick, Samuel; Kropf, Saskia; Knop, Stefan; Buck, Andreas K.; Einsele, Hermann; Wester, Hans-Juergen; Kortüm, K. Martin
    CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma
    In: Theranostics Jg. 7 (2017) Nr. 6, S. 1589 - 1597
  • Brumberg, Joachim; Küsters, Sebastian; Al-Momani, Ehab; Marotta, Giorgio; Cosgrove, Kelly P.; van Dyck, Christopher H.; Herrmann, Ken; Homola, György A.; Pezzoli, Gianni; Buck, Andreas K.; Volkmann, Jens; Samnick, Samuel; Isaias, Ioannis U.
    Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging study
    In: Annals of Clinical and Translational Neurology Jg. 4 (2017) Nr. 9, S. 632 - 639
  • Bodei, Lisa; Ambrosini, Valentina; Herrmann, Ken; Modlin, Irvin
    Current Concepts in 68Ga-DOTATATE Imaging of Neuroendocrine Neoplasms : Interpretation, Biodistribution, Dosimetry, and Molecular Strategies
    In: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 11, S. 1718 - 1726
  • Ruhlmann, Verena; Pöppel, Thorsten; Veit, Johannes; Nagarajah, James; Umutlu, Lale; Hoffmann, Thomas K.; Bockisch, Andreas; Herrmann, Ken; Sauerwein, Wolfgang
    Diagnostic accuracy of 18F–FDG PET/CT and MR imaging in patients with adenoid cystic carcinoma
    In: BMC Cancer Jg. 17 (2017) Nr. 1, S. 887
  • Fendler, Wolfgang; Stuparu, Andreea D.; Evans-Axelsson, Susan; Lückerath, Katharina; Wei, Liu; Kim, Woosuk; Poddar, Soumya; Said, Jonathan; Radu, Caius G.; Eiber, Matthias; Czernin, Johannes; Slavik, Roger; Herrmann, Ken
    Establishing 177Lu-PSMA-617 Radioligand Therapy in a Syngeneic Model of Murine Prostate Cancer
    In: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 11, S. 1786 - 1792
  • Sawicki, Lino M; Deuschl, Cornelius; Beiderwellen, Karsten; Ruhlmann, Verena; Pöppel, Thorsten; Heusch, Philipp; Lahner, Harald; Führer, Dagmar; Bockisch, Andreas; Herrmann, Ken; Forsting, Michael; Antoch, Gerald; Umutlu, Lale
    Evaluation of 68Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with 68Ga-DOTATOC PET/CT
    In: European Radiology Jg. 27 (2017) Nr. 10, S. 4091 - 4099
  • Eiber, Matthias; Herrmann, Ken
    From NETTER to PETTER : PSMA-Targeted radioligand therapy
    In: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 1, S. 9 - 10
  • Barrio, Martin J.; Spick, Claudio; Radu, Caius G.; Lassmann, Michael; Eberlein, Uta; Allen-Auerbach, Martin; Schiepers, Christiaan; Slavik, Roger; Czernin, Johannes; Herrmann, Ken
    Human Biodistribution and Radiation Dosimetry of 18F-Clofarabine, a PET Probe Targeting the Deoxyribonucleoside Salvage Pathway
    In: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 3, S. 374 - 378
  • Kirchner, Julian; Deuschl, Cornelius; Schweiger, Bernd; Herrmann, Ken; Forsting, Michael; Buchbender, Christian; Antoch, Gerald; Umutlu, Lale
    Imaging children suffering from lymphoma : an evaluation of different ; 18F-FDG PET/MRI protocols compared to whole-body DW-MRI
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 44 (2017) Nr. 10, S. 1742 - 1750
  • Werner, Rudolf A.; Weich, Alexander; Higuchi, Takahiro; Schmid, Jan S.; Schirbel, Andreas; Lassmann, Michael; Wild, Vanessa; Rudelius, Martina; Kudlich, Theodor; Herrmann, Ken; Scheurlen, Michael; Buck, Andreas K.; Kropf, Saskia; Wester, Hans-Jürgen; Lapa, Constantin
    Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative Approach
    In: Theranostics Jg. 7 (2017) Nr. 6, S. 1489 - 1498
  • Erfanian, Youssef; Grueneisen, Johannes; Kirchner, Julian; Wetter, Axel; Podleska, Lars; Bauer, Sebastian; Pöppel, Thorsten; Forsting, Michael; Herrmann, Ken; Umutlu, Lale
    Integrated 18F–FDG PET/MRI compared to MRI alone for identification of local recurrences of soft tissue sarcomas : a comparison trial
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 44 (2017) Nr. 11, S. 1823 - 1831
  • Bluemel, Christina; Hahner, Stefanie; Heinze, Britta; Fassnacht, Martin; Kroiss, Matthias; Bley, Thorsten A; Wester, Hans-Juergen; Kropf, Saskia; Lapa, Constantin; Schirbel, Andreas; Buck, Andreas K; Herrmann, Ken
    Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients
    In: Clinical Nuclear Medicine Jg. 42 (2017) Nr. 1, S. e29 - e34
  • Calais, Jeremie; Czernin, Johannes; Eiber, Matthias; Fendler, Wolfgang P.; Gartmann, Jeannine; Heaney, Anthony P.; Hendifar, Andrew E.; Pisegna, Joseph R.; Randolph Hecht, J.; Wolin, Edward M.; Slavik, Roger; Gupta, Pawan; Quon, Andrew; Schiepers, Christiaan; Allen-Auerbach, Martin S.; Herrmann, Ken
    Most of the Intended Management Changes After 68Ga-DOTATATE PET/CT Are Implemented
    In: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 11, S. 1793 - 1796
  • Frilling, Andrea; Herrmann, Ken; Kämmerer, Daniel; Toumpanakis, Christos
    Neuroendocrine Tumors of the Gastrointestinal Tract
    In: Visceral Medicine Jg. 33 (2017) Nr. 5, S. 368 - 371
  • Schwarzenboeck, Sarah M.; Rauscher, Isabel; Bluemel, Christina; Fendler, Wolfgang P.; Rowe, Steven P.; Pomper, Martin G.; Asfhar-Oromieh, Ali; Herrmann, Ken; Eiber, Matthias
    PSMA ligands for PET imaging of prostate cancer
    In: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 10, S. 1545 - 1552
  • Lütje, Susanne; Slavik, Roger; Fendler, Wolfgang; Herrmann, Ken; Eiber, Matthias
    PSMA ligands in prostate cancer – Probe optimization and theranostic applications
    In: Methods: A Companion to Methods in Enzymology Jg. 130 (2017) S. 42 - 50
  • Eiber, Matthias; Fendler, Wolfgang P.; Rowe, Steven P.; Calais, Jeremie; Hofman, Michael S.; Maurer, Tobias; Schwarzenboeck, Sarah M.; Kratowchil, Clemens; Herrmann, Ken; Giesel, Frederik L.
    Prostate-specific membrane antigen ligands for imaging and therapy
    In: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. Suppl. 2, S. 67S - 76S
  • Okamoto, Shozo; Thieme, Anne; Allmann, Jakob; D'Alessandria, Calogero; Maurer, Tobias; Retz, Margitta; Tauber, Robert; Heck, Matthias M; Wester, Hans-Juergen; Tamaki, Nagara; Fendler, Wolfgang P; Herrmann, Ken; Pfob, Christian H; Scheidhauer, Klemens; Schwaiger, Markus; Ziegler, Sibylle; Eiber, Matthias
    Radiation Dosimetry for 177Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer : Absorbed Dose in Normal Organs and Tumor Lesions
    In: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 3, S. 445 - 450
  • Hadaschik, Boris; Herrmann, Ken
    Re: Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-ligand-PET/CT Before Salvage Lymph Node Dissection for Recurrent Prostate Cancer
    In: European Urology Jg. 72 (2017) Nr. 3, S. 470 - 471
  • Deuschl, Cornelius; Mönninghoff, Christoph; Göricke, Sophia Luise; Kirchner, Julian; Köppen, Susanne; Binse, Ina; Pöppel, Thorsten; Quick, Harald H.; Forsting, Michael; Umutlu, Lale; Herrmann, Ken; Hense, Jörg; Schlamann, Marc
    Response assessment of bevacizumab therapy in GBM with integrated 11C-MET-PET/MRI : a feasibility study
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 44 (2017) Nr. 8, S. 1285 - 1295
  • Lapa, Constantin; Kircher, Stefan; Schirbel, Andreas; Rosenwald, Andreas; Kropf, Saskia; Pelzer, Theo; Walles, Thorsten; Buck, Andreas K.; Weber, Wolfgang A.; Wester, Hans-Juergen; Herrmann, Ken; Lückerath, Katharina
    Targeting CXCR4 with [68Ga]Pentixafor : A suitable theranostic approach in pleural mesothelioma?
    In: OncoTarget Jg. 8 (2017) Nr. 57, S. 96732 - 96737
  • Barrio, Martin; Czernin, Johannes; Fanti, Stefano; Ambrosini, Valentina; Binse, Ina; Du, Lin; Eiber, Matthias; Herrmann, Ken; Fendler, Wolfgang P.
    The impact of somatostatin receptor-directed PET/CT on the management of patients with neuroendocrine tumor : A systematic review and meta-analysis
    In: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 5, S. 756 - 761
  • Herrmann, Ken; Larson, Steven M.; Weber, Wolfgang A.
    Theranostic concepts: More than just a fashion trend-introduction and overview
    In: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) S. 1S - 2S
  • Ceci, Francesco; Herrmann, Ken; Hadaschik, Boris; Castellucci, Paolo; Fanti, Stefano
    Therapy assessment in prostate cancer using choline and PSMA PET/CT
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 44 (2017) Nr. Suppl. 1, S. S78 - S83
  • Lapa, Constantin; Arias-Loza, Paula; Hayakawa, Nobuyuki; Wakabayashi, Hiroshi; Werner, Rudolf A; Chen, Xinyu; Shinaji, Tetsuya; Herrmann, Ken; Pelzer, Theo; Higuchi, Takahiro
    Whitening and Impaired Glucose Utilization of Brown Adipose Tissue in a Rat Model of Type 2 Diabetes Mellitus
    In: Scientific Reports Jg. 7 (2017) Nr. 1, S. 16795
  • Kirchner, Julian; Sawicki, Lino Morris; Suntharalingam, Saravanabavaan; Grueneisen, Johannes; Ruhlmann, Verena; Aktas, Bahriye; Deuschl, Cornelius; Herrmann, Ken; Antoch, Gerald; Forsting, Michael; Umutlu, Lale
    Whole-body staging of female patients with recurrent pelvic malignancies : Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CT
    In: PLoS ONE Jg. 12 (2017) Nr. 2, S. e0172553
  • Lapa, Constantin; Schreder, Martin; Schirbel, Andreas; Samnick, Samuel; Kortüm, Klaus Martin; Herrmann, Ken; Kropf, Saskia; Einsele, Herrmann; Buck, Andreas K; Wester, Hans-Jürgen; Knop, Stefan; Lückerath, Katharina
    [68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F]FDG and laboratory values
    In: Theranostics Jg. 7 (2017) Nr. 1, S. 205 - 212
  • Lapa, Constantin; Garcia-Velloso, Maria J; Lückerath, Katharina; Samnick, Samuel; Schreder, Martin; Otero, Paula Rodriguez; Schmid, Jan-Stefan; Herrmann, Ken; Knop, Stefan; Buck, Andreas K; Einsele, Hermann; San-Miguel, Jesus; Kortüm, Klaus Martin
    ¹¹C-Methionine-PET in Multiple Myeloma : A Combined Study from Two Different Institutions
    In: Theranostics Jg. 7 (2017) Nr. 11, S. 2956 - 2964
  • Eiber, Matthias; Herrmann, Ken; Fendler, Wolfgang P; Maurer, Tobias
    (68)Ga-labeled Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Imaging : The New Kid on the Block-Early or Too Early to Draw Conclusions?
    In: European Urology Jg. 70 (2016) Nr. 6, S. 938 - 940
  • Herrmann, Ken; Schottelius, Margret; Lapa, Constantin; Osl, Theresa; Poschenrieder, Andreas; Hänscheid, Heribert; Lückerath, Katharina; Schreder, Martin; Bluemel, Christina; Knott, Markus; Keller, Ulrich; Schirbel, Andreas; Samnick, Samuel; Lassmann, Michael; Kropf, Saskia; Buck, Andreas K.; Einsele, Hermann; Wester, Hans-Juergen; Knop, Stefan
    First-in-human experience of CXCR4-directed endoradiotherapy with ¹⁷⁷Lu-and ⁹⁰Y-labeled pentixather in advanced-stage multiple myeloma with extensive intra-and extramedullary disease
    In: Journal of Nuclear Medicine (JNM) Jg. 57 (2016) Nr. 2, S. 248 - 251
  • Bluemel, Christina; Linke, Fraenze; Herrmann, Ken; Simunovic, Iva; Eiber, Matthias; Kestler, Christian; Buck, Andreas K; Schirbel, Andreas; Bley, Thorsten A; Wester, Hans-Juergen; Vergho, Daniel; Becker, Axel
    Impact of (68)Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy
    In: EJNMMI Research Jg. 6 (2016) Nr. 1, 78
  • Wakabayashi, Hiroshi; Werner, Rudolf A; Hayakawa, Nobuyuki; Javadi, Mehrbod S; Xinyu, Chen; Herrmann, Ken; Rowe, Steven P; Lapa, Constantin; Higuchi, Takahiro
    Initial Preclinical Evaluation of 18F-Fluorodeoxysorbitol PET as a Novel Functional Renal Imaging Agent
    In: Journal of Nuclear Medicine (JNM) Jg. 57 (2016) Nr. 10, S. 1625 - 1628
  • Barrio, Martin; Fendler, Wolfgang P; Czernin, Johannes; Herrmann, Ken
    Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer
    In: Expert Review of Molecular Diagnostics Jg. 16 (2016) Nr. 11, S. 1177 - 1188
  • Barrio, Martin; Czernin, Johannes; Yeh, Michael W; Palma Diaz, Miguel F; Gupta, Pawan; Allen-Auerbach, Martin; Schiepers, Christiaan; Herrmann, Ken
    The incidence of thyroid cancer in focal hypermetabolic thyroid lesions : an 18F-FDG PET/CT study in more than 6000 patients
    In: Nuclear Medicine Communications Jg. 37 (2016) Nr. 12, S. 1290 - 1296
  • Lapa, Constantin; Knop, Stefan; Schreder, Martin; Rudelius, Martina; Knott, Markus; Jörg, Gerhard; Samnick, Samuel; Herrmann, Ken; Buck, Andreas K.; Einsele, Hermann; Lückerath, Katharina
    ¹¹C-methionine-PET in multiple myeloma : Correlation with clinical parameters and bone marrow involvement
    In: Theranostics Jg. 6 (2016) Nr. 2, S. 254 - 261
  • Philipp-Abbrederis, Kathrin; Herrmann, Ken; Knop, Stefan; Schottelius, Margret; Eiber, Matthias; Lückerath, Katharina; Pietschmann, Elke; Habringer, Stefan; Gerngroß, Carlos; Franke, Katharina; Rudelius, Martina; Schirbel, Andreas; Lapa, Constantin; Schwamborn, Kristina; Steidle, Sabine; Hartmann, Elena; Rosenwald, Andreas; Kropf, Saskia; Beer, Ambros J.; Peschel, Christian; Einsele, Hermann; Buck, Andreas K.; Schwaiger, Markus; Götze, Katharina; Wester, Hans-Jürgen; Keller, Ulrich
    In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma
    In: EMBO Molecular Medicine Jg. 7 (2015) Nr. 4, S. 477 - 487
  • Lückerath, Katharina; Lapa, Constantin; Albert, Christa; Herrmann, Ken; Jörg, Gerhard; Samnick, Samuel; Einsele, Herrmann; Knop, Stefan; Buck, Andreas K.
    ¹¹C-Methionine-PET : A novel and sensitive tool for monitoring of early response to treatment in multiple myeloma
    In: OncoTarget Jg. 6 (2015) Nr. 10, S. 8418 - 8429
  • Buder, Kristina; Lapa, Constantin; Kreissl, Michael C.; Schirbel, Andreas; Herrmann, Ken; Schnack, Alexander; Bröcker, Eva-Bettina; Goebeler, Matthias; Buck, Andreas K.; Becker, Jürgen
    Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imaging
    In: BMC Cancer Jg. 14 (2014) Nr. 1,
  • Lapa, Constantin; Lückerath, Katharina; Malzahn, Uwe; Samnick, Samuel; Einsele, Herrmann; Buck, Andreas K.; Herrmann, Ken; Knop, Stefan
    ¹⁸FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation
    In: OncoTarget Jg. 5 (2014) Nr. 17, S. 7381 - 7391
  • Caldarelli, Antonio; Müller, Jörg P.; Paskowski-Rogacz, M.; Herrmann, Ken; Bauer, Reinhard F.; Koch, Sina; Heninger, Anne Kristin; Krastev, Dragomir Blazhev; Ding, Li; Kasper, Stefan; Fischer, Thomas A.; Brodhun, Michael; Böhmer, Frank Dietmar; Buchholz, Frank
    A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signaling
    In: Leukemia Jg. 27 (2013) Nr. 12, S. 2301 - 2310